Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3021584	s-pappa	mU/l (mu/l)	14005	20368	0.00%
3021584	s-pappa	mU/L (mu/l)	8852	12893	0.00%
3021584	s-pappa	— (—)	6857	8582	100.00%	Distribution not available
3021584	s-plasmaproteiinia,raskauteenliittyvä	mU/l (mu/l)	991	1029	0.00%
3021584	s-plasmaproteiinia,raskauteenliittyvä	mU/L (mu/l)	468	484	0.00%
3021584	s-pappa	mU/L______ (mu/l)	368	466	0.00%
3021584	plasmaproteiinia,raskauteenliittyvä	mU/l (mu/l)	284	315	0.00%
3021584	s-plasmaproteiinia,raskauteenliittyvä	mU/L______ (mu/l)	160	174	0.00%
3021584	s-plasmaproteiinia,raskauteenliittyvä	mU/l______ (mu/l)	70	70	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Pregnancy examination and test

2840

730

36.59

307.65

1.7

1.3

950.45

995.55

mu/l

0.57

2305

625

Complications of labour and delivery

5998

11553

3.29

307.65

1.6

1.5

997.71

997.99

mu/l

0.01

5214

9846

Supervision of normal pregnancy

3071

735

32.24

307.65

1.7

1.3

978.78

991.43

mu/l

0.12

2715

630

Other complications of labour and delivery, not elsewhere classified

3356

10023

5.46

307.65

1.7

1.5

968.76

995.35

mu/l

0.76

2866

8521

Single spontaneous delivery

3754

1523

15.76

307.65

1.7

1.2

982.02

935.38

mu/l

0.75

3339

1224

Perineal laceration during delivery

3996

10903

4.56

307.65

1.6

1.5

1002.80

996.10

mu/l

0.15

3328

9262

False labour

4544

8359

4.32

307.65

1.7

1.4

1031.03

1020.42

mu/l

0.15

3912

7025

Other disorders of amniotic fluid and membranes

2143

7070

3.82

307.65

1.6

1.4

959.11

1023.63

mu/l

2.09

1849

5864

Labour and delivery complicated by fetal stress [distress]

4647

10842

3.81

307.65

1.6

1.5

1036.21

993.60

mu/l

0.79

3964

9182

Maternal care for known or suspected malpresentation of fetus

3135

7427

3.97

307.65

1.7

1.4

1003.47

1020.78

mu/l

0.39

2673

6174

Single delivery by caesarean section

3051

1453

17.40

307.65

1.6

1.2

1024.43

929.17

mu/l

1.46

2723

1162

Long labour

3307

10214

3.39

307.65

1.6

1.5

1040.88

997.51

mu/l

1.28

2806

8595

Obstructed labour due to malposition and malpresentation of fetus

2598

9530

2.98

307.65

1.6

1.5

1055.79

996.23

mu/l

1.63

2180

7964

Single delivery by forceps and vacuum extractor

2913

1424

19.40

307.65

1.6

1.2

1023.19

929.68

mu/l

1.94

2535

1137

Delivery, wide proxy

3770

697

36.57

307.65

1.6

1.1

981.03

925.01

mu/l

0.79

3349

610

Spontaneous abortion

4457

16169

2.03

307.65

1.8

1.5

924.50

1045.01

mu/l

12.10

3765

13757

Other obstetric conditions, not elsewhere classified

7464

17705

3.85

307.65

1.7

1.5

1022.62

1016.28

mu/l

0.12

6395

14918

Multiple delivery

439

558

8.87

307.65

1.6

1.2

1650.90

937.23

mu/l

9.54

360

416

Diabetes mellitus in pregnancy

6166

14181

3.69

307.65

1.6

1.5

869.60

1081.81

mu/l

30.93

5243

12002

Delivery

3929

1530

16.54

307.65

1.6

1.2

979.28

935.73

mu/l

0.68

3489

1230

Maternal care related to the fetus and amniotic cavity and possible delivery problems

5372

8472

4.50

307.65

1.7

1.4

993.46

1019.71

mu/l

0.81

4723

7125

Maternal care for known or suspected abnormality of pelvic organs

3800

7713

4.27

307.65

1.8

1.4

1018.82

1016.68

mu/l

0.02

3233

6436

Outcome of delivery

2795

707

35.94

307.65

1.7

1.3

1087.52

1000.31

mu/l

0.86

2003

605

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

7470

17700

3.90

307.65

1.7

1.5

1022.60

1015.89

mu/l

0.13

6405

14913

Contraceptive management

1371

734

13.82

307.65

1.6

1.3

1073.85

992.92

mu/l

0.81

1126

628

Gestational diabetes (for exclusion)

7074

19534

3.31

307.65

1.6

851.42

1077.85

mu/l

47.34

5898

16614

Premature rupture of membranes

3880

8016

4.73

307.65

1.6

1.4

1046.71

1023.67

mu/l

0.30

3434

6710

Maternal care for known or suspected fetal abnormality and damage

3044

7345

5.04

307.65

1.8

1.4

913.10

1020.41

mu/l

3.40

2557

6115

Factors influencing health status and contact with health services

589

256

11.84

307.65

1.6

1.3

975.90

1081.42

mu/l

0.84

512

224

Prolonged pregnancy

3189

7867

5.08

307.65

1.7

1.4

1010.97

1017.65

mu/l

0.14

2852

6586

Other maternal disorders predominantly related to pregnancy

6463

14407

3.28

307.65

1.7

1.5

932.84

1080.28

mu/l

16.80

5579

12213

Postpartum haemorrhage

4123

10855

4.11

307.65

1.7

1.5

1095.43

993.66

mu/l

5.88

3537

9192

Supervision of high-risk pregnancy

2812

721

31.65

307.65

1.7

1.3

965.93

1000.47

mu/l

0.38

2479

616

Maternal care for other known or suspected fetal problems

4609

8290

4.89

307.65

1.7

1.4

938.33

1021.03

mu/l

4.57

3912

6962

Antenatal screening

3298

737

34.14

307.65

1.6

1.3

980.11

991.76

mu/l

0.11

2935

631

Pregnancy, childbirth and the puerperium

2999

318

61.08

307.65

1.6

1.0

963.69

1085.02

mu/l

1.73

2656

289

Procreative management

1865

719

23.63

307.65

1.7

1.3

926.79

1000.64

mu/l

1.11

1650

616

Maternal care for other conditions predominantly related to pregnancy

2881

12944

2.60

307.65

1.7

1.5

972.00

1084.55

mu/l

7.58

2421

10873

Postpartum hemorraghe, all women as controls

4123

21608

2.25

307.65

1.7

1.6

1095.43

998.06

mu/l

5.83

3537

18191

Postpartum care and examination

3006

724

43.99

307.65

1.7

1.3

986.74

997.51

mu/l

0.09

2731

619

Persons encountering health services in circumstances related to reproduction

2901

740

28.68

307.65

1.6

1.3

967.17

993.06

mu/l

0.29

2547

634

Other abnormal products of conception

4261

15523

2.06

304.82

1.9

1.5

921.47

1045.59

mu/l

12.51

3595

13158

Abnormal findings on antenatal screening of mother

1811

8290

3.13

268.97

1.8

1.5

936.21

1092.73

mu/l

9.46

1684

7055

Failed induction of labour

1243

4815

3.85

260.29

1.5

926.39

998.50

mu/l

1.88

1108

4109

Female infertility

4013

13794

2.00

256.41

1.5

1.6

939.51

1034.39

mu/l

4.76

3528

11835

Haemorrhage in early pregnancy

2439

11810

2.22

245.96

1.7

1.5

945.37

1088.34

mu/l

8.75

2019

9838

Female infertility, cervical, vaginal, other or unspecified origin

3644

13334

2.00

237.47

1.5

1.6

927.79

1027.97

mu/l

8.12

3172

11410

Medical treatment for female infertility

3011

16834

2.08

226.91

1.5

1.6

904.29

1044.58

mu/l

13.89

2598

13836

Antepartum haemorrhage, not elsewhere classified

1033

3865

3.26

209.90

1.7

1.4

1012.76

1027.09

mu/l

0.16

876

3166

Use of hypnotics and sedatives

1394

17919

0.43

205.28

1.4

1.6

1035.90

1022.08

mu/l

0.16

1084

14836

Persons encountering health services for specific procedures and health care

2232

24805

0.52

196.87

1.5

1.6

1004.07

1016.18

mu/l

0.18

1859

21059

Complications predominantly related to the puerperium

2961

17160

1.94

196.40

1.7

1.6

1018.11

1018.41

mu/l

0.01

2406

14529

Statin medication

825

12682

0.35

195.07

1.4

1.5

913.77

1030.75

mu/l

2.57

594

10295

Pregnancy with abortive outcome

5190

17388

1.64

191.42

1.7

1.5

949.10

1041.91

mu/l

8.24

4427

14889

Finngen Rheumatological endpoints

2236

23580

0.52

188.90

1.5

1.6

989.36

1016.04

mu/l

0.68

1833

19947

Preterm labour and delivery

1425

6393

2.39

183.42

1.6

1.5

996.73

1007.35

mu/l

0.14

1193

5296

Diseases of oesophagus, stomach and duodenum

1821

20717

0.51

171.96

1.5

1.6

1006.43

1022.21

mu/l

0.10

1474

17396

Sleep apnoea, including avohilmo

977

14153

0.41

168.90

1.4

1.6

814.62

1036.16

mu/l

10.97

773

11609

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

3863

21339

1.68

165.76

1.6

867.79

1037.38

mu/l

24.71

3266

17901

Diabetes, insulin treatment (Kela reimbursement)

802

12273

0.38

163.42

1.5

1.6

782.87

1027.55

mu/l

12.24

621

10124

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

802

12112

0.38

159.85

1.5

1.6

782.87

1042.84

mu/l

13.65

621

9987

Tramadol

977

13640

0.42

156.97

1.5

1.6

963.87

1035.63

mu/l

1.22

754

11367

Exclusions for E4_PCOS_CONSORTIUM

2083

23127

0.54

155.59

1.5

1.6

1044.93

1012.22

mu/l

0.54

1717

19539

Pregnancy hypertension

3694

21194

1.67

155.35

1.6

856.27

1038.97

mu/l

28.12

3135

17748

Postpartum hemorraghe, parous women as controls

4123

23346

1.69

152.09

1.7

1.6

1095.43

1005.11

mu/l

4.91

3537

19745

Benzodiazepine use

2099

25123

0.55

151.80

1.4

1.6

1029.15

1015.13

mu/l

0.23

1694

21326

Polyhydramnios

658

2338

3.66

151.22

1.7

1.4

1040.25

1001.65

mu/l

0.16

582

1933

Oral corticosteroids

2203

22603

0.56

149.62

1.5

1.6

993.23

1019.52

mu/l

0.61

1803

19082

ILD medications: prednisolone, methylprednisolone, prednisone

2565

23985

0.58

149.31

1.5

1.6

991.78

1019.88

mu/l

0.74

2096

20388

Pre-eclampsia or poor fetal growth

3261

20700

1.72

148.11

1.7

1.6

925.10

1027.06

mu/l

7.36

2775

17295

Placenta praevia

582

1953

3.79

145.77

1.7

1.4

1130.33

996.18

mu/l

1.68

482

1594

Other obstetric trauma

733

2816

3.31

145.33

1.7

1.5

1083.58

993.91

mu/l

1.32

554

2357

Nerve, nerve root and plexus disorders

1891

20542

0.54

144.44

1.5

1.6

947.49

1020.08

mu/l

2.16

1544

17156

Other assisted single delivery

175

207

10.95

142.92

1.6

1.2

983.30

850.66

mu/l

0.89

132

154

Any event in cancer register

1948

20245

0.55

141.38

1.5

1.6

1038.21

1017.48

mu/l

0.34

1526

16940

Liveborn infants according to place of birth

105

27.64

134.88

2.0

1.2

953.86

810.19

mu/l

0.58

Metabolic disorders

895

12164

0.43

133.66

1.4

1.6

997.88

1021.58

mu/l

0.25

716

10070

Multiple gestation

800

3272

2.78

131.81

1.6

1.4

1713.18

1007.27

mu/l

10.18

665

2675

Twin gestation

779

3174

2.80

129.47

1.6

1.4

1698.27

1007.26

mu/l

9.52

648

2601

Cardiovascular diseases (excluding rheumatic etc)

2579

23667

0.60

128.48

1.5

1.6

1030.64

1017.36

mu/l

0.10

2130

20019

Pain in throat and chest

1882

19489

0.56

128.16

1.6

989.16

1017.42

mu/l

0.48

1510

16567

Influenza and pneumonia

2550

25412

0.60

126.86

1.6

979.60

1019.06

mu/l

1.06

2117

21587

Sleep apnoea

642

10218

0.39

125.55

1.4

1.5

776.25

1025.90

mu/l

8.36

506

8302

Other bacterial diseases, including avohilmo

1656

18564

0.54

123.35

1.6

955.02

1018.81

mu/l

1.76

1354

15629

Diabetes, varying definitions

2213

21314

0.59

122.57

1.6

741.00

1039.59

mu/l

51.31

1843

17879

Other heart diseases, wide

1917

19949

0.57

122.42

1.5

1.6

994.69

1018.73

mu/l

0.47

1575

16761

Diabetes mellitus

2268

21604

0.59

122.04

1.6

741.61

1038.96

mu/l

52.09

1883

18139

Other intervertebral disc disorders

1322

15006

0.51

120.02

1.5

1.6

915.14

1032.40

mu/l

4.27

1056

12513

All pneumoniae

2206

23611

0.59

119.50

1.6

978.22

1015.30

mu/l

0.98

1825

19948

Pneumonias (Asthma/COPD co-morbidities)

2185

23450

0.59

117.16

1.6

980.39

1015.16

mu/l

0.88

1810

19803

Symptoms and signs involving cognition, perception, emotional state and behaviour

1773

20501

0.56

116.36

1.6

1130.37

1010.20

mu/l

0.94

1434

17286

Malignant neoplasm, including Hilmo

949

11622

0.47

115.59

1.5

1024.35

1021.92

mu/l

0.02

701

9498

Artrosis, including avohilmo

834

10069

0.44

115.24

1.4

1.5

903.61

1033.65

mu/l

3.77

628

8016

Malignant neoplasm, wide definition

938

11503

0.47

114.85

1.5

1029.37

1021.28

mu/l

0.08

694

9392

Hypertensive diseases

622

8618

0.40

113.42

1.5

856.71

1030.36

mu/l

4.29

492

6912

Hypertension

622

8586

0.40

112.44

1.5

856.71

1030.06

mu/l

4.28

492

6887

Inflammatory bowel disease treatment related agents

2926

24813

0.64

111.85

1.5

1.6

990.20

1018.63

mu/l

0.82

2421

21081

Poor fetal growth

1971

12284

1.91

108.77

1.7

1.6

938.01

1022.96

mu/l

3.45

1686

10392

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2043

22314

0.60

108.70

1.6

973.93

1016.72

mu/l

1.16

1690

18804

Hypertensive diseases (excluding secondary)

622

8611

0.41

106.65

1.5

856.71

1027.92

mu/l

4.20

492

6946

Diabetes medication

2308

21399

0.62

105.30

1.6

730.87

1042.69

mu/l

60.07

1933

17944

Excessive vomiting in pregnancy

895

4332

2.41

102.89

1.6

1.5

1219.05

1075.50

mu/l

1.61

763

3672

Malignant neoplasm

822

10225

0.46

102.84

1.5

1046.08

1018.64

mu/l

0.32

599

8339

Solid cancers, including Hilmo

880

10630

0.47

102.73

1.5

1036.26

1019.99

mu/l

0.18

647

8657

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1579

18385

0.57

102.41

1.5

1.6

972.51

1013.61

mu/l

0.93

1321

15655

Intracranial trauma

1644

18803

0.57

101.58

1.6

960.03

1028.98

mu/l

2.43

1392

16113

Malignant neoplasm

818

10148

0.46

101.53

1.5

1047.33

1020.02

mu/l

0.31

598

8272

ILD medications

3100

24772

0.66

101.42

1.5

1.6

984.17

1019.02

mu/l

1.16

2551

21109

Gestational [pregnancy-induced] hypertension

2586

17041

1.64

100.26

1.6

825.07

1048.01

mu/l

32.84

2220

14183

Hypertension, essential

550

7586

0.40

98.55

1.5

816.48

1025.19

mu/l

5.55

439

6063

Retained placenta and membranes, without haemorrhage

670

2857

2.54

97.92

1.7

1.5

1007.84

998.55

mu/l

0.09

569

2373

Type 2 diabetes

1922

18090

0.60

96.94

1.6

693.51

1037.03

mu/l

66.56

1606

15082

Other puerperal infections

1368

8056

2.12

96.67

1.7

1.6

1019.28

1012.75

mu/l

0.08

1135

6884

Periodontitis

1449

16093

0.56

96.65

1.5

1.6

984.76

1025.59

mu/l

0.70

1156

13413

Chronic periodontitis, including avohilmo

1445

16015

0.56

95.22

1.5

1.6

984.74

1026.12

mu/l

0.71

1153

13350

Fall on same level

3219

24892

0.68

93.59

1.6

955.02

1022.51

mu/l

3.42

2654

21183

Conjunctivitis (acute, non atopic), including avohilmo

4362

18820

1.43

93.34

1.6

1019.65

1023.58

mu/l

0.07

3692

16030

Other diseases of intestines

3080

25026

0.67

93.02

1.5

1.6

1029.01

1013.32

mu/l

0.38

2573

21262

All kidney diseases

2418

24567

0.65

90.79

1.6

1001.39

1017.62

mu/l

0.34

2025

20840

Female infertility, associated with anovulation

1515

9343

1.99

90.48

1.6

970.53

1031.93

mu/l

0.80

1321

7933

Solid cancers

760

9277

0.47

89.73

1.5

1058.01

1021.86

mu/l

0.42

551

7525

Autoimmune diseases excluding thyroid diseases, strict definition

2665

21593

0.66

89.28

1.5

1.6

1013.19

1024.16

mu/l

0.23

2215

18407

Abnormalities of breathing

2618

22295

0.66

88.60

1.5

1.6

1040.14

1017.13

mu/l

0.19

2149

19019

Pain in limb

2339

22561

0.64

88.44

1.6

984.56

1019.29

mu/l

0.47

1908

19263

Dentofacial anomalies [including malocclusion]

4066

22947

1.43

87.98

1.6

1012.25

1017.84

mu/l

0.12

3483

19328

Autoimmune diseases excluding thyroid diseases

2723

21832

0.66

87.93

1.5

1.6

1010.61

1024.18

mu/l

0.30

2262

18603

Polyarthropathies

1180

13562

0.55

87.58

1.5

1.6

1002.38

1022.77

mu/l

0.31

958

11417

Pneumonia, organism unspecified

1725

19096

0.61

85.79

1.5

1.6

975.04

1020.82

mu/l

1.10

1416

16070

Shoulder lesions

590

7864

0.44

83.82

1.5

999.36

1027.53

mu/l

0.30

473

6418

First line medication for Crohn's disease

3207

24540

0.69

83.66

1.5

1.6

982.50

1019.74

mu/l

1.31

2652

20897

Codeine or tramadol medication

3147

24359

0.69

83.06

1.5

1.6

952.43

1023.67

mu/l

2.69

2527

20762

Other obstructed labour

517

2142

2.68

81.96

1.7

1.5

1012.92

1014.71

mu/l

0.01

445

1767

Chronic apical periodontitis

3093

24696

0.69

81.62

1.6

1006.25

1016.68

mu/l

0.09

2537

21009

Arthrosis

464

6149

0.41

81.06

1.4

1.5

915.61

1033.03

mu/l

1.99

350

4916

Abnormalities of forces of labour

596

2653

2.43

79.20

1.7

1.5

1029.63

986.62

mu/l

0.35

481

2173

Tonsillectomy and adenotomy

4272

22068

1.40

78.01

1.6

1005.82

1019.14

mu/l

0.31

3581

18719

Infections of genitourinary tract in pregnancy

966

5282

2.07

78.01

1.6

1.5

1047.84

1082.72

mu/l

0.37

846

4480

Other bacterial diseases

1160

13388

0.56

77.32

1.6

968.24

1009.72

mu/l

0.78

950

11306

Antihypertensive medication - note that there are other indications

3298

23882

0.70

77.13

1.5

1.6

938.37

1027.07

mu/l

5.08

2747

20470

Disorders of gallbladder, biliary tract and pancreas

1512

15319

0.60

76.76

1.5

1.6

856.88

1032.86

mu/l

8.05

1221

12670

Condition for Implicit Sepsis (Organ dysfunction codes)

1229

14524

0.58

76.17

1.5

1.6

985.04

1011.90

mu/l

0.41

1030

12356

Atopic dermatitis

3843

22467

1.40

75.55

1.6

995.89

1018.05

mu/l

0.35

3267

19040

Leiomyoma of uterus

680

7747

0.48

75.14

1.4

1.5

945.18

1028.84

mu/l

1.19

544

6060

Labour and delivery complicated by umbilical cord complications

402

1555

2.96

74.76

1.7

1.5

1044.93

1014.98

mu/l

0.22

334

1269

Codeine

3068

23258

0.70

74.43

1.5

1.6

955.74

1024.69

mu/l

2.53

2476

19914

Type 2 diabetes, definitions combined, including avohilmo

1738

15715

0.63

73.64

1.6

683.73

1043.52

mu/l

64.52

1455

13120

Cardiac arrhythmias

1546

15720

0.61

72.04

1.5

1.6

987.02

1040.84

mu/l

1.24

1270

13199

Other antidepressants

2635

19315

0.68

71.84

1.5

1.6

1008.61

1021.33

mu/l

0.22

2094

16640

Asthma/COPD (KELA code 203)

2538

24317

0.68

70.92

1.5

1.6

975.01

1019.55

mu/l

1.62

2135

20662

Caries of enamel

4173

20333

1.37

70.47

1.6

1028.85

1018.57

mu/l

0.18

3487

17271

Substance abuse, excluding more controls

1009

14711

0.56

69.96

1.5

1.6

941.72

1008.59

mu/l

1.33

819

12669

Acute upper respiratory infections of multiple and unspecified sites

3761

20216

1.39

69.70

1.6

976.43

1026.52

mu/l

2.08

3087

17271

Personality disorders, excluding more controls

894

15650

0.54

67.94

1.5

1.6

987.11

1015.22

mu/l

0.33

709

13498

Complications of surgical and medical care, not elsewhere classified

2179

21233

0.67

67.05

1.5

1.6

1015.47

1022.06

mu/l

0.05

1762

17823

Schizophrenia or delusion, excluding more controls

456

9906

0.44

66.94

1.5

1.6

1054.87

1004.61

mu/l

0.44

384

8510

Kela-code for severe mental illness

523

10913

0.46

65.98

1.5

1.6

961.35

1008.67

mu/l

0.47

438

9252

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2221

18865

0.68

65.91

1.6

979.07

1034.75

mu/l

1.73

1844

16135

2221

18865

0.68

65.91

1.6

979.07

1034.75

mu/l

1.73

1844

16135

Disorders of adult personality and behaviour

929

16020

0.55

65.80

1.5

1.6

989.43

1008.66

mu/l

0.22

744

13801

Spondylopathies

636

7493

0.50

65.80

1.5

1.6

971.66

1021.12

mu/l

0.67

533

6140

Type 2 diabetes, strict (exclude DM1)

1703

15120

0.64

64.24

1.6

683.61

1042.45

mu/l

62.57

1435

12626

Type 2 diabetes, definitions combined

1704

15122

0.65

64.16

1.6

683.39

1042.73

mu/l

62.80

1436

12627

Other (not insulin) diabetes medications

1765

15682

0.65

64.10

1.6

685.50

1045.61

mu/l

65.66

1488

13106

Implicit Sepsis, including avohilmo

1183

13910

0.60

63.72

1.6

964.00

1009.48

mu/l

0.92

992

11832

Lower back pain or/and sciatica

2941

25089

0.72

62.77

1.5

1.6

948.20

1021.99

mu/l

3.57

2379

21387

Unspecified mental disorder

775

13887

0.54

60.64

1.5

1.6

970.35

1008.40

mu/l

0.51

642

11787

Constipation

1121

12530

0.60

60.47

1.5

1.6

1100.77

1000.13

mu/l

2.54

891

10500

Injuries to the head

3115

24994

0.73

60.00

1.6

990.13

1018.05

mu/l

0.88

2621

21214

Other specific joint derangements/joint disorders

2668

22918

0.71

59.73

1.5

1.6

969.16

1020.16

mu/l

1.92

2178

19610

Type 2 diabetes, wide definition

314

4922

0.40

59.06

1.4

1.5

621.08

1042.96

mu/l

26.52

251

3996

Other disorders of ear

1195

12440

0.61

58.05

1.6

1027.33

1012.69

mu/l

0.16

981

10477

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1266

12677

0.62

57.03

1.6

1.5

1108.45

1024.50

mu/l

0.40

1029

10330

Pre-eclampsia

1500

9900

1.61

56.76

1.6

893.90

1039.03

mu/l

6.94

1267

8279

Other heart diseases

936

10268

0.58

56.34

1.5

1.6

978.19

1024.12

mu/l

0.85

772

8597

Pre-eclampsia or eclampsia

1522

10079

1.60

56.32

1.6

892.95

1041.10

mu/l

7.31

1280

8427

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2698

23282

0.72

55.97

1.7

1.6

955.44

1020.00

mu/l

2.93

2338

19605

Low back pain

2367

22188

0.71

55.38

1.5

1.6

948.81

1024.57

mu/l

3.52

1909

18962

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2109

20079

0.70

53.83

1.6

1075.20

1014.17

mu/l

0.61

1726

16849

Renal tubulo-interstitial diseases

2024

21045

0.69

53.80

1.6

1009.62

1016.50

mu/l

0.11

1708

17864

Concussion

1570

17987

0.66

53.29

1.6

953.40

1028.70

mu/l

2.70

1332

15418

Disorders of tooth development and eruption

1090

5439

1.71

53.18

1.6

992.50

1020.68

mu/l

0.44

945

4621

Personality disorders

894

14730

0.58

52.95

1.5

1.6

987.11

1009.46

mu/l

0.25

709

12677

Schizophrenia or delusion

456

9220

0.48

52.60

1.5

1.6

1054.87

1006.05

mu/l

0.42

384

7853

Schizophrenia, schizotypal and delusional disorders

456

9215

0.48

52.50

1.5

1.6

1054.87

1005.76

mu/l

0.43

384

7849

Special screening examination for infectious and parasitic diseases

2318

12191

1.45

52.30

1.5

1.6

1055.95

1018.40

mu/l

0.84

1932

10342

Disorders of lipoprotein metabolism and other lipidaemias

292

4317

0.41

51.93

1.4

1.5

979.34

1002.90

mu/l

0.10

230

3509

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

799

8672

0.57

51.82

1.6

1.5

1193.78

1024.88

mu/l

0.59

679

7100

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

4220

21108

1.30

50.90

1.6

992.77

1022.67

mu/l

0.86

3495

17971

Complications of the puerperium, not elsewhere classified

559

3003

2.25

50.82

1.6

1003.27

1002.89

mu/l

0.00

493

2529

Infections of breast associated with childbirth

540

2894

2.31

50.53

1.7

1.6

1051.22

996.01

mu/l

0.69

456

2458

Injuries to the shoulder and upper arm

1334

15608

0.65

50.11

1.6

981.21

1005.94

mu/l

0.48

1084

13396

Bleeding

678

8507

0.55

49.92

1.5

1.6

1117.28

1009.31

mu/l

0.33

550

7190

Lumbar disc prolapse

1008

11983

0.61

49.26

1.5

1.6

927.79

1032.81

mu/l

2.59

810

9895

Cholelithiasis, broad definition with cholecystitis

1363

13678

0.65

49.15

1.5

1.6

847.98

1035.63

mu/l

8.02

1103

11246

Dyspnoea

1728

17910

0.69

48.73

1.5

1.6

1075.27

1016.64

mu/l

0.37

1405

15078

Hard cardiovascular diseases

242

3625

0.39

47.51

1.5

1055.31

994.69

mu/l

0.36

191

2908

Hyperkinetic disorders, excluding more controls

944

13632

0.59

47.34

1.5

1.6

1062.78

1012.78

mu/l

0.56

756

11959

Specific personality disorders

815

13331

0.58

47.22

1.5

1.6

983.72

1009.93

mu/l

0.28

648

11485

Placental disorders

153

467

4.72

46.97

1.7

1.4

1694.93

1040.33

mu/l

0.50

124

387

Disorders of eyelid, lacrimal system and orbit

1622

17130

0.68

46.76

1.5

1.6

1045.70

1013.97

mu/l

0.60

1323

14346

Other nutritional deficiencies

3415

24160

1.32

46.72

1.6

692.45

1058.95

mu/l

75.82

2825

20521

Heart failure, not strict

136

2947

0.31

44.87

1.4

1.5

935.33

1009.56

mu/l

0.41

106

2388

Biguanides

1715

14709

0.69

44.56

1.6

686.52

1038.59

mu/l

60.55

1449

12312

Other and unspecified nonorganic psychotic disorders

360

7347

0.47

43.69

1.5

1.6

1061.62

993.05

mu/l

0.53

305

6262

Personal history of other diseases and conditions

1101

7223

1.65

43.46

1.9

1.6

931.04

1013.44

mu/l

2.16

991

6151

Migraine, single triptan purchase ok & required. ICD-code if available is included

3989

21443

1.28

43.13

1.5

1.6

992.96

1018.34

mu/l

0.82

3360

18308

Triptan medication for migraine, single purchase ok

3989

21443

1.28

43.13

1.5

1.6

992.96

1018.34

mu/l

0.82

3360

18308

Any reimbursement code in KELA

3143

20271

0.76

43.05

1.5

1.6

961.19

1025.59

mu/l

2.79

2629

17377

Polycystic ovarian syndrome, broad definition

1794

13283

1.52

42.74

1.6

949.26

1015.09

mu/l

1.11

1552

11390

Habitual aborter

372

1891

2.61

42.20

2.0

1.6

806.80

1036.90

mu/l

5.76

317

1562

Implicit Sepsis

949

10988

0.63

42.01

1.5

1.6

936.15

1010.03

mu/l

1.71

790

9372

Menorrhagia

1269

10399

0.66

41.95

1.5

1.6

1019.83

1041.01

mu/l

0.18

1003

8743

Hernia

1367

13262

0.68

41.63

1.6

1033.32

1025.46

mu/l

0.08

1110

11001

Cholelithiasis

1340

13294

0.68

40.13

1.5

1.6

845.24

1034.68

mu/l

7.91

1081

10918

Intrahepatic Cholestasis of Pregnancy (ICP)

781

4906

1.79

39.66

1.6

991.12

1011.33

mu/l

0.24

650

4111

Care involving use of rehabilitation procedures

872

12343

0.63

39.59

1.5

1.6

1037.16

1003.77

mu/l

0.31

708

10386

Diseases of middle ear and mastoid

3671

23999

1.28

38.61

1.6

979.08

1019.80

mu/l

0.99

3125

20330

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

781

4906

1.75

38.40

1.6

991.12

1011.33

mu/l

0.24

650

4111

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

601

3513

1.87

38.07

1.5

774.44

1030.22

mu/l

11.12

499

2853

Disorders of choroid and retina

570

6935

0.57

37.76

1.5

1.6

939.49

1012.38

mu/l

1.13

456

5782

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1700

19898

0.70

37.61

1.5

1.6

1017.21

1011.77

mu/l

0.07

1408

17400

Schizophrenia

2904

0.24

37.45

1.4

1.6

1438.74

992.36

mu/l

1.14

2434

Ectopic pregnancy

923

5996

1.61

36.69

1.6

1.5

966.35

1058.21

mu/l

1.90

735

5040

Gonarthrosis

216

2909

0.42

36.59

1.4

1.5

866.84

1021.09

mu/l

1.96

165

2257

Premature separation of placenta [abruptio placentae]

181

677

3.07

36.26

1.8

1.4

1567.09

1032.51

mu/l

0.49

150

558

Dizziness and giddiness

1315

14599

0.69

36.19

1.6

1147.27

1013.32

mu/l

0.77

1054

12288

ILD medications: immunosuppressive drugs

1410

17903

0.70

35.67

1.5

1.6

1026.94

1020.13

mu/l

0.09

1149

15048

Endometriosis diagnosis and infertility diagnosis occurring together

893

5877

1.64

35.34

1.4

1.6

895.11

1035.56

mu/l

5.39

753

4840

Emotionally unstable personality disorder

570

9346

0.57

35.29

1.5

1.6

996.05

1007.47

mu/l

0.08

450

8095

Rotator cuff syndrome

301

4280

0.48

35.22

1.4

1.5

876.54

1030.63

mu/l

2.84

244

3456

Mental and behavioural disorders due to psychoactive substance use

1054

14232

0.67

35.18

1.5

1.6

938.23

1012.06

mu/l

1.65

862

12197

Acute upper respiratory infections

4153

20218

1.25

35.10

1.6

1008.69

1026.52

mu/l

0.44

3446

17271

Asthma, unspecified (mode), excluding more controls

1190

12286

0.68

34.96

1.5

1.6

964.16

1042.85

mu/l

2.10

978

10489

Insomnia

4043

22897

1.25

34.65

1.5

1.6

1021.39

1012.99

mu/l

0.19

3400

19483

Other disorders of breast and lactation associated with childbirth

347

1900

2.60

34.29

1.8

1.6

1107.11

1012.91

mu/l

0.77

204

1614

Inflammatory disorders of breast

754

4877

1.74

34.25

1.8

1.6

1062.37

1007.11

mu/l

0.65

664

4176

Gonarthrosis [arthrosis of knee](FG)

216

2875

0.43

33.94

1.4

1.5

866.84

1018.99

mu/l

1.93

165

2233

939

12237

0.66

33.84

1.5

1.6

930.04

1012.14

mu/l

1.89

771

10500

Malaise and fatigue

901

10725

0.65

33.83

1.5

1.6

1020.27

1014.89

mu/l

0.04

724

9155

Erysipelas, including avohilmo

575

7163

0.59

33.76

1.5

1.6

822.62

1013.88

mu/l

4.60

449

5981

Opioids

3712

23606

0.80

33.74

1.5

1.6

972.00

1023.49

mu/l

0.91

3023

20240

Any event in hilmo or specialist outpatient

+∞

33.66

1.7

0.0

905.34

—

mu/l

—

Asthma, unspecified (mode)

1190

12291

0.69

33.37

1.5

1.6

964.16

1042.79

mu/l

2.10

978

10492

Anaemias

1272

11396

0.69

33.30

1.6

1132.30

1032.25

mu/l

0.65

1056

9899

Any mental disorder

3028

19083

0.79

32.97

1.5

1.6

1025.25

1015.28

mu/l

0.16

2524

16311

Ischemic heart diseases

200

2778

0.43

32.23

1.5

952.82

1017.72

mu/l

0.47

160

2235

Pure hypercholesterolaemia

237

3278

0.46

32.02

1.4

1.6

875.97

1001.21

mu/l

1.35

190

2676

Other soft tissue disorders, not elsewhere classified

3218

22706

0.79

31.78

1.6

999.41

1019.06

mu/l

0.30

2641

19401

Chronic lower respiratory diseases

3779

24319

0.81

31.67

1.5

1.6

985.75

1019.56

mu/l

1.25

3166

20664

Substance abuse

1009

13650

0.68

31.62

1.5

1.6

941.72

1011.27

mu/l

1.41

819

11699

Bipolar affective disorders

618

9785

0.61

31.12

1.4

1.6

1010.63

1002.74

mu/l

0.04

504

8397

Exposure to unspecified factor

2967

25144

0.79

30.97

1.6

994.53

1017.32

mu/l

0.26

2434

21403

Major coronary heart disease event

132

2154

0.36

30.81

1.5

1025.14

1040.48

mu/l

0.06

105

1717

Malignant neoplasm of breast, including Hilmo

226

3137

0.46

30.43

1.4

1.5

1072.94

1021.76

mu/l

0.29

157

2451

Malignant neoplasm of breast, HER2-negative, including Hilmo

227

3145

0.46

30.39

1.4

1.5

1068.32

1022.36

mu/l

0.26

158

2458

Phobic anxiety disorders

606

9481

0.60

30.35

1.5

1.6

1158.23

1002.45

mu/l

1.11

500

8270

Conductive and sensorineural hearing loss

532

5898

0.59

30.14

1.5

1.6

1077.22

1004.16

mu/l

0.59

446

4922

Oxicams

300

3320

0.50

29.76

1.4

1.6

1072.01

1121.76

mu/l

0.21

237

2780

Disturbance of activity and attention

923

12792

0.66

29.44

1.5

1.6

1068.56

1008.36

mu/l

0.71

740

11164

Medical abortion

3862

17224

1.24

29.40

1.6

1.5

1039.28

1042.83

mu/l

0.04

3171

14735

Malignant neoplasm of breast

201

2893

0.44

29.34

1.3

1.5

1103.03

1008.87

mu/l

0.58

138

2253

Hyperkinetic disorders

945

13031

0.66

29.27

1.5

1.6

1062.99

1007.34

mu/l

0.66

757

11364

Other neurological diseases

679

8175

0.64

28.59

1.5

1.6

1060.11

1011.48

mu/l

0.55

566

6831

Hypothyroidism, drug reimbursement

434

5154

0.56

28.56

1.5

1.6

919.88

1034.62

mu/l

1.44

345

4335

Artificial joint operation, meniscal resection

530

5597

0.60

28.56

1.5

1.6

1160.54

1001.34

mu/l

0.40

437

4638

Malignant neoplasm of breast, HER2-negative

202

2870

0.45

28.47

1.3

1.5

1097.57

1010.65

mu/l

0.52

139

2235

Emergency coronary revascularization (for ACS)

122

2005

0.37

28.41

1.5

983.00

1027.66

mu/l

0.20

1596

Venous complications and haemorrhoids in pregnancy

212

984

2.61

28.30

1.7

1.5

1660.35

1069.37

mu/l

0.56

179

806

883

11536

0.67

28.27

1.5

1.6

931.29

1012.60

mu/l

1.73

726

9921

Sleep disorders

3892

22186

1.22

28.26

1.5

1.6

1014.38

1012.34

mu/l

0.04

3281

18896

Coronary revascularization (ANGIO or CABG)

122

2006

0.37

28.09

1.5

983.00

1027.48

mu/l

0.20

1598

Percutaneous Coronary Intervention

122

2002

0.37

27.90

1.5

983.00

1027.12

mu/l

0.19

1596

Chronic diseases of tonsils and adenoids

3693

19196

1.23

27.88

1.6

1016.30

1022.52

mu/l

0.09

3090

16415

Dental pulpitis, including avohilmo

4358

23375

1.21

27.80

1.6

979.32

1023.50

mu/l

0.79

3633

19907

Any death

1502

0.23

27.71

1.2

1.5

893.54

1012.49

mu/l

0.39

1214

Disorders of psychological development

502

7425

0.59

27.00

1.6

1101.67

980.28

mu/l

0.82

430

6567

Suicide or other Intentional self-harm

573

8991

0.62

27.00

1.5

1.6

938.91

999.58

mu/l

0.89

457

7725

Injuries to the knee and lower leg

3746

24364

0.82

26.91

1.5

1.6

976.25

1020.84

mu/l

0.83

3105

20731

Selective serotonin reuptake inhibitors

3023

19315

0.80

26.80

1.5

1.6

1010.69

1021.33

mu/l

0.17

2548

16640

Depression medications

1827

11866

0.75

26.73

1.5

1.6

1024.06

1029.25

mu/l

0.07

1514

10326

Cystitis

4022

19945

1.21

26.66

1.5

1.6

1058.20

998.64

mu/l

1.67

3341

17041

Endometriosis

1710

12904

0.75

26.51

1.5

1.6

976.18

1029.94

mu/l

1.53

1417

11021

Psychiatric diseases

2680

16692

0.80

26.33

1.5

1.6

1020.74

1012.83

mu/l

0.14

2242

14285

Social phobias

366

6218

0.55

26.09

1.5

1.6

1046.17

999.46

mu/l

0.34

294

5431

Persistent mood disorders

324

5827

0.54

26.08

1.4

1.6

931.44

989.65

mu/l

0.62

258

4983

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4065

18014

1.21

25.90

1.5

1.6

1016.64

1024.82

mu/l

0.15

3453

15155

Sensorineural hearing loss

377

4390

0.57

25.50

1.5

1.6

1074.87

1004.34

mu/l

0.39

311

3647

All anxiety disorders

3482

22460

1.22

25.21

1.5

1.6

1007.82

1015.70

mu/l

0.13

2853

19166

Other disorders of urethra and urinary system

2112

18562

0.78

25.21

1.6

1012.81

1000.51

mu/l

0.24

1694

15846

Autoimmune diseases related-to ILD

2315

24096

0.79

24.84

1.6

999.83

1015.49

mu/l

0.34

1966

20330

Gastro-oesophageal reflux disease

963

11438

0.70

24.72

1.5

1.6

959.77

1017.25

mu/l

1.21

774

9539

Behavioural syndromes associated with physiological disturbances and physical factors

3907

22188

1.20

24.38

1.5

1.6

1029.47

1012.37

mu/l

0.45

3282

18898

Other retinal disorders

427

5393

0.60

24.18

1.5

1.6

918.50

1012.91

mu/l

1.32

341

4491

Other arthrosis

178

2571

0.46

23.67

1.4

1.5

866.78

1017.14

mu/l

1.93

136

2041

Alcohol use disorder, Swedish definition

700

9385

0.67

23.46

1.5

1.6

920.86

1012.14

mu/l

1.64

571

8005

Oxycodone

2280

0.36

23.44

1.3

1.6

981.54

1022.28

mu/l

0.11

1855

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

484

7581

0.62

23.26

1.5

1.6

947.16

999.48

mu/l

0.62

391

6495

Wide developmental disorders, excluding more controls

2064

0.31

23.04

1.5

1.6

1041.82

987.56

mu/l

0.13

1835

STROKE

249

3193

0.52

22.90

1.5

1010.55

1009.47

mu/l

0.01

201

2592

Meniscus derangement

364

4131

0.58

22.87

1.6

1323.90

1017.60

mu/l

0.55

284

3373

Other arrhythmias

1227

12259

0.74

22.71

1.5

1.6

1000.23

1015.96

mu/l

0.20

1006

10280

Gonarthrosis,primary

142

1976

0.43

22.44

1.4

1.5

931.76

1014.17

mu/l

0.56

112

1511

Symptoms and signs involving the urinary system

1008

10456

0.72

22.20

1.6

997.10

1005.41

mu/l

0.10

814

8871

Schizoaffective disorder

2281

0.34

22.19

1.3

1.6

1065.12

999.14

mu/l

0.17

1919

Polyp of the female genital tract

701

5797

0.67

22.05

1.5

1.6

998.55

1053.52

mu/l

0.71

567

4706

Cerebrovascular diseases

231

3078

0.52

21.85

1.5

1.6

1074.64

998.86

mu/l

0.47

180

2505

Poisoning by drugs, medicaments and biological substances

727

10381

0.68

21.63

1.5

1.6

964.86

1008.71

mu/l

0.63

592

8910

Disorders of lens

123

1829

0.41

21.51

1.5

1.6

843.72

1019.87

mu/l

1.91

1477

Bronchitis

4493

23113

1.18

21.28

1.6

964.43

1025.33

mu/l

3.19

3700

19694

Mental and behavioural disorders due to alcohol

783

10548

0.70

21.02

1.5

1.6

935.30

1008.81

mu/l

1.31

641

9059

Uterine polyps

525

4700

0.64

21.02

1.5

952.56

1042.35

mu/l

1.32

423

3783

Disorders of synovium and tendon

1329

14688

0.76

20.77

1.5

1.6

1003.40

1018.69

mu/l

0.17

1093

12352

Autism spe, excluding more controls

1670

0.27

20.58

1.5

1.6

1166.62

980.19

mu/l

0.42

1478

Injuries to the elbow and forearm

1948

20733

0.80

20.40

1.6

980.30

1014.31

mu/l

0.80

1670

17841

Diseases of arteries, arterioles and capillaries

281

3652

0.56

20.33

1.5

1.6

1078.99

1001.49

mu/l

0.61

234

3013

Cardiovascular diseases

3791

23501

0.84

20.33

1.6

1028.15

1012.44

mu/l

0.18

3178

20099

Asthma (diagnoses ohter than nonallergic)

2582

25171

0.82

20.30

1.6

955.42

1022.30

mu/l

3.34

2161

21374

Poisoning by medicine

673

9622

0.68

20.27

1.5

1.6

961.10

1007.20

mu/l

0.65

547

8252

Other degenerative diseases of the nervous system

251

3329

0.54

20.19

1.4

1.6

1041.30

1013.17

mu/l

0.17

200

2764

Disorders of thyroid, IBD co-morbidities

874

8192

0.71

20.14

1.6

928.92

1066.02

mu/l

4.26

712

6981

Maternal care for cervical incompetence

303

1767

1.89

19.97

1.8

1.6

1105.90

1012.80

mu/l

0.90

271

1504

Carpal tunnel syndrome

782

9495

0.71

19.66

1.5

1.6

828.46

1025.04

mu/l

9.32

632

7733

Wide developmental disorders

1930

0.34

19.05

1.5

1.6

1041.82

966.08

mu/l

0.19

1692

Autism

1633

0.29

18.85

1.5

1.6

1131.23

965.95

mu/l

0.37

1430

Cerebrovascular diseases (FINNGEN)

187

2556

0.51

18.84

1.4

1.5

1027.68

993.54

mu/l

0.16

144

2068

Complications of procedures, not elsewhere classified

1914

19027

0.80

18.72

1.5

1.6

1010.48

1022.57

mu/l

0.08

1543

15887

Autism spe

1583

0.29

18.41

1.5

1.6

1166.62

973.06

mu/l

0.44

1389

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

3422

22731

1.19

18.24

1.5

1.6

1034.24

1008.70

mu/l

0.69

2825

19202

Obesity

3011

24003

1.20

18.21

1.6

631.07

1056.52

mu/l

95.14

2463

20366

Migraine

3430

22851

1.19

18.20

1.5

1.6

987.73

1020.39

mu/l

1.03

2818

19528

Generalized anxiety disorder

1034

13443

0.74

18.13

1.5

1.6

1025.79

1002.12

mu/l

0.29

866

11748

Obesity and other hyperalimentation

3015

24016

1.20

18.09

1.6

631.82

1056.64

mu/l

95.02

2466

20377

Headache

3199

21008

1.19

17.94

1.6

976.53

1019.41

mu/l

1.43

2679

17916

Infections, IBD-co-morbidities

262

3174

0.57

17.73

1.5

1.6

1074.09

1053.11

mu/l

0.11

215

2697

Nonorganic sleeping disorders, excluding more controls

793

10756

0.72

17.55

1.5

1.6

1014.22

1007.98

mu/l

0.05

649

9306

Puerperal sepsis

405

2585

1.61

17.32

1.7

1.6

989.88

1002.45

mu/l

0.09

328

2150

Other disorders of skin and subcutaneous tissue

1090

12028

0.76

17.28

1.5

1.6

1019.28

1016.44

mu/l

0.03

893

10088

Dislocation, sprain and strain of joints and ligaments of knee

1970

21659

0.81

17.19

1.5

1.6

997.00

1022.33

mu/l

0.19

1616

18419

Sciatica+with lumbago

1011

11789

0.75

17.15

1.5

1.6

956.64

1030.01

mu/l

1.21

804

9831

Anxiety (asthma-related co-morbidities)

3260

21194

1.18

17.12

1.5

1.6

1010.75

1016.71

mu/l

0.09

2666

18117

Other specified and unspecified personality disorders

192

3510

0.52

17.09

1.6

930.51

1006.53

mu/l

0.57

151

2975

KRA_PSY_EATING, excluding more controls

812

10530

0.71

16.79

1.6

1105.93

1000.83

mu/l

2.56

673

9265

All chronic kidney diseases

609

6906

0.70

16.67

1.6

995.24

1000.64

mu/l

0.05

534

5848

Bacterial infection, other or unspecified, including avohilmo

624

7238

0.70

16.64

1.6

970.75

1006.93

mu/l

0.43

514

6110

Ovarian hyperstimulation (induction)

247

1492

2.00

16.15

1.5

1.6

941.89

1047.95

mu/l

0.89

213

1235

Symptoms and signs involving the nervous and musculoskeletal systems

1089

14064

0.77

16.11

1.5

1.6

1053.88

1006.93

mu/l

0.73

924

11859

Fever of other and unknown origin

1437

15561

0.79

16.10

1.6

946.57

1020.39

mu/l

1.80

1193

13296

Complications associated with artificial fertilization

262

1610

1.94

15.98

1.5

1.6

945.02

1036.15

mu/l

0.73

224

1338

General examination and investigation of persons without complaint and reported diagnosis

1934

12231

0.81

15.98

1.5

1.6

970.37

1018.16

mu/l

1.17

1661

10377

Polycystic ovarian syndrome, consortium definition

3694

24338

0.86

15.93

1.6

983.51

1019.57

mu/l

1.28

3058

20726

Osteopathies and chondropathies

784

9671

0.73

15.76

1.5

1.6

979.96

1007.18

mu/l

0.26

647

8205

Family history of certain disabilities and chronic diseases leading to disablement

437

2961

1.59

15.56

1.9

1.6

906.32

990.10

mu/l

1.30

399

2506

Other symptoms and signs involving the nervous and musculoskeletal systems

852

11290

0.74

15.40

1.5

1.6

1040.29

1008.52

mu/l

0.37

727

9505

Mood disorders, excluding more controls

2769

19082

0.85

15.17

1.5

1.6

1031.02

1015.28

mu/l

0.24

2253

16311

Mental and behavioural disorders due to alcohol, excluding acute intoxication

531

7508

0.69

15.12

1.5

1.6

922.33

1010.59

mu/l

1.14

429

6397

Disorders of skin appendages

1821

21827

0.82

14.76

1.5

1.6

1019.94

1009.08

mu/l

0.17

1534

18646

Mixed and other personality disorders

157

2910

0.52

14.68

1.4

1.6

1110.79

1001.19

mu/l

0.39

122

2435

Postpartum haemorrhage due to anatomy

2121

18357

1.27

14.58

1.7

1.6

1077.31

1003.95

mu/l

1.88

1809

15792

Organic, including symptomatic, mental disorders

1215

0.38

14.53

1.5

1.6

758.42

1004.29

mu/l

2.34

1009

Noninflammatory disorders of female genital tract

3358

14640

1.18

14.38

1.6

977.22

1030.33

mu/l

2.11

2908

12624

Presence of other functional implants

130

1789

0.50

14.36

1.4

1.6

996.71

1027.50

mu/l

0.10

106

1467

Iron deficiency

406

2803

1.63

14.35

1.8

1.6

1065.68

1042.55

mu/l

0.18

365

2405

L04AX Other immunosuppressants

1072

13643

0.78

14.22

1.5

1.6

995.79

1015.74

mu/l

0.27

863

11460

Open wound of wrist and hand

1168

14206

0.78

14.20

1.5

1.6

972.74

1006.91

mu/l

0.69

955

12231

Diabetic nephropathy, excluding more controls

1377

0.38

14.20

1.5

1.6

723.74

742.71

mu/l

0.10

1148

Other reaction to severe stress, and adjustment disorders

1647

19893

0.81

14.13

1.5

1.6

1003.19

1019.13

mu/l

0.27

1319

16955

Ovarian cyst

2029

13789

0.82

14.03

1.6

1031.25

1024.92

mu/l

0.07

1658

11836

Diverticular disease of intestine

178

2005

0.55

13.85

1.4

1.5

945.13

1016.68

mu/l

0.45

137

1557

Second line medication for Crohn's disease

1180

14785

0.79

13.79

1.5

1.6

1012.10

1015.65

mu/l

0.04

952

12450

Speech and linguistic disorders, excluding more controls

385

5257

0.66

13.70

1.6

1.7

975.33

972.84

mu/l

0.01

328

4690

Post-traumatic stress disorder

604

8082

0.71

13.62

1.6

960.82

1004.33

mu/l

0.45

497

7047

Acute tubulo-interstitial nephritis

1699

17289

0.82

13.48

1.6

998.77

1014.26

mu/l

0.27

1428

14751

Malignant neoplasm of breast, ER-positive, including Hilmo

1572

0.46

13.45

1.4

1.5

1018.07

1036.20

mu/l

0.05

1200

Inguinal hernia

521

4882

0.70

13.39

1.6

1042.61

1006.34

mu/l

0.30

435

4113

Sleep disorders (combined)

3646

21700

0.87

13.31

1.5

1.6

1006.58

1016.72

mu/l

0.22

3087

18506

Other diseases of urinary system

4034

19945

1.14

13.30

1.5

1.6

1050.52

998.64

mu/l

1.95

3347

17041

Spondylosis

200

2691

0.58

13.27

1.4

1.5

895.39

1014.09

mu/l

1.16

165

2123

Alcohol use disorder, ICD-based

503

7065

0.71

13.17

1.5

1.6

926.80

999.72

mu/l

0.82

407

6007

Dissociative [conversion] disorders

147

2625

0.52

13.11

1.4

1.6

1044.12

997.29

mu/l

0.19

122

2274

Bacterial infection, other or unspecified

457

5517

0.69

13.09

1.6

961.14

1007.18

mu/l

0.48

370

4630

Benign neoplasms

3858

23788

0.87

13.08

1.5

1.6

1006.33

1016.70

mu/l

0.22

3261

20258

Renal failure

110

1918

0.49

13.08

1.5

1.6

1010.99

1013.85

mu/l

0.01

1587

Syncope and collapse

846

9176

0.76

13.03

1.6

980.80

1010.33

mu/l

0.42

724

7940

Intracranial injury

1483

16815

0.81

13.03

1.6

958.02

1017.08

mu/l

1.69

1257

14526

Malignant neoplasm of breast, HER-positive

1551

0.47

12.93

1.4

1.5

1018.07

1032.17

mu/l

0.04

1183

Substance use, excluding alcohol

413

5953

0.68

12.93

1.5

1.6

936.36

1008.75

mu/l

0.62

343

5060

Insulin, fast-acting (human)

299

4579

0.64

12.89

1.4

1.6

969.00

1019.30

mu/l

0.41

231

3800

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

138

2552

0.52

12.86

1.4

1.6

980.06

994.24

mu/l

0.05

116

2172

Arthropathies

4018

22918

0.88

12.75

1.6

995.90

1020.16

mu/l

0.40

3347

19610

Alcohol dependence

126

2430

0.51

12.69

1.4

1.6

1048.40

1004.32

mu/l

0.11

100

2014

Stroke, including SAH

134

1835

0.52

12.69

1.4

1.6

1048.14

1027.42

mu/l

0.07

103

1476

Other medical care

502

5886

0.71

12.58

1.5

1.6

997.00

996.48

mu/l

0.00

430

4947

Insulin, intermediate and long-acting

618

8050

0.73

12.58

1.5

1.6

843.60

1020.94

mu/l

5.06

498

6746

Postpartum haemorrhage due to retained placenta

1792

15313

1.24

12.55

1.6

1132.76

1004.33

mu/l

4.92

1580

13205

Dorsalgia

3721

22331

0.88

12.51

1.5

1.6

954.35

1025.21

mu/l

4.07

3055

19097

Depression or dysthymia

1632

10753

0.82

12.36

1.5

1.6

1020.98

1025.26

mu/l

0.05

1348

9283

Unspecified maternal hypertension

147

821

2.14

12.35

1.6

812.35

1049.08

mu/l

3.40

121

674

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

544

6510

0.72

12.34

1.5

1.6

1066.82

1012.00

mu/l

0.49

442

5377

Other joint disorders

3900

22918

0.88

12.15

1.6

990.29

1020.16

mu/l

0.50

3250

19610

Ischaemic heart disease, wide definition

112

1378

0.50

12.15

1.6

1.5

1029.35

1036.05

mu/l

0.02

1078

Conjunctivitis

3463

24569

1.14

12.08

1.6

1012.65

1015.63

mu/l

0.06

2850

20925

Injuries to the ankle and foot

3301

24802

1.15

11.94

1.5

1.6

956.53

1022.62

mu/l

3.03

2752

21079

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2019

17245

1.20

11.92

1.5

1.6

982.20

1017.54

mu/l

0.73

1716

14732

Non-selective monoamine reuptake inhibitors

237

3633

0.62

11.89

1.4

1.6

1030.14

1000.77

mu/l

0.12

190

2978

L04AA Selective immunosuppressants

287

4377

0.65

11.88

1.5

1.6

993.60

1008.34

mu/l

0.10

230

3634

Erysipelas

321

4152

0.66

11.87

1.5

1.6

807.41

1006.68

mu/l

5.17

249

3448

Neurological diseases

3677

20855

0.88

11.83

1.6

973.21

1025.49

mu/l

2.23

3099

17868

Inflammatory diseases of female pelvic organs

3945

24043

1.14

11.80

1.6

1002.81

1016.60

mu/l

0.34

3197

20530

Episodal and paroxysmal disorders

4008

22851

0.88

11.79

1.5

1.6

990.54

1020.39

mu/l

0.65

3330

19528

Panic disorder

863

10883

0.77

11.77

1.5

1.6

1037.65

1005.91

mu/l

0.24

705

9474

Sub-endpoint used in defining T1D endpoints

546

7283

0.73

11.69

1.5

1.6

942.25

1012.17

mu/l

0.91

432

6134

Dermatitis and eczema

4257

22468

1.13

11.63

1.5

1.6

990.55

1018.05

mu/l

1.07

3616

19040

Obsessive-compulsive disorder

408

5656

0.68

11.51

1.5

1.6

953.05

992.40

mu/l

0.40

339

4928

Hallux valgus (acquired)

242

2738

0.63

11.44

1.5

1049.70

1014.04

mu/l

0.28

192

2226

Other and unspecified mood [affective] disorders

344

4928

0.67

11.43

1.5

1.6

971.98

986.24

mu/l

0.09

259

4276

Acute and transient psychotic disorders

136

2460

0.54

11.43

1.5

1.6

1135.49

1000.42

mu/l

0.67

112

2044

Insulin medication

938

9818

0.79

11.38

1.6

771.09

1036.69

mu/l

17.70

784

8239

Exposure to other specified factors

2573

25366

0.86

11.36

1.5

1.6

1037.27

1013.06

mu/l

0.21

2097

21597

Bacterial Sepsis

307

3807

0.66

11.35

1.6

1031.75

1008.93

mu/l

0.15

254

3239

Epilepsy

513

6969

0.73

11.33

1.5

1.6

1114.28

1017.87

mu/l

0.66

429

5929

Falls/tendency to fall

4009

22513

0.89

11.29

1.6

967.06

1024.83

mu/l

2.98

3318

19198

Injuries to the hip and thigh

533

6482

0.73

11.19

1.6

972.81

1001.06

mu/l

0.25

439

5527

Convulsions, not elsewhere classified

609

7950

0.74

11.13

1.6

1041.23

1004.90

mu/l

0.23

522

6954

Stroke, excluding SAH

111

1550

0.51

11.07

1.4

1.5

1092.13

1038.13

mu/l

0.16

1248

Other cataract

1365

0.48

11.07

1.5

885.02

1031.82

mu/l

1.13

1094

Inflammatory disease of uterus

1104

9027

1.27

10.95

1.7

1.6

1004.51

1014.80

mu/l

0.11

924

7688

Other systemic involvement of connective tissue (FG)

379

5286

0.70

10.84

1.5

1.6

1032.85

1012.34

mu/l

0.19

321

4421

Type 1 diabetes, wide definition

500

6766

0.73

10.83

1.5

1.6

922.19

1033.50

mu/l

1.77

394

5693

Hypothyroidism, strict autoimmune, 3 medication purchases required

3064

23299

0.88

10.67

1.6

961.62

1019.65

mu/l

1.89

2589

19705

Type 1 diabetes

545

7260

0.74

10.60

1.5

1.6

941.10

1034.71

mu/l

1.39

431

6115

Implicit bacterial Sepsis, including avohilmo

237

3072

0.64

10.56

1.6

1043.87

990.22

mu/l

0.35

192

2577

Systemic connective tissue disorders

484

6584

0.73

10.56

1.5

1.6

1021.12

1012.27

mu/l

0.08

409

5512

Other symptoms and signs involving cognitive functions and awareness

314

4080

0.68

10.41

1.6

991.83

1005.61

mu/l

0.07

249

3439

Coxarthrosis

1119

0.48

10.40

1.3

1.5

1061.51

1074.14

mu/l

0.03

870

Acne

785

9756

0.77

10.40

1.5

1.6

1123.02

1004.22

mu/l

1.93

679

8554

Agoraphobia

121

2135

0.53

10.39

1.5

1.6

1546.64

982.95

mu/l

0.76

1844

Persons encountering health services in other circumstances, wide

3928

18014

1.13

10.38

1.5

1.6

1002.82

1024.82

mu/l

0.54

3350

15155

Female infertility, tubal origin

278

1855

1.57

10.36

1.5

1.6

819.58

1053.99

mu/l

4.89

210

1523

Abnormal findings on examination of blood, without diagnosis

415

5228

0.71

10.32

1.6

901.50

1009.85

mu/l

1.23

354

4387

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

143

801

1.85

10.28

1.5

1044.83

1044.02

mu/l

0.00

122

649

Implicit bacterial Sepsis

165

2382

0.59

10.26

1.6

1028.42

1001.36

mu/l

0.13

132

1996

Type 1 diabetes, wide definition, subgroup 1

497

6663

0.73

10.18

1.5

1.6

922.79

1033.28

mu/l

1.72

391

5611

Other eating disorders

414

5534

0.69

10.07

1.6

997.50

979.77

mu/l

0.17

349

4829

Insulin, fast-acting or short human

569

7499

0.75

10.06

1.5

1.6

895.66

1012.67

mu/l

2.16

456

6304

Nonorganic sleeping disorders

793

9963

0.78

10.01

1.5

1.6

1014.22

1004.40

mu/l

0.08

649

8545

Neurotic, stress-related and somatoform disorders

3650

22460

1.13

10.01

1.5

1.6

1008.20

1015.70

mu/l

0.13

3000

19166

Use of disulfiram, acamprosate or naltrexone

834

0.28

9.86

1.3

1.6

985.82

988.79

mu/l

0.00

667

Childhood allergy (age < 16)

1677

15957

0.83

9.81

1.6

966.22

1010.34

mu/l

1.30

1481

14215

Oter anti-inflammatory and antirheumatic agents, non-steroids

882

0.47

9.80

1.4

1.5

925.96

1145.16

mu/l

0.91

637

Ischaemic Stroke, excluding all haemorrhages

1328

0.51

9.67

1.4

1.5

1119.85

1027.95

mu/l

0.25

1058

Insulin, fast-acting

569

7453

0.76

9.65

1.5

1.6

895.66

1018.14

mu/l

2.32

456

6256

Acne, including avohilmo

2324

21267

0.86

9.59

1.5

1.6

1062.49

1009.83

mu/l

1.48

2010

18484

Obstructed labour due to maternal pelvic abnormality

187

1143

1.65

9.57

1.6

1.5

1131.53

989.42

mu/l

1.15

152

914

Other systemic involvement of connective tissue

384

5319

0.71

9.50

1.5

1.6

1045.25

1011.26

mu/l

0.33

326

4449

Anxiety disorders

3652

22454

1.12

9.47

1.5

1.6

1008.82

1015.68

mu/l

0.12

3002

19162

Rheumatoid arthritis

352

4386

0.70

9.43

1.5

1.6

997.35

1030.66

mu/l

0.27

266

3628

Supplementary factors related to causes of morbidity and mortality classified elsewhere

690

8784

0.78

9.43

1.5

1.6

941.62

998.84

mu/l

1.06

622

7556

Mental and behavioural disorders due to opioids

1545

0.48

9.37

1.4

1.6

1128.08

996.88

mu/l

0.23

1304

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1241

0.48

9.37

1.4

1.5

618.82

1079.49

mu/l

5.58

975

Fibromyalgia

204

3149

0.63

9.37

1.4

1.6

900.79

1001.57

mu/l

0.82

157

2627

Intentional self-harm by sharp object

1534

0.48

9.37

1.4

1.6

954.38

966.41

mu/l

0.04

1344

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

179

1127

1.75

9.29

1.7

1.6

1014.13

977.37

mu/l

0.11

144

923

Disorders of conjunctiva

3536

24569

1.12

9.25

1.6

1010.24

1015.63

mu/l

0.11

2908

20925

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

166

2706

0.61

9.22

1.4

1.5

438.56

1039.88

mu/l

48.76

120

2157

Glucagon-like peptide-1 (GLP-1) analogues

166

2706

0.61

9.22

1.4

1.5

438.56

1039.88

mu/l

48.76

120

2157

Intestinal infectious diseases

3660

24445

1.12

9.16

1.6

1008.02

1016.11

mu/l

0.17

3090

20741

Valvular heart disease excluding rheumatic fever

222

2423

0.65

9.01

1.5

1.6

1008.83

1007.21

mu/l

0.01

188

2018

Emotional disorders starting during childhood or adolecense, excluding more controls

373

4826

0.70

8.96

1.5

1.7

921.41

979.07

mu/l

0.64

321

4380

Senile cataract

663

0.39

8.94

1.3

1.6

823.11

1000.50

mu/l

0.72

519

Unspecified abortion

121

672

1.85

8.94

1.8

1.5

824.52

1041.90

mu/l

1.89

558

Intestinal infectious diseases, including avohilmo, including avohilmo

4118

20715

1.11

8.89

1.6

994.07

1024.37

mu/l

0.92

3437

17640

Heart failure,strict

745

0.39

8.86

1.5

1.6

1052.56

1037.20

mu/l

0.03

588

Fracture of lower leg, including ankle

965

11552

0.81

8.81

1.6

912.62

1017.32

mu/l

3.79

812

9872

Heart failure, strict

739

0.39

8.78

1.5

1.6

1052.56

1033.57

mu/l

0.04

585

Coxibs

890

5762

0.80

8.77

1.5

1.6

922.01

1075.95

mu/l

5.48

742

5034

Type of accident

619

7910

0.77

8.77

1.5

1.6

928.45

1000.84

mu/l

1.40

558

6782

Non-rheumatic valve diseases

218

2369

0.65

8.71

1.5

1.6

1001.08

1005.92

mu/l

0.03

186

1974

Complications specific to multiple gestation

167

3.14

8.66

1.7

1.5

1213.00

1153.60

mu/l

0.11

130

Continuous positive airway pressure

836

0.39

8.60

1.3

1.6

956.26

1075.61

mu/l

0.19

689

Other diseases of pleura

120

1817

0.57

8.60

1.5

1.6

919.30

1020.39

mu/l

0.56

100

1480

Accidents

3036

17040

0.89

8.59

1.6

975.72

1028.12

mu/l

2.12

2515

14622

Soft tissue disorders

4021

22715

0.90

8.55

1.6

1007.88

1018.93

mu/l

0.18

3366

19409

Hydatidiform mole

531

2.03

8.45

1.8

1.4

1172.87

1025.06

mu/l

0.50

439

Persons with potential health hazards related to communicable diseases

2659

23514

1.14

8.42

1.6

1032.69

1014.44

mu/l

0.38

2280

20026

Other disorders of fluid, electrolyte and acid-base balance

124

2000

0.58

8.41

1.6

1030.92

1013.99

mu/l

0.08

101

1648

Cholecystectomy

1154

11711

0.83

8.40

1.5

1.6

839.16

1025.45

mu/l

6.42

928

9629

Chronic periodontitis, complicated

380

5043

0.73

8.34

1.4

1.6

924.08

1010.94

mu/l

1.07

290

4162

External causes of morbidity and mortality

2722

15344

0.88

8.32

1.6

985.78

1029.34

mu/l

1.46

2267

13217

Eating disorder

812

9769

0.79

8.18

1.6

1105.93

997.89

mu/l

2.67

673

8508

Infections with a predominantly sexual mode of transmission, including avohilmo

3033

24983

1.13

8.13

1.5

1.6

1043.48

1012.16

mu/l

0.73

2517

21265

All-cause Heart Failure

713

0.41

8.09

1.5

1.6

1052.56

1022.94

mu/l

0.06

563

Missing teeth due to accident, extraction or parodontitis

484

5659

0.76

8.05

1.5

1.6

989.77

1013.49

mu/l

0.16

381

4722

Speech and linguistic disorders

385

4911

0.73

8.04

1.6

975.33

984.97

mu/l

0.05

328

4335

Open wound of head

735

8571

0.80

7.96

1.5

1.6

1014.96

1007.14

mu/l

0.08

610

7352

Coxarthrosis [arthrosis of hip](FG)

1094

0.53

7.94

1.3

1.5

1061.51

1055.23

mu/l

0.02

849

Other enthesopathies

377

5084

0.74

7.90

1.5

1.6

960.94

1015.72

mu/l

0.64

304

4228

Non-invasive ventilation

611

6663

0.78

7.89

1.6

1025.56

1073.10

mu/l

0.63

593

5703

Acne vulgaris

602

7479

0.77

7.85

1.5

1.6

1121.50

992.33

mu/l

1.67

523

6532

Fenamates

469

4163

0.75

7.82

1.5

1.6

902.09

1104.21

mu/l

5.57

362

3552

Fracture of forearm

1301

13713

0.85

7.81

1.6

976.12

1005.87

mu/l

0.57

1120

11886

Eating disorders

826

9915

0.80

7.78

1.6

1087.82

999.45

mu/l

2.03

682

8624

Liquid cancers, including Hilmo

163

2260

0.63

7.77

1.5

1.6

901.98

998.11

mu/l

0.77

129

1890

Abnormal findings in secretions and smears from cervix uteri vagina vulva

3392

22647

1.12

7.61

1.5

1.6

1034.22

1009.04

mu/l

0.67

2802

19123

Diabetic nephropathy

1295

0.50

7.56

1.5

1.6

723.74

767.99

mu/l

0.26

1064

Focal epilepsy

310

4268

0.72

7.56

1.5

1.6

1151.90

1007.10

mu/l

0.65

256

3618

Contact with and exposure to communicable diseases

2463

21959

1.14

7.54

1.6

1034.53

1014.59

mu/l

0.40

2111

18728

Diabetic retinopathy, excluding more controls

226

1856

0.67

7.49

1.5

1.6

932.22

722.30

mu/l

2.34

179

1560

Other menopausal disorders

354

2682

0.73

7.48

1.3

1.5

1042.60

1060.78

mu/l

0.12

235

1975

Mental and behavioural disorders due to sedatives or hypnotics

1592

0.55

7.45

1.3

1.6

1012.86

1002.96

mu/l

0.02

1327

Other surgical follow-up care

182

1196

1.59

7.43

1.6

942.49

970.53

mu/l

0.14

171

1018

Other external causes of accidental injury

3064

17040

0.89

7.42

1.6

977.07

1028.12

mu/l

1.95

2521

14622

Asthma, hospital admissions , main diagnosis only

2597

25202

0.89

7.41

1.6

972.57

1020.15

mu/l

1.81

2181

21404

Migraine without aura

1289

14954

0.84

7.40

1.5

1.6

978.20

1019.18

mu/l

0.65

1072

12757

Neurological diseases, wide definition

1962

11187

0.87

7.38

1.6

992.66

1054.95

mu/l

1.77

1653

9718

Infections of the skin and subcutaneous tissue

1636

18453

0.87

7.31

1.6

940.48

1019.55

mu/l

2.60

1352

15700

Injury, poisoning and certain other consequences of external causes

2344

13211

0.88

7.22

1.6

978.76

1029.31

mu/l

1.70

1977

11374

Cough

839

9474

0.82

7.20

1.6

959.93

1012.30

mu/l

1.00

683

8188

Open wound of forearm

164

2500

0.64

7.13

1.5

1.6

1047.22

983.71

mu/l

0.23

136

2155

Bacterial pneumoniae

548

6086

0.79

7.06

1.6

979.76

1015.19

mu/l

0.41

463

5153

Hirsutism in women

1592

0.55

7.05

1.5

1.6

790.13

983.68

mu/l

1.52

1362

Other abnormal uterine and vaginal bleeding

675

5979

0.80

7.04

1.6

1074.43

1027.99

mu/l

0.42

547

5030

Spinal stenosis

782

0.46

7.03

1.4

1.5

821.21

1042.35

mu/l

1.18

594

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

994

11384

0.84

6.97

1.6

998.92

1023.10

mu/l

0.27

822

9559

Focal epilepsy, strict definition

251

3527

0.70

6.95

1.5

1.6

1179.79

997.58

mu/l

0.69

207

2991

Mycoses, including avohilmo

3541

24560

1.10

6.89

1.6

973.59

1020.90

mu/l

2.15

2949

20878

Reimbursement for rheumatic diseases

1059

12413

0.84

6.84

1.6

995.77

1012.61

mu/l

0.23

877

10389

Hypertrichosis

106

1706

0.57

6.79

1.5

1.6

773.07

996.29

mu/l

2.14

1453

Coronary atherosclerosis

872

0.53

6.73

1.6

1.5

1042.84

1061.27

mu/l

0.05

691

Unspecified haematuria

221

2586

0.69

6.73

1.6

1081.95

990.74

mu/l

0.69

185

2164

Viral hepatitis, IBD co-morbidity

123

1957

0.61

6.66

1.4

1.6

1092.17

1066.91

mu/l

0.06

1667

Other functional intestinal disorders

861

9371

0.83

6.64

1.6

1092.03

999.94

mu/l

1.71

715

7969

Somatoform disorder

419

5395

0.76

6.58

1.5

1.6

974.18

1001.17

mu/l

0.24

348

4572

Alcohol abuse, main dg, excluding more controls

294

3975

0.73

6.51

1.6

1020.97

979.90

mu/l

0.23

241

3455

Hypermobility syndrome

229

3174

0.69

6.50

1.5

1.6

1017.33

992.84

mu/l

0.18

197

2678

Varicose veins

288

2975

0.73

6.48

1.5

1013.92

1030.76

mu/l

0.11

245

2365

Bitten or struck by other mammals

391

5050

0.76

6.46

1.5

1.6

965.74

1005.79

mu/l

0.30

319

4300

Diseases of arteries, arterioles and capillaries (FINNGEN)

801

0.51

6.45

1.5

993.99

1013.83

mu/l

0.06

642

Focal epilepsy, mode (most common among epilepsy diagnosis)

258

3552

0.72

6.37

1.5

1.6

1191.65

999.30

mu/l

0.76

214

3019

Anxious personality disorder

1014

0.48

6.33

1.3

1.6

847.54

1007.64

mu/l

1.23

874

Cervicobrachial syndrome

337

4455

0.75

6.30

1.4

1.6

1075.83

1004.32

mu/l

0.65

262

3709

Mental disorders, not otherwise specified

291

3890

0.73

6.30

1.5

1.6

952.65

1014.21

mu/l

0.65

232

3301

Diseases of liver

265

3638

0.72

6.30

1.5

1.6

870.36

1002.72

mu/l

1.50

205

3019

Combinations of oral blood glucose lowering drugs

630

0.35

6.29

1.5

452.66

1066.01

mu/l

5.56

487

Complications of medical and surgical care

1597

16314

0.87

6.27

1.5

1.6

1041.05

1023.86

mu/l

0.10

1273

13586

L02BG Aromatase inhibitors

359

2681

1.33

6.25

1.5

1.6

849.73

1000.26

mu/l

3.47

329

2244

Vocal cord dysfunction

265

3186

0.72

6.23

1.5

1.6

1007.23

1037.71

mu/l

0.25

217

2706

Bacterial pneumonia, not elsewhere classified

511

5631

0.79

6.21

1.6

989.65

1017.61

mu/l

0.29

431

4763

Venous complications and haemorrhoids in the puerperium

363

2.04

6.21

2.0

1.6

833.06

982.71

mu/l

0.86

301

Complications of anaesthesia during labour and delivery

234

2.55

6.19

1.8

1.5

1100.74

1040.04

mu/l

0.16

195

Paroxysmal tachycardia

432

4583

0.77

6.17

1.6

983.16

1007.23

mu/l

0.23

356

3861

Disorders of the thyroid gland

3969

23690

1.09

6.14

1.6

962.81

1024.01

mu/l

2.54

3337

20132

Hyperkalaemia

155

0.00

6.14

0.0

1.6

—

965.60

—

129

Other and unspecified mental retardation

286

0.20

6.12

1.2

1.6

1544.01

961.82

mu/l

—

249

Mouth breathing

363

4723

0.76

6.04

1.5

1.6

853.73

1010.44

mu/l

2.96

299

3962

Major coronary heart disease event excluding revascularizations

543

0.44

6.00

1.6

1.5

1358.30

1026.04

mu/l

0.78

414

Migraine without aura and triptan purchases

1061

12269

0.85

5.98

1.5

1.6

981.60

1018.48

mu/l

0.46

888

10442

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

395

5001

0.77

5.92

1.5

1.6

1044.05

992.21

mu/l

0.46

340

4293

Abdominal and pelvic pain

3536

16263

1.10

5.84

1.6

977.08

1013.01

mu/l

1.26

2980

14015

Disorders of ocular muscles, binocular movement, accommodation and refraction

1767

19651

0.88

5.82

1.5

1.6

1004.41

1016.63

mu/l

0.19

1527

16792

Lateral epicondylitis

1576

0.60

5.75

1.4

1.5

897.45

1050.56

mu/l

1.22

1257

Bacterial pneumonia (organism specified)

575

6390

0.81

5.73

1.6

993.34

1014.45

mu/l

0.22

485

5405

Type 1 diabetes, strict definition

297

3891

0.74

5.73

1.5

1.6

1039.94

1030.73

mu/l

0.05

236

3288

Emotional disorders and disorders of social functioning with onset specific to childhood

400

4887

0.76

5.72

1.6

942.43

969.55

mu/l

0.25

343

4394

Other special examinations and investigations of persons without complaint or reported diagnosis

2168

12231

0.89

5.70

1.6

1002.59

1018.16

mu/l

0.30

1865

10377

Psychotic depression

159

2309

0.67

5.65

1.5

1.7

977.25

989.38

mu/l

0.07

132

2030

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

480

0.41

5.63

1.6

1.5

1181.82

1107.97

mu/l

0.12

383

Unknown and unspecified causes of morbidity

1485

0.60

5.63

1.5

1.6

917.04

1005.34

mu/l

0.50

1252

Enterobiasis, including avohilmo

248

1862

1.45

5.62

1.7

1.6

1034.71

995.69

mu/l

0.26

199

1576

Vitreous haemorrhage

911

0.49

5.59

1.3

1.6

1020.18

990.12

mu/l

0.09

747

Medical observation and evaluation for suspected diseases and conditions

2151

12231

0.89

5.57

1.6

986.60

1018.16

mu/l

0.73

1850

10377

Genitourinary diseases

1977

8845

1.13

5.54

1.6

981.45

1018.05

mu/l

0.97

1683

7701

L04AC Interleukin inhibitors

100

1599

0.61

5.54

1.6

992.32

1013.97

mu/l

0.09

1335

Exclusions for E4_PCOS_BROAD

348

4481

0.77

5.53

1.5

1.6

999.98

1006.88

mu/l

0.05

298

3790

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

992

11518

0.85

5.53

1.6

1006.33

1005.09

mu/l

0.01

838

9911

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2019

17980

1.12

5.50

1.5

1.6

982.20

1018.28

mu/l

0.74

1716

15452

Symptoms and signs involving the digestive system and abdomen

3533

16263

1.09

5.50

1.6

978.05

1013.01

mu/l

1.21

2976

14015

Maternal care for known or suspected disproportion

130

847

1.58

5.46

1.5

1.4

1103.58

1033.38

mu/l

0.41

108

642

Type 1 diabetes, strict (exclude DM2)

327

4201

0.76

5.40

1.5

1.6

1046.68

1033.39

mu/l

0.08

261

3547

Type 1 diabetes, definitions combined

327

4201

0.76

5.40

1.5

1.6

1046.68

1033.59

mu/l

0.07

261

3546

Acute alcohol intoxication

369

4711

0.78

5.34

1.5

1.6

1000.72

996.90

mu/l

0.02

311

4064

Other septicaemia, including avohilmo

327

3981

0.77

5.29

1.6

1032.06

1002.01

mu/l

0.21

280

3372

Other chronic obstructive pulmonary disease, including avohilmo

109

1404

0.64

5.26

1.6

999.77

1003.99

mu/l

0.01

1143

Sequelae of cerebrovascular disease

901

0.54

5.25

1.4

1.5

1130.98

1025.67

mu/l

0.25

715

Persons encountering health services for examination and investigation

2204

12231

0.90

5.15

1.6

1028.31

1018.16

mu/l

0.16

1881

10377

Dermatitis

1514

16653

0.88

5.14

1.6

985.03

1023.13

mu/l

0.83

1268

14034

Other condition

257

3414

0.74

5.14

1.5

1.6

907.09

995.31

mu/l

1.02

232

2913

Obesity due to excess calories

2198

19954

1.11

5.09

1.6

631.20

1057.87

mu/l

60.37

1794

16909

Angina pectoris

465

0.44

5.09

1.7

1.5

1184.82

1010.52

mu/l

0.35

353

COPD

1015

0.58

5.08

1.6

1081.17

1016.59

mu/l

0.14

846

Cerebral cysts

133

1955

0.66

5.08

1.5

1.6

818.20

1000.59

mu/l

2.52

111

1655

General symptoms and signs

3890

21009

0.92

5.08

1.6

1001.90

1019.41

mu/l

0.42

3234

17916

Type1 diabetes, definitions combined, early onset

277

3584

0.75

5.08

1.5

1.6

1006.80

1003.03

mu/l

0.02

221

3052

Type 1 diabetes, strict definition, subgroup 1

297

3822

0.75

5.07

1.5

1.6

1039.94

1033.34

mu/l

0.04

236

3236

Anankastic personality disorder

119

1775

0.65

5.06

1.4

1.6

956.38

1006.80

mu/l

0.18

100

1492

Other and unspecified polyneuropathies, also in other diseases

854

0.50

5.04

1.5

1.6

1095.93

991.22

mu/l

0.35

684

Rheumatism, unspecified

1509

0.62

5.01

1.6

1082.74

1045.11

mu/l

0.11

1220

Heart failure and coronary heart disease

225

0.28

5.00

1.3

1.5

911.73

1014.29

mu/l

—

177

Diarrhoea and gastroenteritis of presumed infectious origin

2382

23308

0.91

5.00

1.6

1002.53

1012.01

mu/l

0.17

1962

19742

Biological medication for rheuma

512

6230

0.81

4.99

1.5

1.6

1011.98

1007.35

mu/l

0.04

429

5253

Hypertrophy of breast

419

5208

0.79

4.98

1.4

1.6

986.84

1001.72

mu/l

0.12

315

4339

Coxarthrosis, primary

664

0.49

4.97

1.4

1.5

779.42

1029.52

mu/l

2.06

504

Dialysis

294

0.27

4.96

1.4

1.6

1212.49

987.67

mu/l

—

241

Acetic acid derivatives and related substances

949

5697

0.85

4.96

1.5

1.6

977.06

1077.68

mu/l

1.78

778

4974

Hypertrophy of breast in women and men

419

5208

0.80

4.94

1.4

1.6

986.84

1001.72

mu/l

0.12

315

4339

Insulin, combination of fast acting with intermediate-acting or long-acting

938

9858

0.86

4.93

1.6

771.09

1021.67

mu/l

15.95

784

8286

Fracture at wrist and hand level

780

9122

0.85

4.92

1.6

1012.31

1004.31

mu/l

0.09

645

7872

Diabetic retinopathy

232

1945

0.74

4.90

1.5

1.6

916.92

720.97

mu/l

2.17

184

1625

Congenital malformations and deformations of the musculoskeletal system

324

4093

0.77

4.88

1.6

1053.47

986.47

mu/l

0.55

284

3532

Acute alcohol intoxication, ICD10

368

4630

0.79

4.81

1.5

1.6

1003.42

998.02

mu/l

0.03

310

3993

Mental and behavioural disorders due to use of other stimulants, including caffeine

1150

0.58

4.80

1.4

1.6

1031.86

983.66

mu/l

0.15

976

Other septicaemia

318

3847

0.78

4.77

1.6

1037.57

1000.72

mu/l

0.27

273

3259

Other anxiety disorders

2863

22446

1.09

4.76

1.5

1.6

983.54

1015.81

mu/l

0.85

2359

19160

Injuries to the wrist and hand

3451

24657

0.92

4.72

1.5

1.6

986.50

1018.93

mu/l

1.19

2861

20974

Liquid cancers

143

1955

0.69

4.70

1.5

1.6

958.25

998.22

mu/l

0.22

114

1641

Hyperlipidaemia, other/unspecified

903

0.56

4.70

1.3

1.5

952.29

1038.56

mu/l

0.29

720

Transient ischemic attack

124

1470

0.67

4.69

1.5

1037.12

1027.58

mu/l

0.03

103

1172

Sequelae of injuries of head

786

0.50

4.69

1.4

1.6

994.46

1016.48

mu/l

0.05

660

Algoneurodystrophy

932

0.54

4.65

1.4

1.6

850.38

1000.65

mu/l

0.65

775

Other disorders of adrenal gland

975

0.55

4.65

1.6

1048.95

1014.91

mu/l

0.09

825

Asthma, hospital admission 2, infections

1660

17988

0.89

4.65

1.6

937.12

1018.18

mu/l

2.86

1375

15334

Asthma-related infections

1660

17988

0.89

4.65

1.6

937.12

1018.18

mu/l

2.86

1375

15334

Female genital prolapse

516

3490

0.82

4.64

1.6

1.5

1116.96

1047.52

mu/l

0.82

401

2783

Persistent delusional disorders

678

0.47

4.62

1.5

1.6

942.78

999.07

mu/l

0.16

545

Symptoms and signs involving the circulatory and respiratory systems

4154

22295

0.93

4.60

1.6

986.96

1017.13

mu/l

0.71

3442

19019

Dorsopathies

4120

22345

0.93

4.57

1.5

1.6

982.54

1025.23

mu/l

1.64

3461

19110

Diseases of the musculoskeletal system and connective tissue

3023

16415

0.92

4.56

1.6

971.00

1024.01

mu/l

2.10

2538

14170

Use of biperiden

491

0.38

4.54

1.3

1.6

607.37

1016.85

mu/l

2.31

401

Presence of cardiac and vascular implants and grafts

667

0.54

4.53

1.5

1072.17

1004.42

mu/l

0.19

539

Other noninflammatory disorders of uterus, except cervix

145

1389

0.69

4.52

1.6

1010.21

1047.34

mu/l

0.20

120

1109

Malignant neoplasm of skin, including Hilmo

185

1710

0.72

4.52

1.5

983.84

1041.11

mu/l

0.35

136

1364

Use of pramipexole

1497

0.64

4.50

1.4

1.5

940.89

1027.93

mu/l

0.36

1204

Fitting and adjustment of other devices

167

2051

0.71

4.47

1.5

1.6

841.42

1002.91

mu/l

1.53

142

1708

Leisure time condition

375

4661

0.80

4.46

1.5

1.6

946.55

1002.82

mu/l

0.66

340

3995

Pain, not elsewhere classified

785

9121

0.85

4.46

1.5

1.6

988.52

1017.57

mu/l

0.29

601

7718

Peripheral artery disease

597

0.50

4.46

1.5

1.6

973.25

989.56

mu/l

0.04

475

Septicaemia

387

4384

0.80

4.44

1.6

1021.45

1011.80

mu/l

0.07

328

3712

Other and unspecified coagulation defects

225

1700

1.36

4.37

1.6

942.97

1017.98

mu/l

0.59

182

1410

Disorders of parathyroid gland

1006

0.58

4.37

1.3

1.6

969.31

1036.43

mu/l

0.14

812

Non-ischemic cardiomyopathy

573

0.50

4.35

1.6

1032.88

1019.15

mu/l

0.03

460

Mixed disorders of conduct and emotions, excluding more controls

164

2204

0.70

4.34

1.6

848.43

973.35

mu/l

1.35

122

1957

Follow-up examination after treatment for conditions other than malignant neoplasms

1642

12125

0.90

4.33

1.6

1007.90

1018.12

mu/l

0.15

1343

10278

Chronic viral hepatitis

106

1574

0.66

4.32

1.4

1.6

1107.08

1007.14

mu/l

0.24

1315

malignant neoplasm of female genital organs, including Hilmo

112

1583

0.67

4.31

1.5

1.6

1112.22

1022.75

mu/l

0.46

1299

Hypokalaemia

1137

0.60

4.31

1.6

1075.91

1032.79

mu/l

0.15

940

Abnormalities of heart beat

941

10434

0.87

4.27

1.6

975.66

1017.29

mu/l

0.77

787

8950

Bulimia nervosa (incl. atypical)

311

3825

0.77

4.23

1.6

1061.16

990.31

mu/l

0.69

255

3279

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

690

0.50

4.23

1.2

1.5

1057.05

1018.88

mu/l

0.06

533

Conduction disorders

166

1839

0.72

4.23

1.5

1.6

1106.56

1009.71

mu/l

0.61

139

1551

Glomerular diseases

167

2297

0.72

4.22

1.6

977.35

1016.22

mu/l

0.19

144

1892

Benign intracranial hypertension

823

0.53

4.22

1.4

1.6

558.99

983.77

mu/l

7.24

695

Fracture of femur

1079

0.62

4.22

1.6

1091.11

1011.56

mu/l

0.23

922

Other follicular disorders

216

2837

0.75

4.22

1.4

1.6

836.80

1005.51

mu/l

2.09

177

2398

Personal history of risk-factors, not elsewhere classified

621

0.47

4.19

1.6

650.93

1020.65

mu/l

3.49

532

Other fall from one level to another

625

7338

0.84

4.16

1.6

1057.83

994.78

mu/l

0.30

531

6365

Dementia, including avohilmo

430

0.47

4.13

1.5

1.6

654.54

958.77

mu/l

2.79

356

Tumor necrosis factor alpha inhibitors

482

5780

0.82

4.13

1.5

1.6

1008.87

1015.83

mu/l

0.05

405

4882

Exclusion endpoint for clefts

686

0.50

4.10

1.8

1.6

1025.85

969.54

mu/l

0.12

591

Atrial fibrillation and flutter

116

1100

0.68

4.10

1.4

1.5

866.03

998.77

mu/l

1.12

893

Gout, idiopatic and unspecified

253

0.28

4.10

1.7

1.5

836.56

1029.53

mu/l

—

202

Anomalies of dental arch relationship, including avohilmo

865

8940

0.86

4.09

1.6

1020.66

995.83

mu/l

0.24

763

7785

Diseases of the skin and subcutaneous tissue

3478

18726

0.93

4.09

1.6

987.47

1023.75

mu/l

1.28

2925

15945

Adalimumab

239

3090

0.76

4.09

1.5

1.6

966.71

995.00

mu/l

0.17

194

2597

Diseases of appendix

2232

21713

0.91

4.07

1.6

1024.19

1016.26

mu/l

0.09

1846

18222

Haemorrhage from respiratory passages

282

3180

0.78

4.05

1.4

1.6

996.17

1014.35

mu/l

0.13

229

2715

Cervical disc disorders

203

2698

0.75

4.05

1.4

1.5

936.79

1016.00

mu/l

0.61

168

2132

Other specified congenital malformation syndromes affecting multiple systems

550

0.45

4.04

1.7

1.6

1055.21

960.90

mu/l

0.16

472

Disorders of continuity of bone

170

2306

0.73

4.04

1.6

958.54

1011.40

mu/l

0.33

151

1951

Feeding problems of newborn

212

2.16

4.03

1.6

1052.61

970.56

mu/l

0.18

191

Elevated blood glucose level

1333

0.64

4.03

1.6

660.38

1007.16

mu/l

5.06

1135

Monoamine oxidase A inhibitors

1358

0.65

4.00

1.4

1.6

854.58

1015.69

mu/l

1.29

1126

Other headache syndromes

1408

15581

0.89

3.99

1.6

1054.20

1021.40

mu/l

0.26

1132

13151

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

335

2698

1.27

3.95

1.6

921.10

1017.90

mu/l

1.11

286

2223

Sleep disorders, other/unspecified

112

1604

0.68

3.92

1.6

1003.99

973.64

mu/l

0.14

1374

Certain conditions originating in the perinatal period

511

5347

0.83

3.90

1.6

969.77

970.15

mu/l

0.00

456

4837

Dental caries

444

5047

0.82

3.89

1.5

1.6

944.67

1019.73

mu/l

0.76

375

4307

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1499

13609

1.12

3.88

1.6

1016.89

1006.12

mu/l

0.14

1216

11655

Excessive earwax

884

9146

0.87

3.88

1.6

992.02

1002.49

mu/l

0.10

758

7763

Viral hepatitis

140

1939

0.71

3.87

1.4

1.6

1099.20

1011.83

mu/l

0.25

111

1610

Drug-induced neutropenia

633

0.50

3.86

1.4

1.6

1428.35

990.85

mu/l

0.75

507

Other chronic obstructive pulmonary disease

929

0.62

3.85

1.6

1087.28

1019.01

mu/l

0.15

771

Appendicitis, broad definition

2226

21672

0.92

3.83

1.6

1024.56

1016.28

mu/l

0.09

1840

18184

Diseases of salivary glands

736

8490

0.86

3.83

1.5

1.6

985.79

1009.72

mu/l

0.29

597

7195

Previous suicide attempt

545

0.46

3.83

1.7

1.6

640.38

988.15

mu/l

3.26

471

Umbilical hernia

543

4582

1.19

3.82

1.7

1.6

1004.09

1015.82

mu/l

0.10

429

3805

Viral hepatitis, including avohilmo

156

2117

0.72

3.80

1.4

1.6

1050.30

1010.85

mu/l

0.11

124

1758

Hyperparathyroidism

688

0.53

3.76

1.4

1.5

771.97

979.76

mu/l

0.87

550

Helminthiases, including avohilmo

277

2212

1.30

3.75

1.7

1.6

1020.46

999.97

mu/l

0.13

226

1871

Golimumab

986

0.60

3.74

1.4

1.6

836.08

1003.64

mu/l

1.59

818

Volume depletion

795

0.56

3.73

1.6

1422.49

997.99

mu/l

1.20

688

Cervicalgia

324

4008

0.80

3.72

1.6

973.26

1007.46

mu/l

0.29

261

3369

Pervasive developmental disorders excl. Autism + Asperger

484

0.45

3.70

1.5

1.6

777.52

966.52

mu/l

0.64

435

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

740

0.55

3.69

1.4

1.6

1068.64

1010.95

mu/l

0.15

617

Malignant neoplasm of eye, brain and central nervous system

500

0.45

3.67

1.3

1.6

1478.74

992.77

mu/l

1.15

414

Congenital malformations of the nervous system

1020

0.61

3.67

1.6

1081.85

983.57

mu/l

0.34

888

Other disorders of bone

446

5331

0.83

3.67

1.6

1004.19

1008.74

mu/l

0.02

362

4525

Specific development disorders of scholastic skills

215

2691

0.76

3.66

1.5

1.6

941.51

970.02

mu/l

0.12

184

2378

Malignant neoplasm of brain, including Hilmo

619

0.51

3.65

1.3

1.6

1169.15

998.84

mu/l

0.42

511

Other viral hepatitis, including avohilmo

149

2019

0.72

3.64

1.5

1.6

1054.08

1004.52

mu/l

0.14

119

1683

Myocardial infarction

410

0.49

3.63

1.6

1161.92

1034.23

mu/l

0.23

315

Demyelinating diseases of the central nervous system

250

3156

0.78

3.63

1.4

1.6

1039.30

1001.97

mu/l

0.24

201

2619

MS-disease / Multiple Sclerosis

221

2827

0.77

3.61

1.4

1.6

1068.37

1008.64

mu/l

0.40

182

2338

Other viral hepatitis

135

1855

0.71

3.61

1.4

1.6

1099.59

1007.76

mu/l

0.26

107

1546

Caries of dentine

373

4369

0.82

3.60

1.5

1.6

939.41

1017.14

mu/l

0.68

318

3751

Agranulocytosis

1372

0.67

3.59

1.5

1.6

1238.91

1044.06

mu/l

0.71

1123

Alcohol abuse, main dg

294

3654

0.80

3.59

1.6

1020.97

991.27

mu/l

0.16

241

3148

malignant neoplasm of female genital organs

1297

0.67

3.59

1.4

1.6

1072.06

1039.65

mu/l

0.13

1055

Abnormal findings on diagnostic imaging of lung

146

1893

0.73

3.58

1.4

1.5

1136.37

1043.90

mu/l

0.44

113

1505

Congenital absence of the uterus

0.00

3.58

0.0

1.7

—

804.56

—

Other mental disorders due to brain damage and dysfunction and to physical disease

456

0.44

3.57

1.3

1.6

811.38

967.09

mu/l

0.36

378

Myalgia

791

9015

0.87

3.56

1.6

1019.93

1014.73

mu/l

0.05

656

7711

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

552

4657

1.20

3.55

1.6

975.02

1000.32

mu/l

0.18

458

3983

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

202

2607

0.76

3.54

1.5

1.6

992.73

984.91

mu/l

0.04

169

2248

Lesion of ulnar nerve

127

1767

0.71

3.53

1.5

1.6

926.70

1011.81

mu/l

0.53

110

1467

1057

9523

1.14

3.53

1.6

1183.91

1021.61

mu/l

0.88

786

8048

Strabismus

774

8803

0.87

3.52

1.6

987.35

1000.21

mu/l

0.14

663

7535

Polyneuropathies and other disorders of the peripheral nervous system

1178

0.65

3.52

1.4

1.6

988.31

1022.16

mu/l

0.15

967

Methotrexate

179

2361

0.75

3.52

1.5

1.6

886.24

1001.14

mu/l

1.18

146

1961

Haemorrhoids and perianal venous thrombosis

613

5223

1.17

3.51

1.6

1038.18

999.39

mu/l

0.49

511

4376

Dementia

387

0.49

3.50

1.5

1.6

661.70

946.43

mu/l

2.37

319

Glomerular disorders in diseases classified elsewhere

1365

0.68

3.50

1.6

867.10

1010.07

mu/l

1.04

1131

Other dorsopathies, not elsewhere classified

4054

22340

0.94

3.50

1.5

1.6

965.60

1025.31

mu/l

2.82

3368

19106

Glaucoma

220

2407

0.77

3.49

1.4

1.5

1044.73

1025.03

mu/l

0.09

164

1953

Pulmonary heart disease, diseases of pulmonary circulation

155

2090

0.74

3.49

1.5

1.6

1099.22

999.21

mu/l

0.40

115

1722

Other coagulation defects

277

2217

1.27

3.48

1.6

912.90

1022.24

mu/l

1.24

222

1846

Other CVD (FINNGEN)

767

0.62

3.46

1.7

1.6

954.46

1008.25

mu/l

0.14

651

Symptoms and signs involving the skin and subcutaneous tissue

2017

20650

0.92

3.46

1.6

983.62

1021.29

mu/l

1.07

1664

17338

Diabetic maculopathy, excluding more controls

140

1907

0.73

3.45

1.5

1.6

829.25

1050.31

mu/l

2.73

115

1591

Primary gonarthrosis, bilateral

502

0.52

3.44

1.2

1.5

874.23

1079.94

mu/l

0.80

362

Cerebral palsy and other paralytic syndromes

142

1929

0.73

3.44

1.5

1.6

1109.63

1014.95

mu/l

0.40

123

1607

Other diseases of the respiratory system

977

0.62

3.44

1.5

1.6

926.07

1017.49

mu/l

0.40

809

Other respiratory disorders and diseases

977

0.62

3.44

1.5

1.6

926.07

1017.49

mu/l

0.40

809

Other diseases of liver

169

2241

0.75

3.43

1.5

1.6

814.45

1018.47

mu/l

1.95

132

1844

Venous thromboembolism

440

5051

0.84

3.43

1.6

1127.49

1009.97

mu/l

0.33

353

4166

Used for control exclusion in common control thyroid runs

3977

21277

0.94

3.42

1.6

973.58

1024.47

mu/l

2.01

3394

18152

COPD, early/later onset

924

0.64

3.42

1.6

1087.28

1009.62

mu/l

0.17

761

Disorders of optic nerve and visual pathways

230

2913

0.78

3.41

1.5

1.6

1001.73

994.97

mu/l

0.04

195

2438

Nonalcoholic fatty liver disease

1297

0.67

3.41

1.5

1.6

707.71

1031.50

mu/l

2.29

1067

Injury of muscle and tendon at shoulder and upper arm level

110

1562

0.70

3.41

1.5

1.6

1072.13

1024.13

mu/l

0.25

1263

Autoimmune diseases

4092

22013

0.94

3.40

1.6

988.58

1023.43

mu/l

1.10

3474

18751

Deep bite

297

3212

0.80

3.40

1.6

1069.06

969.05

mu/l

0.67

267

2810

L04AD Calcineurin inhibitors

121

1681

0.71

3.38

1.6

1190.54

1017.18

mu/l

0.81

103

1405

Internal derangement of knee

804

9041

0.88

3.38

1.6

935.25

1021.24

mu/l

2.29

652

7676

Emotional disorders starting during childhood or adolescence

373

4384

0.81

3.37

1.5

1.6

921.41

968.57

mu/l

0.50

321

3926

Pyogenic granuloma

490

1.59

3.35

1.6

1079.62

982.43

mu/l

0.51

419

Embedded teeth, including avohilmo

654

7460

0.86

3.35

1.6

1075.43

995.80

mu/l

1.13

589

6504

COPD, hospital admissions

923

0.65

3.35

1.6

1087.28

1009.62

mu/l

0.17

761

Trochanteric bursitis

101

1448

0.69

3.35

1.4

1.6

946.87

1033.50

mu/l

0.59

1186

Lack of expected normal physiological development

1221

0.68

3.35

1.6

986.31

958.17

mu/l

0.11

1102

Aplastic and other anaemias

361

4001

0.82

3.34

1.6

1331.81

998.59

mu/l

0.63

292

3348

Paranoid personality disorder

527

0.49

3.34

1.5

1.6

928.96

1008.59

mu/l

0.19

431

Early lumbar disc prolapse, operated

344

4154

0.82

3.31

1.5

1.6

949.79

1013.25

mu/l

0.42

272

3451

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1376

15079

0.90

3.31

1.5

1.6

1030.41

1010.50

mu/l

0.30

1134

12878

Open wound of lower leg

270

3354

0.80

3.31

1.5

1.6

986.64

998.16

mu/l

0.08

229

2896

Other disorders of eye and adnexa

356

4291

0.82

3.29

1.5

1.6

983.49

1007.97

mu/l

0.20

285

3621

Complications following abortion and ectopic and molar pregnancy

324

1.70

3.28

1.7

1.4

1293.04

1061.19

mu/l

0.21

265

Other diseases of blood and blood-forming organs, wide

220

2799

0.78

3.27

1.6

1074.40

1008.40

mu/l

0.40

176

2320

Brachial plexus disorders

230

2897

0.78

3.27

1.5

1.6

1046.22

1008.27

mu/l

0.25

196

2399

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

2949

25160

1.07

3.25

1.6

1046.98

1011.20

mu/l

1.07

2531

21306

Hidradenitis suppurativa

137

1832

0.72

3.25

1.4

1.6

770.86

995.84

mu/l

2.06

112

1544

Other and unspecified dermatitis

1290

14228

0.90

3.24

1.6

974.11

1026.50

mu/l

1.20

1073

11987

Gout, unspecified

188

0.27

3.22

2.0

1.5

791.92

1016.52

mu/l

—

150

COPD (mode)

646

0.60

3.22

1.7

1.6

1165.18

1002.65

mu/l

0.28

546

Seborrhoeic dermatitis

105

1480

0.70

3.21

1.5

1.6

1155.20

1013.31

mu/l

0.61

1240

DVT of lower extremities and pulmonary embolism

258

3201

0.80

3.18

1.5

1.6

960.52

1002.66

mu/l

0.24

207

2632

Crossbite

196

2305

0.77

3.17

1.5

1.6

988.84

964.16

mu/l

0.13

172

2033

Primary_lymphoid and hematopoietic malignant neoplasms

115

1597

0.72

3.17

1.6

945.61

1003.06

mu/l

0.35

1347

Superficial injury of lower leg

806

9096

0.88

3.15

1.5

1.6

930.86

1011.44

mu/l

1.81

676

7894

Soft tissue disorders related to use, overuse and pressure

236

2963

0.79

3.13

1.4

1.6

1000.80

1000.61

mu/l

0.00

178

2467

Pulmonary embolism

142

1904

0.74

3.12

1.5

1.6

1059.02

1006.91

mu/l

0.17

105

1563

Other diseases of the digestive system

232

2918

0.79

3.12

1.5

1.6

1415.60

991.17

mu/l

0.49

188

2466

L02BA Anti-estrogens

1216

0.68

3.12

1.4

1.5

1011.61

1054.24

mu/l

0.10

921

Secondary hypertension

935

0.64

3.11

1.5

1.6

945.36

1002.02

mu/l

0.20

768

Fibroblastic disorders

116

1603

0.72

3.11

1.5

828.25

1047.39

mu/l

2.27

1298

Pulmonary heart disease

142

1902

0.74

3.10

1.5

1.6

1059.02

1006.77

mu/l

0.17

105

1562

Other disorders of glucose regulation and pancreatic internal secretion

125

1696

0.73

3.08

1.5

1.6

888.76

1012.02

mu/l

0.80

102

1435

Mental and behavioural disorders of puerperium, not classified elsewhere

106

771

1.49

3.07

1.6

1058.88

991.75

mu/l

0.20

644

Neuromuscular dysfunction of bladder

1042

0.66

3.06

1.7

1.6

1235.17

994.47

mu/l

1.18

870

Diastasis of muscle

434

1.63

3.05

1.5

1.6

1340.33

1021.10

mu/l

1.47

354

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

547

0.53

3.05

1.2

1.6

1113.75

988.46

mu/l

0.18

428

Diabetic maculopathy

140

1763

0.74

3.04

1.5

1.6

829.25

722.85

mu/l

0.90

115

1473

Other and unspecified nerve root and plexus disorders, also in other diseases

292

3565

0.81

3.03

1.5

1.6

981.52

1014.37

mu/l

0.16

230

2956

Melanocytic naevi

1246

11326

1.11

3.01

1.5

1.6

1081.79

1004.47

mu/l

1.09

1026

9654

Malignant neoplasm of digestive organs, including Hilmo

840

0.67

3.01

1.5

915.16

1014.68

mu/l

0.37

659

Adrenocortical insufficiency

590

0.55

3.00

1.5

1.6

1271.96

1002.79

mu/l

0.65

485

Superficial injury of ankle and foot

514

5940

0.85

2.99

1.6

969.64

1006.16

mu/l

0.36

433

5127

Crowding of teeth, including avohilmo

598

5642

0.86

2.98

1.6

1075.25

976.67

mu/l

1.17

539

5007

Habit and impulse disorders

518

0.52

2.96

1.7

1.6

710.43

981.61

mu/l

1.21

437

Other disorders starting during childhood or adolecense, excluding more controls

347

3911

0.82

2.96

1.6

1108.91

982.01

mu/l

1.22

304

3508

Sequelae of injuries, of poisoning and of other consequences of external causes

368

4383

0.83

2.95

1.5

1.6

1032.60

1011.99

mu/l

0.15

298

3677

Other strabismus

740

8317

0.88

2.95

1.6

991.13

1000.89

mu/l

0.10

634

7128

Implicit viral Sepsis, including avohilmo

440

5153

0.85

2.95

1.6

948.18

1011.06

mu/l

0.78

370

4374

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

911

0.70

2.93

1.6

1.5

1080.48

1061.52

mu/l

0.06

707

Asthma-related pneumonia

525

6054

0.86

2.92

1.5

1.6

992.41

1006.31

mu/l

0.11

443

5127

Other abortion

448

1.61

2.92

1.8

1.5

825.78

1054.96

mu/l

1.32

376

Asthma, excluding more controls

2644

14503

0.93

2.92

1.6

969.48

1042.31

mu/l

3.18

2204

12443

Asthma (only as main-diagnosis), excluding more controls

2450

14503

0.93

2.91

1.6

974.32

1042.31

mu/l

2.70

2044

12443

severe traumatic brain injury, does not include concussion

1387

0.71

2.91

1.5

1.6

1114.43

1029.76

mu/l

0.32

1167

Malignant neoplasm of brain

442

0.49

2.90

1.3

1.6

1451.45

964.31

mu/l

1.06

364

Functional dyspepsia

550

6332

0.86

2.90

1.6

962.74

1005.50

mu/l

0.49

448

5311

Intentional self-harm by unspecified means

730

0.60

2.89

1.5

1.6

797.42

984.95

mu/l

1.20

646

Diseases of the digestive system

653

7378

0.87

2.88

1.5

1.6

1121.96

995.42

mu/l

0.39

539

6278

Other inflammation of vagina/vulva

291

2419

1.25

2.86

1.6

1054.23

1004.53

mu/l

0.37

231

2024

Ehlers-Danlos syndrome, including avohilmo

749

0.60

2.84

1.5

1.6

1025.04

1020.54

mu/l

0.01

620

Nonsuppurative otitis media, including avohilmo

2395

19402

1.08

2.83

1.6

998.56

1019.15

mu/l

0.22

2081

16887

Unspecified privation

168

2159

0.77

2.82

1.5

1.6

934.97

1005.46

mu/l

0.42

130

1803

Seropositive rheumatoid arthritis

235

2896

0.80

2.82

1.5

1.6

1027.15

1020.46

mu/l

0.04

180

2366

Mental and behavioural disorders associated with the puerperium

106

784

1.46

2.81

1.6

1058.88

1007.77

mu/l

0.15

654

Psoriasis

385

4547

0.84

2.81

1.6

899.41

1001.17

mu/l

1.60

321

3786

Asthma, hospital admissions 3, pneumonia

531

6092

0.86

2.78

1.5

1.6

988.78

1005.20

mu/l

0.14

449

5160

Asthma-related pneumonia or sepsis

531

6092

0.86

2.78

1.5

1.6

988.78

1005.20

mu/l

0.14

449

5160

1488

16033

0.92

2.78

1.6

930.21

1018.23

mu/l

2.87

1229

13703

Fall on and from stairs and steps

484

5604

0.86

2.77

1.6

946.69

1002.56

mu/l

0.69

386

4770

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1952

20679

0.92

2.76

1.5

1.6

929.21

1022.34

mu/l

4.26

1636

17783

Sicca syndrome [Sjögren]

1041

0.68

2.76

1.7

1.6

991.71

1013.65

mu/l

0.08

842

GI-bleeding

237

2924

0.81

2.74

1.5

1.6

1380.00

988.73

mu/l

0.45

193

2476

Family history of other conditions

110

815

1.42

2.74

1.8

1.6

995.49

1011.28

mu/l

0.07

696

Adhesive capsulitis of shoulder

1042

0.68

2.73

1.4

1.5

1056.48

1061.39

mu/l

0.01

813

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

486

5620

0.86

2.72

1.5

1.6

987.12

1008.63

mu/l

0.23

389

4750

Irritable bowel syndrome

906

10059

0.89

2.72

1.5

1.6

1027.03

1007.07

mu/l

0.26

770

8497

Neuralgia and neuritis, unspecified

880

0.65

2.71

1.3

1.6

904.66

1042.29

mu/l

0.51

726

Early lumbar disc prolapse operation

351

4145

0.84

2.71

1.5

1.6

941.07

1014.26

mu/l

0.52

278

3420

Intermittent heterotropia

248

3006

0.80

2.71

1.7

1.6

970.73

992.56

mu/l

0.15

222

2608

Plantar fascial fibromatosis

101

1387

0.72

2.70

1.5

837.88

1039.57

mu/l

1.72

1134

Papulosquamous disorders

507

5841

0.86

2.69

1.6

925.61

1005.96

mu/l

1.27

422

4890

Use of teriflunomide

329

0.43

2.68

1.5

981.54

1024.22

mu/l

—

261

Manic episode

955

0.66

2.68

1.4

1.6

1060.47

972.21

mu/l

0.19

815

Radiculopathy

100

1376

0.72

2.68

1.5

1.6

947.68

1018.24

mu/l

0.31

1107

Vasomotor and allergic rhinitis

1624

17133

0.92

2.68

1.5

1.6

959.79

1020.17

mu/l

1.83

1361

14697

Toxic effects of substances chiefly nonmedicinal as to source

289

3470

0.82

2.66

1.6

912.18

993.07

mu/l

1.08

253

2975

Superficial injury of wrist and hand

828

9211

0.89

2.64

1.5

1.6

951.32

1013.85

mu/l

1.23

669

7991

Hypoglycaemia, other or unspecified

100

1366

0.72

2.64

1.5

1.6

869.92

999.03

mu/l

0.93

1147

Visual disturbances and blindness

1201

13128

0.91

2.64

1.6

964.40

1006.03

mu/l

0.68

1025

11166

Asthma

2645

14519

0.94

2.63

1.6

969.54

1042.43

mu/l

3.19

2205

12456

Thyrotoxicosis, other and/or unspecified

633

5587

1.14

2.63

1.6

932.07

1022.60

mu/l

1.65

510

4676

Postmenopausal atrophic vaginitis

556

0.67

2.63

1.6

1.5

896.30

986.30

mu/l

0.38

411

Other acute lower respiratory infections

1386

14348

0.92

2.63

1.6

965.39

1004.46

mu/l

0.64

1138

12328

Raynaud syndrome

235

2871

0.81

2.62

1.5

1.6

1089.59

1010.56

mu/l

0.56

192

2391

Recurrent dislocation of patella

334

3919

0.83

2.61

1.6

927.13

1011.66

mu/l

1.08

285

3388

Other enthesopathy of foot (+metatarsalgia)

185

2324

0.79

2.61

1.5

1.6

1048.49

1015.36

mu/l

0.19

155

1954

Motor disorders, excluding more controls

580

0.59

2.60

1.5

1.7

1529.87

926.21

mu/l

0.42

535

Cutaneous abscess, furuncle and carbuncle

700

7863

0.88

2.59

1.6

923.34

1010.60

mu/l

1.38

566

6706

Other specified/unspecified systemic involvement of connective tissue

1001

0.68

2.59

1.5

1.6

1114.14

1021.49

mu/l

0.40

811

Contact with other sharp object(s)

209

2578

0.80

2.59

1.6

1056.69

988.49

mu/l

0.50

177

2224

Unspecified fall

1107

11922

0.91

2.59

1.6

964.31

1006.50

mu/l

0.83

907

10311

Other sleep disorders

234

2862

0.81

2.59

1.5

1.6

940.43

1015.59

mu/l

0.76

202

2438

Muscle strain

878

0.66

2.58

1.6

944.60

1025.25

mu/l

0.28

743

Coagulation defects, purpura and other haemorrhagic conditions

530

4628

1.15

2.58

1.6

909.57

1015.49

mu/l

2.00

431

3908

Allergic rhinitis

1507

16071

0.92

2.57

1.5

1.6

961.19

1012.81

mu/l

1.48

1267

13820

Viral Sepsis

268

3239

0.82

2.57

1.6

998.28

998.90

mu/l

0.00

221

2757

Colectomy operation

992

0.68

2.56

1.6

1021.36

1013.20

mu/l

0.02

813

Open wound of shoulder and upper arm

483

0.54

2.55

1.7

1.6

908.14

948.44

mu/l

0.11

418

Autonomic disorders

484

0.55

2.55

1.4

1.6

843.73

971.78

mu/l

0.43

409

Other disorders of patella

462

5322

0.86

2.55

1.6

876.35

1024.67

mu/l

4.06

384

4468

Seropositive rheumatoid arthritis, strict definition

148

1907

0.77

2.54

1.6

1027.51

1024.48

mu/l

0.01

112

1564

Total colectomy operation

697

0.62

2.54

1.6

1129.84

990.10

mu/l

0.34

577

Total colectomy

697

0.62

2.54

1.6

1129.84

990.10

mu/l

0.34

577

Disorders of refraction and accommodation

1061

11586

0.91

2.53

1.5

1.6

1032.07

1003.59

mu/l

0.36

916

9997

Malignant neoplasm of digestive organs

705

0.67

2.52

1.5

983.09

1023.47

mu/l

0.10

557

Implicit viral Sepsis

268

3232

0.82

2.52

1.6

998.28

999.41

mu/l

0.01

221

2750

Metatarsalgia

169

2135

0.78

2.52

1.5

1.6

1051.68

1015.90

mu/l

0.20

142

1796

COPD, hospital admission 2, with asthma infections

646

0.64

2.51

1.6

1.5

1138.84

1009.59

mu/l

0.21

534

Specific development disorders of speech and language

206

2439

0.80

2.50

1.6

971.44

963.64

mu/l

0.04

176

2169

SLE (Finngen)

753

0.64

2.50

1.6

1.5

990.52

1021.09

mu/l

0.10

613

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

941

0.67

2.48

1.6

996.74

1023.85

mu/l

0.10

784

Hernia of abdominal wall

712

6346

1.13

2.47

1.6

1039.38

1009.81

mu/l

0.25

562

5232

Injury of muscle and tendon at wrist and hand level

147

1887

0.77

2.47

1.5

1.6

951.21

1020.34

mu/l

0.52

122

1583

Malignant neoplasm of skin

168

1444

0.79

2.45

1.5

997.56

1040.54

mu/l

0.23

125

1146

Other anaemias

318

3529

0.84

2.45

1.6

1368.02

995.39

mu/l

0.61

255

2947

Other local infections of skin and subcutaneous tissue

148

1894

0.77

2.45

1.5

1.6

926.53

1013.81

mu/l

0.59

122

1586

Extrapyramidal and movement disorders

360

4223

0.85

2.45

1.5

1.6

1008.47

1002.61

mu/l

0.04

304

3497

Systemic lupus erythematosus

749

0.64

2.44

1.6

990.52

988.67

mu/l

0.01

615

Hyperkinetic disorders (excl. ADHD)

754

0.64

2.42

1.6

760.09

978.04

mu/l

1.57

648

Anorexia (incl.atypical)

440

5015

0.85

2.42

1.6

1165.63

990.99

mu/l

3.90

374

4337

Endocrine, nutritional and metabolic diseases

4005

19253

1.05

2.41

1.6

882.96

1072.43

mu/l

21.57

3395

16449

Enthesopathies of lower limb, excluding foot

377

4395

0.85

2.41

1.5

1.6

977.20

1003.89

mu/l

0.21

314

3672

Chronic rhinitis, nasopharyngitis and pharyngitis

837

9266

0.90

2.41

1.5

1.6

983.76

1014.04

mu/l

0.42

688

7854

Carrier of infectious disease

125

959

1.35

2.41

1.6

909.25

1003.66

mu/l

0.62

111

806

Other shoulder lesions

179

2233

0.79

2.41

1.5

1.6

1149.12

1025.28

mu/l

0.90

145

1873

Pilonidal cyst

236

2854

0.82

2.40

1.6

795.82

1001.61

mu/l

3.22

193

2417

Other peripheral vascular diseases

130

1684

0.76

2.40

1.5

1.6

1134.33

1023.47

mu/l

0.52

107

1384

Rheumatoid arthritis, including avohilmo

488

5580

0.87

2.37

1.5

1.6

970.35

1014.48

mu/l

0.49

376

4629

Congenital deformities of feet, including avohilmo

111

1458

0.74

2.37

1.6

1159.04

969.20

mu/l

1.16

1263

232

1938

1.26

2.37

1.7

1.6

932.24

994.30

mu/l

0.43

215

1663

Candidiasis, including avohilmo

1418

13132

1.09

2.36

1.6

1017.06

1002.96

mu/l

0.22

1156

11222

Other metabolic disorders

290

3440

0.84

2.35

1.4

1.6

884.95

1015.34

mu/l

1.61

228

2830

Injury of muscle and tendon at hip and thigh level

103

1376

0.74

2.35

1.5

1.6

874.47

1033.08

mu/l

1.39

1144

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1211

0.72

2.34

1.5

1.6

992.68

985.52

mu/l

0.02

1038

Benign leiomyoma with endometriosis

107

1422

0.75

2.33

1.4

1.5

964.82

1043.71

mu/l

0.44

1080

Seropositive rheumatoid arthritis, wide

234

2836

0.82

2.33

1.5

1.6

1030.07

1016.74

mu/l

0.07

179

2313

Type 1 diabetes, strict definition, subgroup 2

0.00

2.32

0.0

1.5

—

1105.01

—

Thyrotoxicosis

693

6205

1.12

2.31

1.6

940.69

1007.24

mu/l

1.05

562

5196

SLE, strict definition

726

0.65

2.30

1.5

1.6

989.73

986.18

mu/l

0.01

599

SLE, ICD10

726

0.65

2.30

1.5

1.6

989.73

986.18

mu/l

0.01

599

Disorders of vitreous body and globe

239

2732

0.83

2.30

1.5

1.6

993.20

1013.62

mu/l

0.13

190

2235

Abnormalities of gait and mobility

910

0.69

2.30

1.5

1.6

1364.35

1010.97

mu/l

1.03

768

Scabies, including avohilmo

607

6803

0.88

2.30

1.5

1.6

998.33

995.57

mu/l

0.02

499

5810

Other and unspecified anaemias

315

3486

0.85

2.30

1.6

1368.09

999.17

mu/l

0.60

252

2911

Disorders of other endocrine glands

1446

15333

0.92

2.29

1.5

1.6

952.09

1017.33

mu/l

1.90

1244

13149

Hypogonadotropic hypogonadism

185

0.37

2.29

1.3

1.7

953.20

917.08

mu/l

—

157

Dysphagia

231

2797

0.82

2.29

1.6

1129.31

1001.55

mu/l

1.02

191

2347

Pain and other conditions associated with female genital organs and menstrual cycle

1624

14520

0.92

2.29

1.5

1.6

1030.50

1030.03

mu/l

0.00

1333

12513

Fracture of skull and facial bones

358

4169

0.85

2.28

1.6

1028.27

998.75

mu/l

0.24

282

3548

Thyrotoxicosis with diffuse goitre

475

4163

1.15

2.28

1.5

1.6

938.99

1029.77

mu/l

1.22

382

3469

Congenital malformations of uterus and cervix

204

1691

1.27

2.28

1.6

1038.52

1006.94

mu/l

0.12

180

1423

Basal cell carcinoma, including Hilmo

817

0.73

2.27

1.7

1.5

1072.16

1056.08

mu/l

0.05

629

Explicit fungal Sepsis

0.00

2.27

0.0

1.6

—

852.37

—

Explicit fungal Sepsis, including avohilmo

0.00

2.27

0.0

1.6

—

852.37

—

Malignant neoplasm of breast, ER-negative, including Hilmo

128

1547

0.77

2.26

1.4

1.5

1111.71

1041.64

mu/l

0.34

1219

547

0.62

2.25

1.4

1.6

1048.88

1005.86

mu/l

0.08

426

Cellulitis

385

4452

0.86

2.25

1.6

952.09

1006.24

mu/l

0.61

323

3784

Other/unspecified rheumatoid arthritis

917

0.69

2.24

1.4

1.6

972.32

997.36

mu/l

0.09

744

Osteoporosis

984

0.72

2.24

1.5

1.6

1011.96

1011.14

mu/l

0.00

815

Trigger finger

147

1862

0.79

2.24

1.4

1.6

1109.95

1048.96

mu/l

0.13

116

1524

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

231

2790

0.82

2.24

1.5

1.6

1014.54

1019.27

mu/l

0.02

176

2278

Injuries to the thorax

607

6811

0.89

2.24

1.5

1.6

1046.96

1004.78

mu/l

0.17

491

5791

Follow-up care involving plastic surgery

614

0.63

2.23

1.3

1.6

1146.92

989.94

mu/l

0.43

490

Other/unspecified seropositive rheumatoid arthritis

231

2789

0.83

2.23

1.5

1.6

1014.54

1019.12

mu/l

0.02

176

2277

Ganglion

599

6718

0.89

2.23

1.5

1.6

989.12

1013.88

mu/l

0.28

477

5677

Other and unspecified local infections of skin and subcutaneous tissue

147

1857

0.78

2.23

1.5

1.6

930.75

1017.45

mu/l

0.58

121

1552

Benign neoplasm of colon, rectum, anus and anal canal

242

2463

0.83

2.22

1.5

986.62

1011.68

mu/l

0.17

187

1984

Pustular psoriasis

553

0.61

2.22

1.6

871.33

1002.00

mu/l

0.35

460

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

170

2109

0.80

2.22

1.5

1.6

863.45

999.37

mu/l

1.46

143

1777

Asthma (only as main-diagnosis)

2451

14519

0.94

2.22

1.6

974.32

1042.43

mu/l

2.71

2044

12456

Other noninflammatory disorders of vulva and perineum

528

4682

1.14

2.21

1.5

1.6

1018.95

1032.25

mu/l

0.12

430

3969

Acute renal failure

868

0.69

2.21

1.4

1.6

1075.19

998.99

mu/l

0.23

712

Hypo-osmolality and hyponatraemia

731

0.66

2.20

1.4

1.6

998.65

984.86

mu/l

0.04

599

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

3344

24766

1.05

2.20

1.6

1021.82

1014.07

mu/l

0.15

2810

21026

Disturbances of skin sensation

964

10534

0.91

2.18

1.6

992.88

1015.13

mu/l

0.31

786

8861

Fracture of lumbar spine and pelvis

203

2468

0.82

2.17

1.7

1.6

987.51

1003.38

mu/l

0.07

166

2073

Certolizumab pegol

160

1297

1.30

2.17

1.6

979.59

981.47

mu/l

0.01

142

1114

Collagenous colitis

121

1560

0.77

2.17

1.5

1.6

1044.37

1000.89

mu/l

0.21

101

1306

Other and unspecified follicular disorders

1055

0.72

2.17

1.4

1.6

889.82

996.34

mu/l

0.67

885

Diseases of the myoneural junction and muscle

1015

0.72

2.16

1.3

1.6

1298.16

980.50

mu/l

1.02

834

Embedded and impacted teeth

2775

21420

1.06

2.16

1.6

1058.00

1008.92

mu/l

0.97

2494

18521

Necrosis of pulp, including avohilmo

1861

19593

0.93

2.16

1.6

977.33

1014.94

mu/l

0.41

1529

16580

Tubulo-interstitial nephritis, not specified as acute or chronic

1195

0.74

2.15

1.7

1.6

998.08

1019.22

mu/l

0.08

987

Malignant neoplasm of corpus uteri, including Hilmo

182

0.38

2.14

1.3

1.6

1430.87

1035.97

mu/l

—

144

Diaphragmatic hernia

180

2219

0.81

2.14

1.5

1.6

879.21

1021.68

mu/l

0.82

145

1815

Systemic lupus erythematosus, unspecified

677

0.65

2.14

1.5

1.6

1025.83

982.60

mu/l

0.13

559

Mixed disorders of conduct and emotions

164

2001

0.79

2.14

1.6

848.43

960.72

mu/l

1.14

122

1757

Mental and behavioural disorders due to cannabinoids

1128

0.73

2.13

1.5

1.6

873.97

998.36

mu/l

0.74

971

Other specified/unspecified arthritis

543

6111

0.88

2.13

1.5

1.6

1005.32

1007.46

mu/l

0.02

449

5173

Urticaria and erythema

1310

14111

0.92

2.12

1.5

1.6

956.11

1010.50

mu/l

1.45

1103

11993

Diseases of peritoneum

940

0.71

2.11

1.4

1.6

1069.28

1026.18

mu/l

0.12

760

Primary hyperparathyroidism

448

0.58

2.11

1.3

1.5

746.75

1028.83

mu/l

0.88

359

Implicit fungal Sepsis, including avohilmo

1077

0.73

2.11

1.5

1.6

902.56

1020.10

mu/l

0.89

903

Gastrointestinal diseases

3237

17038

0.95

2.11

1.6

990.89

1013.12

mu/l

0.63

2730

14622

Neoplasms

4126

22592

0.95

2.11

1.5

1.6

1007.71

1016.26

mu/l

0.18

3469

19339

Chronic hepatitis, not elsewhere classified

470

0.59

2.11

1.6

1059.09

983.87

mu/l

0.12

393

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

574

0.62

2.10

1.5

1.6

840.30

974.52

mu/l

0.62

494

Obesity related asthma

541

6085

0.89

2.09

1.5

1.6

661.14

1001.58

mu/l

22.80

444

5083

Lung diseases due to external agents

667

0.66

2.08

1.3

1.6

1203.97

1005.44

mu/l

0.52

553

Corns and callosities

689

0.66

2.08

1.6

837.64

1041.15

mu/l

0.74

563

Diffuse brain injury

663

0.65

2.08

1.4

1.6

1042.56

993.05

mu/l

0.15

567

Fracture of shoulder and upper arm

534

6000

0.89

2.08

1.6

973.50

995.36

mu/l

0.25

450

5202

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

860

0.70

2.06

1.6

869.66

1029.43

mu/l

0.70

724

Acute appendicitis

2142

21054

0.94

2.06

1.6

1033.05

1016.31

mu/l

0.20

1778

17643

Cerebral palsy

583

0.63

2.06

1.7

1.6

1357.22

999.12

mu/l

0.98

491

Covid-19 confirmed case

974

8917

1.10

2.05

1.6

984.97

1011.10

mu/l

0.38

855

7616

Obesity, other/unspecified

1477

13785

1.08

2.04

1.6

600.14

1058.37

mu/l

88.82

1208

11610

ILD medications: azathioprine

354

4078

0.86

2.03

1.5

1.6

1076.23

1013.85

mu/l

0.53

299

3442

Unspecified acute lower respiratory infection

216

2594

0.83

2.03

1.6

1.5

974.75

1028.26

mu/l

0.32

176

2119

Mood disorders

3461

23154

0.95

2.01

1.5

1.6

1025.75

1014.86

mu/l

0.18

2813

19799

Triptan medication for migraine, min. 3 purchases

3446

24611

1.05

2.01

1.5

1.6

1002.83

1016.68

mu/l

0.32

2813

20975

Cystic fibrosis with intestinal manifestations

0.00

2.01

0.0

1.5

—

874.86

—

Ehlers-Danlos syndrome

596

0.64

2.01

1.6

1064.37

989.77

mu/l

0.23

500

Etanercept

144

1793

0.79

2.00

1.5

1.6

941.70

1002.23

mu/l

0.31

113

1492

Malignant neoplasm of breast, HER-negative

103

1290

0.76

2.00

1.3

1.5

1178.68

1038.77

mu/l

0.70

1004

Other disorders originating in the perinatal period

358

1.53

2.00

1.7

1.6

1140.21

937.19

mu/l

0.47

319

Use of fingolimod

476

0.60

2.00

1.2

1.6

1008.43

1004.35

mu/l

0.01

380

Symptoms and signs concerning food and fluid intake

179

2178

0.81

2.00

1.7

1.6

970.75

1003.88

mu/l

0.20

149

1879

Tooth eruption problems

1336

13789

0.92

1.99

1.6

1008.48

998.89

mu/l

0.13

1210

12131

Postprocedural endocrine and metabolic disorders, not elsewhere classified

276

3234

0.85

1.99

1.4

1.6

883.94

1012.61

mu/l

1.49

216

2653

Vitamin deficiency

868

0.71

1.99

1.5

1.6

945.73

1057.54

mu/l

0.45

729

Vitamin deficiency, wide

868

0.71

1.99

1.5

1.6

945.73

1057.54

mu/l

0.45

729

Primary ovarian failure

1016

0.72

1.99

1.5

1.6

1080.09

1011.23

mu/l

0.25

841

Neurofibromatosis, type 2

0.00

1.98

0.0

1.5

—

874.59

—

Migraine with aura and triptan purchases

1134

12210

0.92

1.98

1.5

1.6

1003.38

1015.17

mu/l

0.16

923

10436

Benign neoplasm of other and unspecified endocrine glands

128

1618

0.79

1.97

1.6

980.88

1009.86

mu/l

0.11

107

1332

Other abnormal findings of blood chemistry

935

0.72

1.97

1.4

1.6

913.14

1010.57

mu/l

0.45

784

Seborrhoeic keratosis

139

1102

1.26

1.96

1.5

1.6

1182.64

1061.64

mu/l

0.61

104

873

Optic neuritis

125

1572

0.78

1.96

1.5

1.6

1126.19

1020.75

mu/l

0.55

102

1298

Bursitis of shoulder

282

0.49

1.96

1.2

1.5

1594.68

1003.98

mu/l

—

231

Astigmatism

182

2199

0.81

1.96

1.5

1.6

986.56

986.26

mu/l

0.00

151

1904

Other respiratory diseases principally affecting the interstitium

561

0.64

1.95

1.6

1143.64

993.88

mu/l

0.34

453

Visual disturbances

1165

12574

0.92

1.95

1.6

969.96

1008.34

mu/l

0.59

996

10710

Azathioprine

354

4063

0.86

1.95

1.5

1.6

1076.23

1015.19

mu/l

0.52

299

3420

Panniculitis affecting regions of neck and back

569

0.64

1.94

1.5

1.6

1123.66

994.02

mu/l

0.30

459

Benign neoplasm: Pituitary gland, craniopharyngeal duct

1138

0.75

1.94

1.6

966.60

1014.71

mu/l

0.16

944

Melanocytic naevi of trunk

412

3625

1.15

1.93

1.5

1.6

1013.29

1000.24

mu/l

0.10

345

3065

Graves disease, strict definition

400

3517

1.15

1.92

1.5

1.6

952.39

1008.73

mu/l

0.58

319

2933

Other noninflammatory disorders of cervix uteri

481

1.41

1.92

1.6

1123.30

1019.98

mu/l

0.34

389

Struck by thrown, projected or falling objec

1282

0.76

1.91

1.6

1051.36

990.14

mu/l

0.28

1107

Viral and other specified intestinal infections, including avohilmo

1733

17700

0.94

1.91

1.6

1002.73

1011.67

mu/l

0.14

1518

15460

Noninfective enteritis and colitis

1233

13244

0.93

1.91

1.6

1050.37

1006.42

mu/l

0.81

1043

11273

Mood [affective] disorders

3460

23151

0.95

1.90

1.5

1.6

1026.20

1014.77

mu/l

0.19

2812

19796

Impingement syndrome of shoulder

946

0.73

1.90

1.5

911.83

1064.11

mu/l

1.20

741

Disorders of vitreous body

233

2630

0.84

1.90

1.5

1.6

990.70

1011.01

mu/l

0.13

187

2151

Complications of other internal prosthetic devices, implants and grafts

457

0.61

1.90

1.4

1.5

1509.83

1011.50

mu/l

1.14

364

Pedal cyclist injured in transport accident

619

6857

0.90

1.90

1.6

1066.23

996.51

mu/l

1.03

542

5867

Cervical polyps

163

1325

1.24

1.90

1.6

1.5

1078.46

1046.64

mu/l

0.14

130

1042

Other congenital malformations of brain

165

0.40

1.90

1.3

1.7

1013.49

938.92

mu/l

—

148

Polyuria

187

2261

0.82

1.89

1.5

1.6

1044.04

999.38

mu/l

0.25

160

1883

Specific developmental disorder of motor function

555

0.64

1.89

1.5

1.7

1529.87

944.59

mu/l

0.41

507

Glomerulonephritis

1216

0.76

1.89

1.7

1.6

1044.62

1025.08

mu/l

0.06

1003

Benign thyroid growths and nodules

346

3695

0.87

1.89

1.5

927.49

1027.11

mu/l

1.26

267

2988

Other disorders of optic [2nd] nerve and visual pathways

119

1503

0.78

1.89

1.5

1.6

850.25

995.00

mu/l

1.44

104

1284

Optic atrophy

237

0.46

1.88

1.3

1.6

938.95

981.67

mu/l

0.08

197

Other predominantly sexually transmitted diseases, not elsewhere classified

967

10461

0.91

1.88

1.5

1.6

1003.99

1011.89

mu/l

0.09

775

8778

Cerebral aneurysm, nonruptured

590

0.66

1.87

1.3

1.6

1106.46

964.20

mu/l

0.42

465

Routine general health check-up of defined subpopulation

817

0.70

1.86

1.5

1.6

1195.58

960.72

mu/l

0.99

687

COPD, hospital admissions 1, only main diagnosis

701

0.71

1.85

1.7

1.6

1109.50

1004.08

mu/l

0.21

581

Cervicocranial syndrome

186

2240

0.82

1.85

1.5

1.6

1159.02

1009.55

mu/l

0.49

154

1887

Other disorders of veins

609

5396

1.11

1.85

1.6

1.5

1085.55

1027.52

mu/l

0.20

468

4345

Cholecystitis

1123

0.75

1.85

1.5

1.6

915.20

1041.93

mu/l

0.64

917

Superficial injury of head

485

5433

0.89

1.85

1.6

1063.32

999.49

mu/l

0.74

400

4646

Visual impairment including blindness (binocular or monocular)

811

0.71

1.85

1.5

1.6

775.33

997.03

mu/l

1.59

690

LSIL lesion of the cervix uteri, vagina or vulva

768

8379

0.91

1.85

1.5

1.6

1103.48

1016.63

mu/l

1.04

627

6995

Pollen allergy

1108

11742

0.92

1.83

1.5

1.6

982.23

1007.81

mu/l

0.41

933

10156

Crohn's disease of large intestine

107

1362

0.77

1.83

1.6

995.99

1018.82

mu/l

0.08

1129

Gastroduodenal ulcer

1005

0.74

1.83

1.4

1.6

867.76

1016.79

mu/l

0.80

819

Convergent concomitant strabismus

178

2140

0.82

1.82

1.5

1.6

1004.60

1001.92

mu/l

0.01

148

1818

Deviated nasal septum

320

3682

0.87

1.82

1.5

1.6

1001.02

1016.60

mu/l

0.10

261

3078

Other and unspecified drugs and medicaments

144

1774

0.80

1.82

1.6

841.31

1000.65

mu/l

1.82

121

1499

Fungal Sepsis

476

0.62

1.82

1.3

1.6

1016.86

984.16

mu/l

0.09

393

Other and unspecified iron deficiency

848

7760

1.09

1.82

1.7

1.6

1020.92

1011.85

mu/l

0.09

711

6564

Myopia

611

6738

0.90

1.82

1.5

1.6

962.48

998.52

mu/l

0.52

527

5766

Degeneration of macula and posterior pole

519

0.68

1.81

1.4

1.6

1009.51

980.79

mu/l

0.10

415

Blood alcohol or alcohol intoxication level

801

0.71

1.81

1.4

1.6

1098.72

975.35

mu/l

0.53

705

Autoimmune hyperthyroidism

210

1766

1.20

1.80

1.5

1.6

962.80

1036.06

mu/l

0.51

163

1456

Other malignant neoplasms of skin (=non-melanoma skin cancer)

794

0.76

1.80

1.7

1.5

1094.36

1065.50

mu/l

0.09

614

Ankle and foot

192

0.45

1.79

1.8

1.5

1061.43

942.14

mu/l

—

166

Other neurotic disorders

474

0.63

1.79

1.3

1.6

889.04

982.18

mu/l

0.30

389

Optic atrophy, wide definition

245

0.48

1.78

1.3

1.6

890.26

973.20

mu/l

0.17

203

Examination and observation for other reasons

2051

12231

0.94

1.78

1.5

1.6

981.76

1018.16

mu/l

0.86

1664

10377

Hyperhidrosis

123

1526

0.79

1.77

1.5

1.6

1041.58

997.65

mu/l

0.21

1305

Intentional self-harm by jumping or lying before moving object

0.00

1.77

0.0

1.5

—

859.09

—

Hyperfunction of pituitary gland

170

2042

0.82

1.76

1.5

1.6

886.46

1015.59

mu/l

1.15

152

1717

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

106

846

1.33

1.76

1.6

1058.88

1009.00

mu/l

0.14

708

Migraine with aura

1629

17250

0.94

1.75

1.6

986.39

1014.81

mu/l

0.57

1351

14770

Pacemaker

898

0.74

1.74

1.5

1.6

840.72

1009.54

mu/l

1.03

743

Coronary artery bypass grafting

0.00

1.74

0.0

1.4

—

914.12

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

732

0.70

1.74

1.6

1038.84

1007.72

mu/l

0.10

611

Calcific tendinitis of shoulder

459

0.63

1.74

1.4

1.5

993.66

1094.60

mu/l

0.21

346

Motor disorders

556

0.66

1.74

1.5

1.6

1529.87

945.51

mu/l

0.41

507

Vitamin D deficiency

550

0.66

1.74

1.4

1.6

1051.04

1051.71

mu/l

0.00

468

Speech therapy

237

2780

0.85

1.73

1.5

1.6

1071.96

1006.09

mu/l

0.48

207

2300

Abnormal results of function studies

141

1730

0.81

1.73

1.6

950.35

1010.72

mu/l

0.37

122

1453

Severe visual impairment, binocular

0.00

1.72

0.0

1.6

—

899.53

—

Disorders of speech understanding and production

115

1408

0.79

1.72

1.6

877.93

941.08

mu/l

0.36

1250

Viral and other specified intestinal infections

1299

13518

0.93

1.72

1.6

1031.24

1002.53

mu/l

0.48

1147

11877

Fracture of foot, except ankle

792

8620

0.91

1.72

1.6

1003.32

1015.64

mu/l

0.12

641

7409

Shock, not elsewhere classified

0.00

1.71

0.0

1.6

—

834.16

—

Asthma, including avohilmo

4161

23792

0.96

1.71

1.5

1.6

985.19

1020.49

mu/l

1.33

3462

20252

Symptoms and signs involving emotional state

1099

0.76

1.71

1.5

1.6

1495.86

979.36

mu/l

0.52

953

Assault

413

4642

0.88

1.71

1.5

1.6

963.65

1001.32

mu/l

0.35

328

3954

Other gastritis (incl. Duodenitis)

172

2072

0.83

1.71

1.4

1.6

930.12

1011.74

mu/l

0.56

137

1719

Aneurysms, operations, SAH

904

0.74

1.71

1.4

1.6

973.25

1008.37

mu/l

0.13

719

Other/unspecified dorsalgia

990

10546

0.92

1.70

1.6

944.94

1016.60

mu/l

1.97

791

8938

Other and unspecified injuries of wrist and hand

1245

0.77

1.70

1.5

1.6

896.79

1004.89

mu/l

0.57

1072

Urticaria

1163

12455

0.93

1.69

1.5

1.6

962.44

1011.01

mu/l

1.13

971

10596

Pustulosis palmaris et plantaris

491

0.65

1.69

1.6

897.59

1010.25

mu/l

0.27

407

Oedema, not elsewhere classified

488

5314

0.89

1.69

1.6

909.04

1002.34

mu/l

1.65

401

4470

Focal brain injury

587

0.68

1.69

1.6

1335.80

998.70

mu/l

0.79

494

Dystonia

887

0.74

1.68

1.4

1.6

1117.00

1021.75

mu/l

0.23

730

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

981

0.75

1.68

1.4

1.6

792.85

1008.62

mu/l

1.69

804

Other and unspecified hydrocephalus

164

0.42

1.68

1.4

1.5

1333.84

941.69

mu/l

—

138

Acute suppurative otitis media

1779

17492

0.94

1.67

1.6

931.99

1018.00

mu/l

3.69

1536

15027

Poisoning by narcotics and psychodysleptics [hallucinogens]

625

0.68

1.67

1.5

1.6

894.01

979.24

mu/l

0.23

535

Complications of anaesthesia during the puerperium

236

1.65

1.67

1.7

1.6

872.21

1021.70

mu/l

0.64

196

Hypopituitarism

1135

0.77

1.67

1.5

1.6

1153.39

991.24

mu/l

0.69

959

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

335

0.61

1.67

1.3

1.6

1182.57

953.04

mu/l

0.36

282

Pediculosis, acariasis and other infestations, including avohilmo

671

7335

0.91

1.66

1.5

1.6

1003.16

993.37

mu/l

0.09

545

6277

Diseases of the eye and adnexa

3808

19837

0.96

1.66

1.6

997.91

1016.90

mu/l

0.52

3246

16930

Viral pneumonia (known virus, not influenza)

378

0.60

1.65

1.5

1.6

1128.14

955.91

mu/l

0.22

326

Asthma (mode)

2655

14607

0.95

1.63

1.6

967.54

1041.37

mu/l

3.29

2209

12527

Periapical abscess

814

8838

0.92

1.63

1.5

1.6

980.78

1014.43

mu/l

0.33

671

7440

Recurrent or chronic depression

1458

10753

0.94

1.63

1.5

1.6

993.66

1025.26

mu/l

0.54

1189

9283

Other orthopaedic follow-up care

790

0.73

1.62

1.6

1023.69

1002.14

mu/l

0.06

659

Congenital deformities of feet

976

0.75

1.62

1.7

1.6

1192.53

983.11

mu/l

1.01

846

Other sexually transmitted chlamydial diseases

632

5801

1.11

1.61

1.5

1.6

1071.65

1000.71

mu/l

0.99

525

4979

Other diseases of lip and oral mucosa

866

9369

0.92

1.61

1.5

1.6

1004.56

1002.42

mu/l

0.02

714

7944

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

196

2307

0.84

1.61

1.5

1.6

942.25

993.01

mu/l

0.35

166

1934

Bronchitis, not specified as acute or chronic

1151

0.78

1.60

1.4

1.6

883.20

1027.18

mu/l

0.87

925

Flat foot [pes planus] (acquired)

101

1274

0.79

1.60

1.5

1.6

931.00

1011.93

mu/l

0.40

1066

Budesonide

370

4166

0.88

1.59

1.7

1.6

1069.09

1007.90

mu/l

0.56

313

3495

Systemic sclerosis (FG)

286

0.55

1.58

1.3

1.6

990.23

962.97

mu/l

—

222

Other disorders of cornea

1105

0.77

1.58

1.7

1.6

1161.43

1031.07

mu/l

0.62

907

LSIL lesion of the cervix uteri

727

7877

0.91

1.58

1.5

1.6

1095.66

1017.23

mu/l

0.85

596

6586

Other (seronegative) rheumatoid arthritis, wide

176

2096

0.84

1.58

1.5

1.6

935.48

1015.62

mu/l

0.61

129

1714

Other and unspecified injuries of lower leg

225

2616

0.85

1.58

1.5

1.6

893.57

997.85

mu/l

1.19

182

2253

Unicornuate uterus

332

1.61

1.58

1.6

1380.18

965.07

mu/l

0.52

276

Enterocolitis due to Clostridium difficile

1071

0.77

1.57

1.5

1.6

1044.39

1013.43

mu/l

0.10

889

Systemic sclerosis, icd10

285

0.55

1.57

1.3

1.6

990.23

1009.88

mu/l

—

225

Vulvovaginal ulceration/inflammation in other diseases

507

4604

1.12

1.56

1.6

959.63

1006.90

mu/l

0.59

403

3904

Disorders of breast

2063

19061

0.95

1.55

1.6

1024.62

1012.09

mu/l

0.22

1732

15972

Divergent concomitant strabismus

145

1750

0.82

1.55

1.5

1.6

988.01

1020.39

mu/l

0.17

122

1455

Carcinoma in situ of endometrium

0.00

1.54

0.0

1.7

—

909.42

—

Implicit fungal Sepsis

455

0.65

1.53

1.3

1.6

1016.86

992.52

mu/l

0.07

377

Systemic sclerosis

282

0.56

1.52

1.3

1.6

990.23

993.15

mu/l

—

222

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

172

2038

0.84

1.52

1.6

986.53

1021.57

mu/l

0.21

142

1692

Psoriasis vulgaris

245

2825

0.86

1.49

1.6

883.89

1002.84

mu/l

1.43

205

2357

Certain infectious and parasitic diseases

3714

19305

0.96

1.49

1.6

1006.00

1024.40

mu/l

0.47

3149

16467

Crohn disease (strict definition, require KELA, min 2 HDR)

188

2203

0.84

1.49

1.5

1.6

951.21

994.79

mu/l

0.28

159

1852

Basal cell carcinoma

728

0.78

1.49

1.7

1.5

1086.58

1071.62

mu/l

0.04

562

Congenital malformation syndromes predominantly affecting facial appearance

123

0.38

1.48

1.4

1.6

784.00

956.81

mu/l

—

105

Malignant neoplasm of cervix uteri

679

0.72

1.48

1.4

1.6

1172.38

1011.32

mu/l

0.49

550

Other arthritis (FG)

624

6813

0.91

1.47

1.5

1.6

1030.66

1006.56

mu/l

0.25

509

5731

Disorders of lacrimal system

838

8890

0.92

1.47

1.5

1.6

1019.42

1010.32

mu/l

0.10

673

7412

Crohn disease (strict definition, require KELA)

189

2211

0.84

1.47

1.5

1.6

948.34

998.05

mu/l

0.33

160

1857

Hyperprolactinaemia

133

1599

0.81

1.47

1.5

1.6

953.38

1007.32

mu/l

0.28

119

1338

Status epilepticus

462

0.66

1.47

1.4

1.6

927.48

959.14

mu/l

0.05

391

Neovascular glaucoma

366

0.62

1.46

1.4

1.6

869.22

984.48

mu/l

0.37

308

Other and unspecified tonsillitis

2177

18923

0.95

1.46

1.6

954.05

1027.07

mu/l

2.36

1812

16337

Abnormal serum enzyme levels

140

1630

0.83

1.46

1.5

1.6

1050.70

1005.86

mu/l

0.12

121

1355

Hypertrophic scar

181

2121

0.84

1.46

1.5

1.6

1027.55

1016.19

mu/l

0.05

145

1792

Induced delusional disorder

0.00

1.45

0.0

1.6

—

911.76

—

Benign mammary dysplasia

179

2108

0.84

1.45

1.5

1.6

1039.55

1000.88

mu/l

0.23

149

1738

Event of undetermined intent

155

1843

0.83

1.45

1.6

894.03

982.84

mu/l

0.71

115

1591

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2462

22573

1.05

1.44

1.5

1.6

1011.91

1016.15

mu/l

0.08

2026

19132

Superficial frostbite

138

0.42

1.44

2.3

1.6

1230.62

917.76

mu/l

—

118

Fall on same level involving ice and snow

1332

14118

0.94

1.43

1.6

967.63

1013.79

mu/l

0.92

1104

12047

Diplopia

175

2062

0.84

1.43

1.6

1015.25

1007.57

mu/l

0.03

136

1720

Early onset COPD

922

0.77

1.43

1.6

1087.28

1009.62

mu/l

0.17

761

Speech disturbances, not elsewhere classified

796

0.75

1.42

1.6

1200.92

1031.87

mu/l

0.61

660

Other noninfective gastroenteritis and colitis

537

5885

0.91

1.42

1.6

1045.56

1000.70

mu/l

0.51

448

5033

Other skin changes

319

2822

1.13

1.42

1.6

990.56

991.94

mu/l

0.01

260

2372

Malignant neoplasm of cervix uteri, including Hilmo

778

0.74

1.42

1.5

1.6

1221.08

1006.55

mu/l

0.79

631

Arthropod-borne viral fevers and viral haemorrhagic fevers

1076

0.79

1.42

1.5

1.6

887.08

1009.14

mu/l

0.69

887

Artificial opening status

339

0.62

1.42

1.5

1.6

635.18

977.52

mu/l

—

281

Hypertrophic disorders of skin

198

2298

0.85

1.42

1.5

1.6

1039.36

1012.83

mu/l

0.13

160

1947

Other embolism and thrombosis

106

1309

0.81

1.41

1.5

1583.93

1023.21

mu/l

0.45

1077

Other disorders of eyelid

200

2201

0.86

1.41

1.5

1.6

944.48

1019.51

mu/l

0.57

158

1791

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

276

0.58

1.41

1.4

598.06

1177.49

mu/l

2.27

189

Other and unspecified disorders of skin and subcutaneous tissue

827

0.76

1.41

1.4

1.6

969.91

1022.67

mu/l

0.21

692

Primary amenorrhea

767

0.73

1.41

1.8

1.6

1217.99

968.22

mu/l

1.27

672

Pedal cyclist injured in noncollision transport accidents

261

2975

0.87

1.40

1.6

1056.63

994.40

mu/l

0.55

220

2516

Nail disorders

150

1784

0.83

1.39

1.5

1.6

1008.13

978.15

mu/l

0.16

124

1516

Polycystic ovarian syndrome

759

7092

1.10

1.39

1.6

878.29

1005.88

mu/l

4.46

667

6109

Abnormal weight loss

104

1283

0.81

1.39

1.7

1.6

1095.48

982.64

mu/l

0.63

1103

Early onset COPD, excluding more controls

917

0.77

1.39

1.6

1087.28

1023.18

mu/l

0.14

767

Other extrapyramidal and movement disorders in other diseases

297

3361

0.88

1.39

1.5

1.6

986.11

992.10

mu/l

0.04

254

2791

Ocular pain

245

2799

0.87

1.39

1.5

1.6

1028.64

992.13

mu/l

0.25

194

2340

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

1.39

0.0

1.5

—

1027.13

—

Assault by bodily force

242

2766

0.87

1.38

1.6

934.96

1002.20

mu/l

0.50

190

2350

Glaucoma secondary to other eye disorders

360

0.63

1.38

1.4

1.6

869.22

977.60

mu/l

0.34

303

Viral haemorrhagic fevers, not elsewhere classified/unspecified

959

0.78

1.37

1.5

1.6

904.70

997.08

mu/l

0.41

791

Acrodermatitis continua

0.00

1.37

0.0

1.6

—

883.31

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

988

10403

0.93

1.37

1.6

1060.32

1013.17

mu/l

0.19

812

8935

Use of dimethyl fumarate

411

0.65

1.36

1.3

1.6

1219.96

992.26

mu/l

0.39

340

Abscess of anal and rectal regions

125

1508

0.82

1.36

1.3

1.6

987.85

994.28

mu/l

0.03

106

1252

Other and unspecified pemphigus

0.00

1.35

0.0

1.5

—

950.05

—

DVT of lower extremities

129

1554

0.83

1.35

1.6

903.24

1020.39

mu/l

0.83

113

1273

All influenza (not pneumonia)

273

3095

0.88

1.35

1.5

1.6

964.78

990.82

mu/l

0.10

227

2628

Bruxism

746

0.74

1.34

1.5

1.6

883.41

996.06

mu/l

0.51

613

Endometriosis of intestine

1107

0.79

1.34

1.4

1.6

858.35

1055.20

mu/l

1.57

893

Recurrent dislocation and subluxation of joint

163

1915

0.84

1.34

1.6

972.06

1022.89

mu/l

0.33

136

1590

Other diseases of spinal cord

369

0.64

1.34

1.4

1.6

1612.03

962.76

mu/l

1.15

296

Congenital deformities of hip, including avohilmo

867

0.76

1.34

1.5

1.6

1090.65

1002.55

mu/l

0.22

759

Tobacco use

183

1570

1.18

1.33

1.4

1.6

836.39

1008.35

mu/l

2.05

144

1340

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

570

0.72

1.33

1.6

1342.56

981.04

mu/l

0.22

466

Myeloproliferative diseases

453

0.68

1.33

1.3

1.6

1039.99

952.82

mu/l

0.15

366

Papilloedema, unspecified

869

0.77

1.33

1.5

1.6

781.17

1004.43

mu/l

2.21

745

Scarlet fever, including avohilmo

355

1.41

1.33

1.7

1.6

1056.10

939.23

mu/l

0.25

312

Use of antiglaucoma preparations and miotics

284

0.60

1.33

1.4

1.6

883.78

920.50

mu/l

0.07

244

Ectropion of eyelid

0.00

1.32

0.0

1.7

—

888.26

—

Mandibular retrognathia

290

2567

1.14

1.32

1.6

1149.29

991.32

mu/l

0.85

253

2200

Other congenital malformations

330

3680

0.89

1.32

1.6

1058.43

987.38

mu/l

0.69

292

3158

Polyarthritis, unspecified

544

0.71

1.32

1.5

1.6

1014.90

1010.06

mu/l

0.01

460

Weight loss

142

1688

0.84

1.32

1.7

1.6

1066.42

981.28

mu/l

0.53

119

1448

Other disorders of bladder

932

0.78

1.32

1.6

911.27

971.42

mu/l

0.28

783

Examination and encounter for administrative purposes

796

0.76

1.31

1.4

1.6

736.79

1005.99

mu/l

2.30

662

Superficial injury of forearm

366

4061

0.89

1.30

1.6

965.69

999.68

mu/l

0.30

307

3498

Spinal instabilities

244

0.57

1.30

1.2

1.6

774.19

1040.87

mu/l

—

189

Other symptoms and signs involving the urinary system

1074

0.80

1.30

1.8

1.6

1038.98

982.41

mu/l

0.18

902

Hodgkin lymphoma, hilmo

700

0.75

1.30

1.5

1.6

928.29

962.90

mu/l

0.12

593

Contusion of ankle

133

1580

0.83

1.29

1.6

930.66

981.37

mu/l

0.29

111

1373

Intestinal stricture

172

2012

0.85

1.29

1.5

1.6

1045.79

1024.85

mu/l

0.09

134

1637

Superficial injury of thorax

255

2893

0.88

1.28

1.5

1.6

979.78

997.22

mu/l

0.10

202

2459

Other facial nerve disorders

470

0.69

1.28

1.5

1.6

983.80

1008.26

mu/l

0.05

396

Psoriatic arthropathies

113

1367

0.82

1.27

1.6

891.91

1034.81

mu/l

1.16

1104

Congenital malformations of genital organs

605

5560

1.09

1.27

1.6

1036.89

1016.76

mu/l

0.17

521

4687

Vascular disorders of the intestines

135

0.44

1.27

2.0

1.7

884.02

963.23

mu/l

—

117

Other diseases of arteries and capillaries

959

0.79

1.27

1.5

1.6

1084.63

1022.06

mu/l

0.22

797

Nontraumatic intracranial haemmorrhage

622

0.74

1.26

1.4

1.6

874.94

985.72

mu/l

0.55

502

Other and unspecified injuries of shoulder and upper arm

664

0.74

1.26

1.5

1.6

896.98

1022.90

mu/l

0.47

560

Hypothermia

158

0.50

1.26

1.1

1.6

1160.36

1014.40

mu/l

—

135

Radial styloid tenosynovitis [de Quervain]

217

1897

1.16

1.25

1.5

1.6

1098.40

1020.16

mu/l

0.29

191

1588

Chronic gastritis

118

1421

0.83

1.25

1.6

1067.12

1021.99

mu/l

0.16

1157

Pre-eclampsia superimposed on chronic hypertension

275

1.46

1.25

1.6

1.5

794.14

1065.81

mu/l

1.25

209

Visual field defects

901

0.78

1.25

1.4

1.6

981.13

1022.45

mu/l

0.16

744

Congenital deformities of hip

790

0.76

1.24

1.5

1.6

1107.00

987.12

mu/l

0.30

697

Non-Hodgkin lymphoma, all, including Hilmo

458

0.70

1.24

1.7

1.5

1032.06

982.29

mu/l

0.11

377

Superficial injury of shoulder and upper arm

256

2894

0.88

1.24

1.6

933.14

997.14

mu/l

0.46

198

2461

Benign neoplasm: Cerebral meninges

504

0.71

1.24

1.4

1.5

981.19

1068.68

mu/l

0.27

390

Other diseases of hard tissues of teeth

1127

5487

1.07

1.24

1.6

1018.50

1019.35

mu/l

0.01

919

4651

Nausea and vomiting

739

7739

0.93

1.23

1.6

1160.97

1011.39

mu/l

0.55

615

6726

Seronegative rheumatoid arthritis

104

1263

0.82

1.22

1.5

1.6

874.33

1035.62

mu/l

1.18

1015

Other general symptoms and signs

151

1750

0.85

1.22

1.5

1.6

1508.32

1012.61

mu/l

0.67

118

1469

Amblyopia ex anopsia

120

1430

0.83

1.22

1.6

879.10

963.59

mu/l

0.66

110

1266

Ovarian dysfunction, other/unspecified

352

0.65

1.22

1.5

1.6

1086.86

990.26

mu/l

0.15

291

Synovial cyst of popliteal space [Baker]

617

0.74

1.22

1.4

1.6

900.77

1018.68

mu/l

0.61

510

Frostbite

187

0.52

1.22

2.0

1.6

977.92

914.96

mu/l

—

163

Other bursopathies

1175

0.81

1.22

1.5

1.6

841.32

1050.84

mu/l

2.21

985

Iron deficiency anaemia

949

8734

1.07

1.21

1.7

1.6

1044.33

1008.93

mu/l

0.44

790

7345

Ingrowing nail

1138

0.81

1.21

1.5

1.6

883.65

1007.85

mu/l

0.99

977

Non-allergic asthma (mode)

410

4469

0.91

1.21

1.7

1.6

961.70

1018.58

mu/l

0.69

355

3924

Whooping cough, including avohilmo

102

844

1.24

1.21

1.8

1.6

935.35

991.77

mu/l

0.34

719

Unspecified urinary incontinence

1118

0.81

1.21

1.6

745.65

978.20

mu/l

3.66

948

Autoimmune polyglandular failure

0.00

1.21

0.0

1.6

—

1002.57

—

Retinal haemorrhage

143

0.49

1.21

1.6

1007.79

990.89

mu/l

—

117

Hydronephrosis

179

1543

1.17

1.21

1.6

1086.40

1002.76

mu/l

0.49

160

1302

Balanced rearrangements and structural markers, not elsewhere classified

245

1.51

1.21

1.7

1.6

965.49

952.46

mu/l

0.03

209

Non-allergic asthma (mode), excluding more controls

410

4468

0.91

1.21

1.7

1.6

961.70

1018.61

mu/l

0.69

355

3924

Congenital dislocation of hip, unilateral

222

0.56

1.21

1.3

1.5

1007.35

957.38

mu/l

0.09

203

Behavioural disorders, excluding more controls

103

1233

0.81

1.20

1.5

1.7

922.01

955.86

mu/l

0.18

1095

Maltreatment syndromes

224

2538

0.87

1.20

1.5

1.6

960.50

983.96

mu/l

0.13

183

2174

Other benign neoplasms of skin

592

5463

1.09

1.20

1.5

1.6

981.04

1014.60

mu/l

0.44

477

4571

Abuse of non-dependence-producing substances

0.00

1.20

0.0

1.7

—

801.95

—

Social disorders starting during childhood or adolecense, excluding more controls

512

0.71

1.20

1.6

1254.73

960.09

mu/l

0.91

455

Open wound of ankle and foot

246

2779

0.88

1.20

1.6

966.71

999.83

mu/l

0.13

215

2391

Complications of internal orthopaedic prosthetic devices, implants and grafts

774

0.77

1.19

1.4

1.6

965.21

1004.03

mu/l

0.16

628

Cluster headache, strict, including avohilmo

137

1611

0.84

1.19

1.5

1.6

1072.01

1007.38

mu/l

0.28

117

1345

Biomechanical lesions, not elsewhere classified

640

1.26

1.19

1.5

1.6

1342.86

998.45

mu/l

1.75

517

Deforming dorsopathies

662

7124

0.93

1.19

1.5

1.6

1020.46

1006.46

mu/l

0.15

570

6150

Diagnoses used for exclusion with ILD

152

1779

0.85

1.18

1.4

1.6

1094.91

1020.72

mu/l

0.38

116

1432

Other diseases of blood and blood-forming organs

533

0.73

1.18

1.5

1.6

949.28

978.48

mu/l

0.07

430

Bacterial intestinal infections, IBD co-morbidities

218

2482

0.88

1.17

1.6

1047.68

1016.39

mu/l

0.17

182

2076

Benign neoplasm of meninges

556

0.73

1.17

1.5

1000.62

1066.49

mu/l

0.21

430

Tic and related disorders

626

0.74

1.17

1.5

1.7

1119.97

950.37

mu/l

0.65

563

Injury of nerves at wrist and hand level

779

0.77

1.17

1.4

1.6

852.34

1001.12

mu/l

1.21

651

Thiamine deficiency

0.00

1.17

0.0

1.5

—

965.89

—

Allergic conjunctivitis

2556

23691

1.04

1.16

1.5

1.6

1014.81

1014.83

mu/l

0.00

2105

20066

Severe mental retardation

0.00

1.16

0.0

1.5

—

847.17

—

Carcinoma in situ of breast, intraductal

381

0.68

1.16

1.5

1186.26

1018.96

mu/l

0.50

294

Other and unspecified effects of external causes

1122

11851

0.94

1.16

1.5

1.6

948.14

1007.42

mu/l

1.50

931

10147

Malignant neoplasm of nasal cavity and sinuses

0.00

1.16

0.0

1.4

—

932.45

—

Gastric ulcer

758

0.78

1.15

1.4

1.6

822.09

984.74

mu/l

0.79

617

Chondropathies

374

4117

0.90

1.15

1.6

1020.23

1008.10

mu/l

0.06

309

3492

Ankylosis of joint

0.00

1.15

0.0

1.6

—

947.67

—

Acute gastritis

610

0.75

1.14

1.5

1.6

903.81

1031.26

mu/l

0.40

494

Viral conjunctivitis, including avohilmo

163

1409

1.17

1.14

1.5

1.6

958.04

983.44

mu/l

0.14

128

1196

Monosomies and deletions from the autosomes, not elsewhere classified

123

0.46

1.14

1.7

865.10

869.10

mu/l

—

104

Torsion of ovary, ovarian pedicle and fallopian tube

137

1172

1.20

1.14

1.5

1.6

1015.10

1012.20

mu/l

0.01

114

979

Injury of other and unspecified intrathoracic organs

518

0.73

1.14

1.6

1044.51

998.94

mu/l

0.12

432

Cluster headache, wide,, including avohilmo

139

1625

0.85

1.14

1.5

1.6

1065.21

1007.42

mu/l

0.25

118

1357

Other Crohn's disease

188

2150

0.87

1.14

1.5

1.6

994.06

1007.53

mu/l

0.07

153

1806

Medicines for HER+ breast cancer

433

3680

1.10

1.13

1.5

1.6

863.89

1005.23

mu/l

3.16

375

3019

Crushed, pushed or stepped on by crowd or human stampede

268

2995

0.89

1.13

1.5

1.6

965.14

992.34

mu/l

0.20

223

2591

Malignant neoplasm of ovary, including Hilmo

529

0.73

1.13

1.5

1.6

922.76

970.59

mu/l

0.19

438

Asthma mixed form (mode)

112

1334

0.83

1.13

1.5

1.6

1113.84

987.97

mu/l

0.71

1143

Conductive hearing loss, unspecified

135

1584

0.85

1.13

1.5

1.6

1082.15

998.32

mu/l

0.43

115

1342

Unspecified lump in breast

390

3550

1.10

1.13

1.5

1.6

991.29

1007.15

mu/l

0.13

331

2941

Diseases of inner ear

622

6408

0.93

1.12

1.5

1.6

993.07

1010.73

mu/l

0.11

507

5323

Other ulcerative colitis

122

1441

0.84

1.12

1.5

1.6

1081.27

1035.50

mu/l

0.20

101

1189

Inflammatory bowel disease

870

9254

0.94

1.12

1.6

1054.71

1009.33

mu/l

0.65

736

7836

Trigeminal neuralgia

919

0.80

1.12

1.6

1087.23

1023.76

mu/l

0.18

751

Crohn disease

363

3993

0.90

1.12

1.5

1.6

961.68

997.23

mu/l

0.31

303

3380

Other bacterial intestinal infections

230

2599

0.88

1.12

1.6

1074.11

1009.01

mu/l

0.40

195

2173

Other otitis externa (chronic)

109

1301

0.83

1.12

1.4

1.6

1492.94

1007.66

mu/l

0.36

1085

Asthma mixed form (mode), excluding more controls

112

1332

0.83

1.11

1.5

1.6

1113.84

987.71

mu/l

0.71

1142

806

0.79

1.11

1.6

1013.71

1006.93

mu/l

0.03

684

Psoriatic and enteropathic arthropathies

160

1852

0.86

1.11

1.6

969.36

1018.06

mu/l

0.30

134

1511

Family history of malignant neoplasm

337

3719

0.90

1.11

1.6

991.11

1017.43

mu/l

0.21

277

3059

Dermatitis due to substances taken internally

122

1438

0.84

1.10

1.6

992.30

1007.51

mu/l

0.07

101

1223

Achilles tendinitis

1061

0.82

1.10

1.6

1203.78

1038.02

mu/l

0.62

875

Ulcerative enterocolitis

737

0.78

1.10

1.6

1154.73

1009.77

mu/l

0.38

603

Benign neoplasm of ovary

205

2329

0.88

1.09

1.5

1.6

1134.16

1011.74

mu/l

0.29

181

1924

Fracture of rib(s), sternum and thoracic spine

228

2575

0.88

1.09

1.5

1.6

1227.89

994.35

mu/l

0.45

186

2158

Spasmodic torticollis

478

0.72

1.09

1.3

1.6

1281.27

1003.42

mu/l

0.38

381

Juvenile rheumatoid arthirtis

1029

0.81

1.09

1.5

1.6

921.10

1013.59

mu/l

0.44

870

Symptoms and signs involving appearance and behaviour

264

0.62

1.08

1.8

1.6

866.15

1004.43

mu/l

0.32

221

4023

19792

1.03

1.08

1.6

996.86

1032.16

mu/l

1.13

3339

16908

Other acute viral hepatitis

277

0.64

1.08

1.3

1.6

1011.22

950.71

mu/l

0.11

231

Other diseases of intestine

806

0.79

1.08

1.5

1.6

1079.98

1039.84

mu/l

0.09

652

Additional codes for the location of defect, injury or illness

1165

0.83

1.08

1.5

1.6

1021.59

998.82

mu/l

0.09

988

Cramp and spasm

1109

0.82

1.07

1.5

1.6

1052.31

1009.59

mu/l

0.18

938

Endometriosis of pelvic peritoneum

806

7786

0.93

1.07

1.5

1.6

1020.87

1038.97

mu/l

0.20

667

6484

Other disorders of bone density and structure

678

0.77

1.07

1.5

1.6

842.02

981.28

mu/l

0.95

572

Lichen ruber planus, wide definition including periferal and oral lichen planus

176

2018

0.87

1.07

1.5

1.6

857.96

1026.05

mu/l

2.33

141

1651

Other renal tubulo-interstitial diseases

372

0.69

1.07

1.3

1.5

1079.92

1059.92

mu/l

0.04

278

Personal history of certain other diseases

190

1685

1.17

1.07

1.5

1.6

1028.37

992.57

mu/l

0.13

163

1444

Alopecia areata

1017

0.81

1.06

1.5

1.6

1114.93

998.07

mu/l

0.62

866

Pedestrian injured in collision with car, pick-up truck or van

610

0.76

1.06

1.4

1.6

1120.82

954.90

mu/l

0.67

522

Iridocyclitis in diseases classified elsewhere

263

1.39

1.05

1.4

1.6

844.39

928.15

mu/l

0.37

225

Secondary uncertain malignant neoplasm

825

0.80

1.05

1.5

1.6

849.61

988.13

mu/l

0.82

682

Crohn disease (strict definition, all UC cases excluded)

142

1644

0.85

1.05

1.5

1.6

887.64

987.10

mu/l

0.77

123

1390

Personal history of malignant neoplasm

1076

0.82

1.05

1.5

787.63

1054.66

mu/l

3.50

873

Pruritus

381

3482

1.10

1.05

1.6

999.04

995.98

mu/l

0.03

329

2939

Pain in joint

2142

12652

1.04

1.05

1.6

958.45

1016.94

mu/l

2.06

1776

10969

Papillary adenocarcinoma of thyroid gland

789

0.79

1.04

1.5

1.6

1203.03

1013.48

mu/l

0.50

633

Nephrotic syndrome

428

0.72

1.04

1.5

1.6

1362.56

972.19

mu/l

0.63

364

Striking against or struck by other objects

1044

10994

0.94

1.03

1.6

955.32

1012.66

mu/l

1.33

868

9481

Diseases caused by chlamydiae

155

1.51

1.03

1.7

1.5

824.88

862.76

mu/l

0.11

128

Abnormal findings on diagnostic imaging of other body structures

143

1658

0.86

1.03

1.5

1.6

1097.68

1026.67

mu/l

0.21

116

1358

Use of interferon beta-1a

794

0.79

1.03

1.3

1.6

1081.95

1030.14

mu/l

0.21

641

IBD patients in KELA-register

710

7572

0.93

1.03

1.6

1071.43

1007.04

mu/l

0.88

603

6422

Blepharochalasis

656

0.78

1.03

1.3

1.5

1018.20

1042.78

mu/l

0.07

495

Injury of muscle and tendon at lower leg level

144

1668

0.86

1.02

1.4

1.6

1019.54

1042.36

mu/l

0.12

114

1367

564

6057

0.93

1.02

1.6

1026.08

1006.36

mu/l

0.19

484

5167

Other and unspecified urticaria

683

7289

0.93

1.02

1.5

1.6

956.36

1001.49

mu/l

0.70

572

6169

Acute generalized exanthematous pustulosis

983

0.82

1.02

1.6

1104.69

1012.04

mu/l

0.41

836

Other psoriatic arthropathies

108

1279

0.84

1.02

1.6

893.85

1031.92

mu/l

1.04

1043

Allergic asthma (mode), excluding more controls

1194

12228

0.95

1.02

1.5

1.6

950.64

1041.42

mu/l

2.88

1007

10580

Pneumonia derived septicemia

592

1.25

1.01

1.7

1.6

930.62

989.40

mu/l

0.24

516

Other/unspecified enthesopathies of lower limb, excluding foot

138

1599

0.86

1.01

1.4

1.6

1021.21

1025.58

mu/l

0.02

111

1318

Retinal detachments and breaks

136

1582

0.86

1.01

1.4

1.6

1004.98

1024.02

mu/l

0.09

111

1289

Lymphoid leukaemia

392

0.71

1.01

1.7

1.6

761.94

959.07

mu/l

1.16

340

Acute sinusitis

2271

19911

1.04

1.01

1.6

1009.93

1027.57

mu/l

0.30

1844

16985

Other and unspecified injuries of head

101

1201

0.84

1.01

1.5

1.6

1077.52

1032.52

mu/l

0.18

1032

Rosacea

316

3478

0.90

1.01

1.5

1.6

985.20

999.17

mu/l

0.11

273

2917

Allergic asthma (mode)

1194

12225

0.95

1.01

1.5

1.6

950.64

1041.65

mu/l

2.89

1007

10575

Thrombocytopenia, unspecified

106

892

1.19

1.00

1.5

1.6

1078.49

1019.09

mu/l

0.23

754

Myeloproliferative diseases (CML excluded)

380

0.71

1.00

1.3

1.6

1026.29

963.97

mu/l

0.08

305

Primary open-angle glaucoma

264

0.66

1.00

1.3

1.6

1146.95

1031.14

mu/l

—

210

Malignant neoplasm of endocrine gland

1156

0.83

1.00

1.5

1.6

1060.49

1021.91

mu/l

0.11

949

Medullary carcinoma of thyroid gland, including Hilmo

0.00

0.99

0.0

1.5

—

1027.34

—

Scar conditions and fibrosis of skin

1174

0.83

0.99

1.6

953.15

1030.31

mu/l

0.42

992

Congenital malformation of biliary tract

0.00

0.99

0.0

1.5

—

899.95

—

Malignant neoplasm of thyroid gland

1068

0.83

0.99

1.4

1.6

1102.03

1024.28

mu/l

0.23

870

Intestinal adhesions without obstruction

448

0.73

0.99

1.4

1.6

995.94

989.51

mu/l

0.01

346

Other diseases caused by chlamydiae

165

1.48

0.99

1.7

1.5

772.89

856.01

mu/l

0.26

136

Injuries to unspecified part of trunk, limb or body region

204

2296

0.88

0.98

1.5

1.6

978.49

993.19

mu/l

0.09

163

1960

Superficial injury of hip and thigh

250

2782

0.89

0.98

1.6

1007.40

995.31

mu/l

0.06

208

2383

Exposure to other specified electric current

833

0.80

0.98

1.6

770.31

997.70

mu/l

2.57

711

Other and unspecified rosacea

163

1861

0.87

0.98

1.5

1.6

999.31

1021.72

mu/l

0.13

144

1534

Inflammatory bowel disease, strict (require KELA)

710

7556

0.94

0.98

1.6

1071.43

1005.74

mu/l

0.90

603

6403

Other congenital malformations of nervous system

628

0.77

0.98

1.6

1108.22

977.82

mu/l

0.33

544

Marfan's syndrome

142

0.55

0.98

1.6

1.7

689.11

957.58

mu/l

—

119

Progressive systemic sclerosis

0.00

0.97

0.0

1.6

—

973.07

—

Acute myringitis

261

1.39

0.97

1.5

1.6

1034.40

988.65

mu/l

0.08

231

Morphin

0.00

0.97

0.0

1.6

—

841.75

—

Follow-up examination after treatment for malignant neoplasms

389

0.72

0.97

1.4

1.6

1038.95

1055.45

mu/l

0.03

307

Gingivitis and periodontal diseases

2814

14058

1.03

0.97

1.6

994.79

1028.71

mu/l

1.01

2343

11845

Malignant neoplasm of endocrine gland, including Hilmo

112

1314

0.85

0.97

1.5

1.6

1024.39

1026.58

mu/l

0.01

1083

Atrial septal defect, secundum type

731

0.79

0.96

1.6

1199.48

1000.61

mu/l

0.67

641

Sequelae of injuries of lower limb

145

1667

0.87

0.96

1.6

949.02

1018.42

mu/l

0.47

114

1389

Other encephalitis

545

0.76

0.96

1.6

796.06

967.13

mu/l

0.95

459

Somnolence, stupor and coma

702

0.79

0.96

1.5

1.6

1072.88

1004.03

mu/l

0.20

596

Other noninflammatory disorders of vagina

299

2718

1.11

0.96

1.6

1135.85

1027.30

mu/l

0.80

237

2295

Other/unspecified synovitis and tenosynovitis

206

2313

0.89

0.95

1.5

1.6

957.03

1017.16

mu/l

0.51

164

1945

Endometriosis ASRM stages 1,2

820

8668

0.94

0.95

1.5

1.6

1023.04

1013.95

mu/l

0.09

679

7199

All influenza

475

5122

0.92

0.95

1.5

1.6

1022.60

1013.19

mu/l

0.05

398

4383

Open wound of hip and thigh

875

0.81

0.95

1.6

777.57

983.06

mu/l

1.64

774

Paralytic strabismus

646

0.79

0.94

1.4

1.6

1050.05

994.56

mu/l

0.17

538

Unspecified event, undetermined intent

654

0.78

0.94

1.6

881.58

990.58

mu/l

0.58

550

Benign neoplasm: Colon

180

1914

0.88

0.94

1.5

982.59

1012.31

mu/l

0.16

136

1537

All dysplastic lesions of the cervix uteri, vagina or vulva

2014

20328

0.96

0.94

1.5

1.6

1050.87

1014.06

mu/l

0.74

1629

16953

Social disorders starting during childhood or adolescence

491

0.74

0.94

1.6

1254.73

962.22

mu/l

0.90

440

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

443

0.74

0.93

1.6

972.97

1007.43

mu/l

0.09

358

Anomalies of pupillary function

663

0.79

0.93

1.6

870.82

975.53

mu/l

0.53

558

Subjective visual disturbances

615

6564

0.93

1.6

1004.10

1004.70

mu/l

0.00

521

5549

Other or unspecified ileus, impaction or obstruction

975

0.83

0.93

1.6

972.10

1012.79

mu/l

0.14

789

Chondrocostal junction syndrome [Tietze]

895

0.82

0.93

1.5

1.6

1187.28

1000.53

mu/l

0.25

766

Psoriatic arthropathies, ICD10

113

1320

0.85

0.93

1.6

891.91

1033.52

mu/l

1.14

1072

Other injuries of upper limb, level unspecified

290

0.68

0.93

1.3

1.6

1070.61

961.72

mu/l

0.22

253

Benign neoplasm of brain and other parts of central nervous system

875

0.82

0.93

1.5

1.6

1201.86

992.97

mu/l

0.86

728

Nontoxic goitre/thyroid nodule

285

3141

0.91

0.93

1.5

839.72

1012.09

mu/l

3.44

213

2547

Other congenital malformations of the digestive system, including avohilmo

122

1401

0.86

0.92

1.5

1.6

993.83

978.39

mu/l

0.06

104

1222

Carcinoma in situ of other and unspecified genital organs

302

0.69

0.92

1.3

1.6

1724.61

992.22

mu/l

1.25

252

Caught, crushed, jammed or pinched in or between objects

121

1401

0.86

0.92

1.6

923.80

993.84

mu/l

0.44

101

1203

Congenital iodine-deficiency syndrome/hypothyroidism

474

0.75

0.92

1.6

836.74

1000.61

mu/l

0.62

390

Hand

127

0.54

0.91

1.3

1.6

1177.21

991.82

mu/l

—

109

Other and unspecified myopathies

498

0.76

0.91

1.3

1.6

1032.67

944.61

mu/l

0.16

413

All dysplastic lesions of the cervix uteri

1963

19984

0.96

0.91

1.5

1.6

1047.55

1016.25

mu/l

0.58

1591

16654

Fetus and newborn affected by maternal use of alcohol

0.00

0.91

0.0

1.5

—

628.11

—

Toxic effect of contact with venomous animals

926

0.82

0.91

1.7

1.6

859.82

1010.04

mu/l

0.98

778

Infective dermatitis

167

1893

0.88

0.91

1.6

990.99

1011.01

mu/l

0.10

145

1576

Other disorders of lacrimal gland

686

7293

0.94

0.91

1.5

1.6

1007.96

999.35

mu/l

0.08

553

6071

Benign neoplasm of other and unspecified female genital organs

710

1.21

0.91

1.5

1.6

1125.95

1013.32

mu/l

0.53

576

Atypical facial pain

860

0.82

0.90

1.6

855.32

1029.04

mu/l

1.03

705

Certain zoonotic bacterial diseases, including avohilmo

528

0.77

0.89

1.6

893.33

997.78

mu/l

0.63

452

Noninfectious colitis NAS

285

3130

0.91

0.89

1.5

1.6

1081.75

996.66

mu/l

0.76

231

2649

Amenorrhoea

616

6530

0.93

0.89

1.7

1.6

1078.99

1021.60

mu/l

0.81

512

5584

Other disorders of kidney and ureter

861

0.82

0.89

1.5

1.6

992.43

1004.83

mu/l

0.03

704

LSIL lesion of the vagina

402

0.73

0.89

1.3

1.6

970.90

997.19

mu/l

0.06

320

Other demyelinating diseases of the central nervous system

125

1436

0.86

0.89

1.5

1.6

1014.46

1034.65

mu/l

0.08

103

1185

Contact with sharp object, undetermined intent

648

0.79

0.88

1.6

840.78

965.38

mu/l

0.53

559

Certain infectious and parasitic diseases, including avohilmo

2459

12725

0.97

0.88

1.6

1013.80

1036.32

mu/l

0.44

2073

10950

Paralytic ileus and intestinal obstruction

147

1676

0.87

0.88

1.5

1.6

1095.33

1010.05

mu/l

0.39

116

1366

Respiratory tuberculosis

119

1.52

0.88

1.6

1.5

1094.36

1049.72

mu/l

0.07

Respiratory tuberculosis, confirmed and not-confirmed

119

1.52

0.88

1.6

1.5

1094.36

1049.72

mu/l

0.07

Nonpyogenic thrombosis of intracranial venous system

239

0.65

0.88

1.8

1.6

836.35

956.52

mu/l

0.24

199

Other bacterial intestinal infections, including avohilmo

437

4709

0.93

0.87

1.6

1032.03

1011.65

mu/l

0.16

373

3965

Other and unspecified injuries of ankle and foot

161

1816

0.88

0.87

1.6

933.83

992.98

mu/l

0.39

137

1571

Occupational exposure to risk-factors

425

0.75

0.87

1.7

1.6

1021.20

983.87

mu/l

0.08

353

Disorders of mineral metabolism

912

0.83

0.87

1.4

1.6

1041.44

1009.79

mu/l

0.08

760

Other disorders of white blood cells

758

0.81

0.86

1.7

1.6

931.18

1002.28

mu/l

0.28

633

Biological medicines for asthma

656

0.80

0.86

1.5

1.6

880.61

998.22

mu/l

0.52

550

Hypothyroidism, strict autoimmune

3099

20898

0.97

0.86

1.6

962.53

1024.32

mu/l

2.02

2610

17768

Lichen planus, including avohilmo

141

1610

0.87

0.86

1.5

1.6

804.99

1030.49

mu/l

3.26

110

1326

Maxillary retrognathism

774

0.81

0.86

1.4

1.6

1005.48

1027.31

mu/l

0.08

676

Maternal care for (suspected) damage to fetus from alcohol

245

1.41

0.86

1.3

1.5

904.80

946.93

mu/l

0.10

206

Atopic dermatitis, strict definition

1862

18832

0.96

0.86

1.6

972.74

1012.51

mu/l

1.15

1603

16188

Pneumococcal septicemia

569

1.22

0.86

1.7

1.6

948.44

965.28

mu/l

0.06

492

Chronic laryngitis and laryngotracheitis

141

1608

0.87

0.85

1.4

1.6

1016.54

1028.16

mu/l

0.05

112

1320

Herpesviral [herpes simplex] infections, including avohilmo

1131

11822

0.95

0.85

1.5

1.6

1012.68

1008.19

mu/l

0.06

950

10031

Deep endometriosis

354

3832

0.92

0.85

1.4

1.6

905.89

1023.17

mu/l

1.55

286

3145

Arthropathic psoriasis

126

1447

0.87

0.85

1.6

866.91

1031.31

mu/l

1.62

102

1177

Lichen planus

834

0.83

0.85

1.5

1.6

808.81

1042.07

mu/l

1.70

669

Stomatitis and related lesions

575

6123

0.94

0.85

1.5

1.6

1040.76

1006.41

mu/l

0.25

474

5234

Generalized skin eruption due to drugs and medicaments

896

0.83

0.85

1.6

1114.45

993.13

mu/l

0.54

763

Narcolepsy and cataplexy

259

0.67

0.85

1.6

1182.39

982.41

mu/l

0.26

227

Scabies

105

1219

0.85

1.6

1056.28

988.38

mu/l

0.28

1039

Bronchiectasis

251

0.68

0.84

1.3

1.7

1288.16

977.08

mu/l

—

211

Disorders of sclera, cornea, iris and ciliary body

1329

13852

0.96

0.84

1.5

1.6

1022.60

1010.71

mu/l

0.14

1105

11652

Pediculosis, acariasis and other infestations

118

1358

0.86

0.84

1.6

1101.03

993.56

mu/l

0.54

101

1158

Dysplasia of cervi uteri

1862

12654

1.04

0.84

1.5

1.6

1053.85

1029.75

mu/l

0.38

1523

10784

Tuberculosis

137

1.46

0.84

1.6

1.5

1117.37

1036.30

mu/l

0.13

111

Ménière disease

668

0.81

0.84

1.3

1.6

1436.58

1026.88

mu/l

0.42

531

Atrial septal defect

899

0.83

1.6

1204.59

984.39

mu/l

0.93

781

Contact with machinery

646

0.80

0.83

1.7

1.6

961.92

992.91

mu/l

0.11

540

All dysplastic lesions of the vulva

732

0.81

0.83

1.4

1.6

1173.49

1004.15

mu/l

0.57

593

Degenerative macular diseases

343

0.73

0.83

1.5

1.6

1034.90

965.06

mu/l

0.19

282

Other congenital malformations of the digestive system

103

1186

0.85

0.83

1.5

1.6

1043.19

979.13

mu/l

0.28

1037

Effects of foreign body entering through natural orifice

460

4934

0.93

0.83

1.5

1.6

1012.80

999.11

mu/l

0.13

393

4234

Hypoparathyroidism

376

0.74

0.83

1.1

1.6

1135.22

955.32

mu/l

0.22

313

Carbimazole or st.post thyroidectomy, condition for graves disease

574

5392

1.07

0.83

1.5

1.6

1010.85

1013.41

mu/l

0.02

466

4487

Enlarged lymph nodes

331

3593

0.92

0.82

1.6

1096.40

1004.71

mu/l

0.89

286

3064

Lupus nephritis

123

0.55

0.82

1.9

1.6

1500.51

946.83

mu/l

—

100

Myeloid leukaemia

165

0.60

0.82

1.4

1.6

969.36

948.39

mu/l

—

140

Other/unspecified enthesopathies, not elsewhere classified

895

0.83

0.82

1.5

1.6

863.43

1037.58

mu/l

1.10

741

Osteonecrosis

307

0.71

0.82

1.2

1.5

772.12

952.22

mu/l

0.92

257

Prophylactic surgery

314

0.71

0.81

1.4

1.6

874.70

964.08

mu/l

0.23

254

Sulfasalazine

637

6754

0.94

0.81

1.5

1.6

978.80

1012.43

mu/l

0.40

521

5644

Encephalitis

575

0.79

0.81

1.6

791.97

975.56

mu/l

1.15

482

Anosmia

226

0.67

0.81

1.7

1.6

1176.75

1017.37

mu/l

0.19

188

Streptococcal septicaemia, including avohilmo

811

1.18

0.81

1.6

951.08

999.56

mu/l

0.21

687

Complicated migraine, drug-induced

0.00

0.80

0.0

1.5

—

892.23

—

Other acute disseminated demyelination

337

0.72

0.80

1.4

1.5

737.98

981.77

mu/l

1.02

271

Hypertrophy of (infrapatellar) fat pad

199

1.38

0.80

1.5

1.7

1146.77

994.80

mu/l

0.23

169

Secondary and unspecified malignant neoplasm of lymph nodes

741

0.82

0.80

1.5

1.6

864.29

974.70

mu/l

0.55

621

Childhood asthma (age<16)

1411

11429

0.96

0.80

1.6

964.03

1048.78

mu/l

2.63

1223

10132

Other disorders of breast

538

5054

1.07

0.80

1.6

1024.50

1013.99

mu/l

0.10

449

4219

Dermatographic urticaria

243

2665

0.90

0.80

1.5

1.6

836.53

1004.85

mu/l

3.08

193

2252

Childhood asthma (age<16), excluding more controls

1411

11426

0.96

0.80

1.6

964.03

1048.43

mu/l

2.61

1223

10131

Malignant neoplasm of ovary

419

0.76

0.80

1.4

1.6

959.73

965.39

mu/l

0.02

352

Hernia of abdominal wall, postoperative

235

2115

1.11

0.80

1.6

1.5

1115.76

998.77

mu/l

0.47

189

1716

Temporomandibular joint disorders, including avohilmo

2689

25335

1.03

0.80

1.6

999.42

1016.66

mu/l

0.38

2297

21477

Generalized epilepsy

143

1613

0.88

0.79

1.5

1.6

1083.12

999.40

mu/l

0.40

122

1366

Felty syndrome

0.00

0.79

0.0

1.4

—

911.70

—

Abnormal findings on examination of urine, without diagnosis

825

0.83

0.79

1.6

899.37

1010.65

mu/l

0.28

694

Obstructive hydrocephalus

175

0.62

0.79

1.6

1.5

656.51

989.81

mu/l

1.18

151

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

781

7455

1.06

0.79

1.6

991.12

1004.36

mu/l

0.15

650

6359

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

100

865

1.18

0.79

1.6

1088.69

960.51

mu/l

0.75

772

Malignant neoplasm of thyroid gland, including Hilmo

101

1170

0.86

0.79

1.4

1.6

1075.62

1034.98

mu/l

0.12

957

Squamous cell neoplasms and carcinomas of the skin

0.00

0.79

0.0

1.5

—

1137.09

—

Acute lymphadenitis

175

1951

0.89

0.79

1.6

1047.11

998.80

mu/l

0.24

146

1646

Thyrotropin deficiency

336

0.73

0.79

1.6

745.70

988.48

mu/l

0.87

274

Disorders of calcium metabolism

585

0.80

0.79

1.3

1.6

1156.77

979.87

mu/l

0.33

480

Periodontal disease, other/unspecified

585

1.21

0.78

1.6

1020.39

970.06

mu/l

0.15

506

Atopic conjunctivitis

145

1633

0.88

0.78

1.5

1.6

1118.35

978.96

mu/l

1.02

122

1410

Lichen sclerosus et atrophicus

154

1366

1.13

0.78

1.6

940.34

1012.20

mu/l

0.47

132

1123

Streptococcal septicaemia

777

1.18

0.78

1.6

928.56

989.20

mu/l

0.27

660

Injuries to the neck

883

9257

0.95

0.77

1.5

1.6

1018.94

1006.91

mu/l

0.11

711

7938

Malignant neoplasm of other and unspecified female genital organs

0.00

0.77

0.0

1.4

—

1065.04

—

Accessory breast

336

1.30

0.77

1.5

1.6

1280.79

968.45

mu/l

0.76

285

All dysplastic lesions of the vagina

636

0.81

0.77

1.3

1.6

1176.43

1002.58

mu/l

0.49

505

Tic and related disorders

589

0.80

0.77

1.5

1.6

1119.97

987.29

mu/l

0.46

523

Car occupant injured in noncollision transport accident

149

1326

1.14

0.77

1.6

880.83

980.45

mu/l

0.60

122

1143

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

1046

0.85

0.76

1.5

1.6

981.99

995.20

mu/l

0.05

881

Valvular operations

326

0.74

0.76

1.3

1.6

1064.22

981.42

mu/l

0.16

271

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

781

7455

1.06

0.76

1.6

991.12

1004.36

mu/l

0.15

650

6359

Abscess of Bartholin gland

133

1497

0.87

0.76

1.6

947.34

1024.17

mu/l

0.50

103

1268

Other diseases of pancreas

325

0.74

0.75

1.7

1.5

906.66

985.76

mu/l

0.22

263

Contusion of toe(s) without damage to nail

100

1148

0.86

0.75

1.5

1.6

1019.06

1012.16

mu/l

0.03

984

Crohn's disease of small intestine

197

2175

0.90

0.75

1.5

1.6

926.71

1001.40

mu/l

0.59

161

1824

Adenocarcinoma and papilloma adenocarcinoma of rectum

1.54

0.75

1.4

1.6

1133.77

1012.15

mu/l

—

Adverse effects, not elsewhere classified

773

8118

0.95

0.75

1.5

1.6

946.16

1003.27

mu/l

1.10

642

6916

Other infectious diseases

971

0.85

0.74

1.5

1.6

1007.87

1009.35

mu/l

0.01

802

Inflammatory diseases of the central nervous system

130

1471

0.88

0.74

1.6

891.13

1019.48

mu/l

0.91

106

1226

Arnold-Chiari syndrome

593

0.80

0.74

1.6

1110.25

977.97

mu/l

0.33

512

Other specified/unspecified soft tissue disorders

612

0.81

0.73

1.4

1.6

1056.99

1028.93

mu/l

0.08

507

Carcinoma in situ of cervix uteri, exocervix

205

0.66

0.73

1.3

1.5

1042.74

1030.37

mu/l

—

159

Conduct disorder

104

1186

0.86

0.73

1.5

1.6

923.91

971.51

mu/l

0.27

1041

Other diseases of peritoneum

468

0.79

0.73

1.4

1.6

938.93

1003.98

mu/l

0.19

374

Benign neoplasm of other and ill-defined parts of digestive system

119

1354

0.88

0.73

1.5

1.6

1050.86

1028.00

mu/l

0.08

1097

Other inflammatory liver diseases

882

0.85

0.72

1.5

1.6

1041.53

994.12

mu/l

0.15

727

157

1736

0.88

0.72

1.6

1.7

1025.00

944.66

mu/l

0.44

133

1559

Other specified/unspecified bacterial intestinal infections

785

0.84

0.72

1.5

1.6

1185.09

990.01

mu/l

0.51

658

Pedestrian injured in transport accident

142

1594

0.89

0.72

1.4

1.6

1004.62

968.70

mu/l

0.20

119

1356

Other specified/unspecified hearing loss

666

0.82

0.72

1.7

1.6

836.31

1003.78

mu/l

0.71

558

Other infectious diseases, including avohilmo

127

1436

0.88

0.72

1.5

1.6

923.41

999.43

mu/l

0.48

103

1197

Nonsuppurative otitis media

1795

16046

0.97

0.72

1.6

1018.79

1014.97

mu/l

0.03

1573

14172

Other hearing loss

150

1628

0.89

0.72

1.6

1009.41

1007.90

mu/l

0.01

129

1357

Invasive ventilation

838

0.84

0.71

1.6

1151.40

993.82

mu/l

0.69

703

Effects of other external causes

117

1031

1.15

0.71

1.5

1.6

928.27

996.97

mu/l

0.45

879

Adjustment and management of implanted device

785

0.84

0.71

1.4

1.6

889.30

984.57

mu/l

0.48

658

Lesion of radial nerve

355

0.76

0.71

1.1

1.6

1955.72

980.52

mu/l

0.52

282

Left ventricular outflow tract obstruction (LVOTO), broad definition

967

0.86

0.71

1.5

1.6

884.78

990.60

mu/l

0.70

810

Problems related to lifestyle

382

4089

0.93

0.71

1.5

1.6

899.96

1014.46

mu/l

1.87

309

3482

Other disorders of pigmentation

620

0.82

0.71

1.4

1.6

1232.27

989.50

mu/l

0.70

518

Acute bronchiolitis

282

2752

0.92

0.71

1.7

1.6

946.65

976.19

mu/l

0.23

262

2510

Other disorders of the genitourinary system

784

0.84

0.71

1.4

1.5

746.49

1022.58

mu/l

2.11

614

Desensitization to allergens

283

3057

0.92

0.71

1.6

1005.83

984.03

mu/l

0.15

244

2607

Glaucoma secondary to eye inflammation

145

0.61

0.71

1.4

1.7

1340.34

852.58

mu/l

—

127

Failed attempted abortion

803

1.18

0.71

1.6

1.4

1215.49

1051.10

mu/l

0.68

660

Primary open-angle glaucoma, strict

217

0.69

0.70

1.3

1.6

1160.17

1005.97

mu/l

—

172

Congenital malformations of heart and great arteries

313

3274

0.92

0.70

1.5

1.6

1129.82

997.60

mu/l

1.37

263

2809

Posteruptive colour changes of dental hard tissues

136

1.45

0.70

1.7

1.6

1470.43

956.88

mu/l

1.06

117

Ankylosing spondylitis, strict definition

867

0.85

0.70

1.7

1.6

1061.14

1000.02

mu/l

0.20

700

Lymphangioma, anys site

249

0.71

0.70

1.6

835.55

935.72

mu/l

0.26

212

Pediculosis and phthiriasis, including avohilmo

304

1.29

0.70

1.6

852.91

941.68

mu/l

0.26

257

Fistulae involving female genital tract

216

0.69

0.70

1.4

1.6

1470.87

1033.67

mu/l

—

174

Bicornuate uterus

489

1.24

0.70

1.7

1.6

825.25

986.09

mu/l

0.78

402

Retention of urine

260

2288

0.92

0.70

1.6

962.76

1004.85

mu/l

0.31

195

1910

Ulcerative colitis

634

6682

0.95

0.70

1.6

1125.08

999.06

mu/l

2.17

538

5650

Behavioural disorders

103

1170

0.87

0.69

1.5

1.6

922.01

972.32

mu/l

0.28

1023

Other diseases of stomach and duodenum

376

0.77

0.69

1.5

1.6

916.99

959.89

mu/l

0.10

311

Dislocation, sprain and strain of joints and ligaments at neck level

718

7532

0.95

0.69

1.5

1.6

1028.93

1004.38

mu/l

0.20

578

6440

Gluteal tendinitis

530

0.81

0.69

1.5

1.6

846.31

1034.76

mu/l

1.13

426

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

585

0.82

0.68

1.7

1.6

751.83

982.95

mu/l

1.62

490

Polymorphous light eruption

225

0.69

0.68

1.1

1.5

1391.83

949.24

mu/l

0.47

186

Acute bronchitis

959

9807

0.96

0.68

1.6

960.86

1011.01

mu/l

0.62

760

8384

Sexual dysfunction

362

0.76

0.68

1.4

1.6

911.67

946.54

mu/l

0.09

296

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

405

0.78

0.68

1.3

1.6

1054.72

916.42

mu/l

0.27

360

Crohn's disease NAS

155

1721

0.89

0.67

1.5

1.6

951.35

1009.53

mu/l

0.36

133

1448

Allergic colitis

129

1151

1.14

0.67

1.7

951.89

947.98

mu/l

0.02

116

1047

Polyarthrosis

225

0.72

0.67

1.3

1.4

1106.97

992.99

mu/l

0.17

166

Nontoxic single thyroid nodule

1120

0.87

0.67

1.4

1.5

774.83

1064.96

mu/l

3.29

900

Melanocytic naevi of ear and external auricular canal

172

1.38

0.67

1.5

1.6

952.37

933.91

mu/l

0.02

148

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

349

3650

0.93

0.66

1.6

1108.47

976.04

mu/l

1.35

305

3241

Other/unspecified soft tissue disorders related to use, overuse and pressure

581

0.82

0.66

1.5

1.6

1332.74

1021.39

mu/l

0.83

486

Injury of intra-abdominal organs

602

0.82

0.66

1.5

1.6

893.68

987.92

mu/l

0.46

517

HSIL lesion of the vulva

349

0.76

0.66

1.4

1.6

965.60

991.37

mu/l

0.05

289

Asthma and opportunity respiratory infection

179

0.67

0.66

1.3

1.5

1295.49

970.69

mu/l

—

152

Injury of nerves at forearm level

326

0.76

0.66

1.5

1.6

1171.09

977.88

mu/l

0.47

272

Other and unspecified paralytic syndromes

213

0.70

0.66

1.5

1.6

1038.03

950.56

mu/l

0.14

181

5-aminosalicylic acid

614

6462

0.95

0.66

1.6

1090.65

1009.63

mu/l

1.04

514

5439

Generalized epilepsy, mode (most common among epilepsy diagnosis)

101

1146

0.87

0.66

1.4

1.6

1142.67

999.01

mu/l

0.59

973

Hypotension

744

0.85

0.65

1.7

1.6

954.46

1004.66

mu/l

0.13

628

Disorders of vestibular function (Vertigo)

546

5615

0.95

0.65

1.5

1.6

1015.37

1009.46

mu/l

0.03

447

4666

Keratoconus

393

0.78

0.65

1.8

1.6

1024.64

990.81

mu/l

0.06

329

Varicose veins of other sites

304

1.25

0.65

1.4

1.5

1361.95

1008.19

mu/l

0.69

244

Fracture of neck

482

0.81

0.65

1.7

1.6

1028.22

994.17

mu/l

0.06

408

Atopic dermatitis, strict definition with reimbursement

1939

19139

0.97

0.64

1.6

977.90

1018.11

mu/l

1.19

1674

16379

Hypothyroidism (congenital or acquired)

2176

11858

1.03

0.64

1.6

959.53

1029.22

mu/l

1.85

1870

10319

Other and unspecified iridocyclitis

998

0.87

0.64

1.5

1.6

920.77

1035.55

mu/l

0.72

838

Psoriasis (vulgaris), strict definition

437

0.80

0.64

1.5

608.95

1012.13

mu/l

4.43

354

Other contact dermatitis

203

2217

0.91

0.64

1.6

947.37

993.90

mu/l

0.33

175

1863

Diseases of the respiratory system

2463

12664

0.97

0.64

1.6

1004.08

1042.46

mu/l

0.92

2075

10913

Disorders of fructose metabolism

0.00

0.64

0.0

1.6

—

922.98

—

Other specific arthropathies, wide

269

0.74

0.64

1.3

1.5

1068.66

987.85

mu/l

0.17

222

Benign neoplasm: Liver/bile ducts

707

0.84

0.64

1.5

1.6

1126.71

1001.95

mu/l

0.34

584

Lesion of lateral popliteal nerve

579

0.82

0.64

1.5

1.6

1187.46

1027.14

mu/l

0.47

481

Malignant neoplasm of colon

315

0.76

0.64

1.7

1.5

741.55

952.48

mu/l

0.64

254

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1.47

0.64

1.4

1.5

1133.77

1018.70

mu/l

—

Benign neoplasm: Short bones of lower limb

226

1.31

0.63

1.5

1.6

881.72

961.69

mu/l

0.31

195

Other and unspecified psoriasis

709

0.84

0.63

1.8

1.6

839.09

997.35

mu/l

1.10

583

Endometriosis in cutaneous scar

202

1.35

0.63

1.4

1.7

951.34

1010.94

mu/l

0.17

166

Ankylosing spondylitis

138

1537

0.89

0.63

1.6

1029.41

1025.67

mu/l

0.01

121

1266

Other deformities of toe(s)

392

0.79

0.63

1.6

920.96

983.25

mu/l

0.13

322

Scoliosis

423

4484

0.94

0.63

1.6

1053.27

1002.55

mu/l

0.60

377

3938

Cushing syndrome

176

0.67

0.63

1.5

988.56

985.50

mu/l

—

144

Other inflammation of eyelid

233

2529

0.92

0.63

1.5

1.6

991.94

994.97

mu/l

0.02

183

2117

Transport accidents

1983

16955

0.97

0.63

1.6

1020.66

1029.17

mu/l

0.09

1661

14562

Acute and subacute iridocyclitis

318

3410

0.93

0.63

1.5

1.6

927.05

993.28

mu/l

0.81

267

2840

Congenital musculoskeletal deformities of head, face, spine and chest

367

0.78

0.62

1.4

1.6

981.83

914.51

mu/l

0.10

324

Granulomatous disorders of skin and subcutaneous tissue

791

0.85

0.62

1.4

1.6

890.87

982.98

mu/l

0.46

658

Other CVD

891

0.86

0.62

1.6

959.27

995.61

mu/l

0.11

743

Congenital malformations of the circulatory system

356

3688

0.93

0.62

1.5

1.6

1110.49

996.52

mu/l

1.17

299

3158

Other forms of systemic lupus erythematosus

175

0.67

0.62

1.6

1.5

1149.88

977.54

mu/l

0.27

142

Early complications of trauma

631

0.84

0.62

1.5

1.6

1236.42

979.53

mu/l

1.26

543

!Aliquae complicationes praecoces traumatis

631

0.84

0.62

1.5

1.6

1236.42

979.53

mu/l

1.26

543

Benign neoplasm: Skin of ear and external auricular canal

361

1.23

0.62

1.5

1.6

905.48

969.99

mu/l

0.21

304

Vitamin B12 deficiency anaemia

501

0.82

0.61

1.6

994.79

1018.58

mu/l

0.06

404

Purpura and other haemorrhagic conditions

267

2475

1.08

0.61

1.6

912.37

1003.94

mu/l

0.97

221

2093

Other symptoms and signs involving the circulatory and respiratory systems

115

1290

0.89

0.61

1.5

1.6

894.24

1000.28

mu/l

0.86

1098

Mesial bite

441

0.80

0.61

1.4

1.6

948.67

930.85

mu/l

0.05

386

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

0.00

0.61

0.0

1.5

—

847.81

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

447

4584

0.94

0.60

1.6

1056.83

991.80

mu/l

0.71

385

3951

Dermatitis due to ingested food

186

1937

0.91

0.60

1.6

1008.88

952.16

mu/l

0.48

166

1725

Oral lichen planus, including avohilmo , including avohilmo

575

0.83

0.60

1.3

1.5

1021.96

1006.13

mu/l

0.05

458

Oligomenorrhoea

257

2393

1.09

0.60

1.7

1.6

901.46

1017.18

mu/l

1.25

214

2031

LSIL lesion of the vulva

421

0.80

0.60

1.4

1.6

1414.05

1006.09

mu/l

1.08

336

Other acute skin changes due to ultraviolet radiation

333

0.78

0.59

1.3

1.6

1265.64

975.39

mu/l

0.50

274

Cardiomyopathy (excluding other)

367

0.79

0.59

1.5

1.6

783.80

1005.87

mu/l

0.78

304

Cardiomyopathies, Secondary/extrinsic

0.00

0.59

0.0

1.5

—

927.51

—

Foreign body on external eye

185

2022

0.91

0.59

1.5

1.6

1037.19

993.95

mu/l

0.27

161

1715

Diseases of the ear and mastoid process

4384

22366

0.98

0.59

1.6

975.92

1022.64

mu/l

1.45

3669

18977

Diseases of spleen

264

1.26

0.59

1.6

1074.55

974.58

mu/l

0.26

220

Ulcerative colitis, NAS

345

3676

0.94

0.59

1.6

1139.91

997.35

mu/l

1.59

292

3114

Lipomatosis, not elsewhere classified

0.00

0.59

0.0

1.7

—

810.71

—

Disorder of carbohydrate metabolism, other/unspecified

0.00

0.59

0.0

1.5

—

702.64

—

Vertigo of central origin

113

0.62

0.58

1.6

3613.96

1010.94

mu/l

—

Acute pancreatitis

148

1634

0.90

0.58

1.6

891.63

1029.11

mu/l

1.31

115

1346

Melanocytic naevi, other sites/unspecified

251

2330

1.08

0.58

1.5

1.6

1025.43

991.65

mu/l

0.23

198

1969

Enterobiasis

250

1.30

0.58

1.6

856.58

922.83

mu/l

0.14

222

Non-allergic asthma

141

1557

0.90

0.58

1.6

1046.07

979.59

mu/l

0.32

122

1332

Pedal cyclist injured in collision with motor vehicle

1061

0.88

0.58

1.5

1.6

1031.15

982.73

mu/l

0.20

919

Use of glatiramer acetate

655

0.84

0.58

1.3

1.6

1067.44

1016.73

mu/l

0.18

524

Abdominal aortic aneurysm (AAA)

0.00

0.58

0.0

1.6

—

940.91

—

Haemolytic anaemias

633

1.16

0.58

1.6

1099.37

976.48

mu/l

0.49

543

Lichen simplex chronicus and prurigo

680

0.85

0.58

1.3

1.6

1068.95

976.96

mu/l

0.23

557

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

134

1212

1.12

0.58

1.4

1.6

1094.34

1026.04

mu/l

0.34

118

1012

Cluster headache, strict

100

1124

0.88

0.57

1.5

1.6

1067.26

1027.85

mu/l

0.12

933

Dermatophytosis, including avohilmo

1839

18497

0.97

0.57

1.5

1.6

946.45

1020.67

mu/l

3.03

1554

15608

Pneumonia due to Streptococcus pneumoniae

582

0.84

0.57

1.6

940.00

999.82

mu/l

0.21

487

Delayed puberty

447

0.81

0.57

1.6

1436.69

949.06

mu/l

1.37

397

Spondyloarthritis

397

4205

0.94

0.57

1.5

1.6

1020.44

1016.58

mu/l

0.03

341

3526

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

477

4879

0.95

0.57

1.6

1045.16

989.83

mu/l

0.60

412

4207

Pigmented purpuric dermatosis

0.56

1.8

1.6

901.14

978.61

mu/l

—

Non-follicular lymphoma

286

0.77

0.56

1.6

1161.73

935.70

mu/l

0.46

241

Restless leg syndrome

224

2420

0.92

0.56

1.5

1.6

999.97

1009.80

mu/l

0.06

192

2002

Spondylopathies (FG)

390

4130

0.94

0.56

1.5

1.6

1016.37

1019.53

mu/l

0.02

335

3468

Hypocalcemia

307

0.78

0.56

1.2

1.5

1259.51

991.48

mu/l

0.26

251

Infliximab

813

0.86

0.56

1.6

1095.91

1018.44

mu/l

0.20

686

Fetus and newborn affected by maternal complications of pregnancy

147

0.67

0.55

1.9

1.5

1074.08

942.44

mu/l

—

134

Hemiplegia

666

0.85

0.55

1.5

1.6

970.71

995.48

mu/l

0.05

552

Other and unspecified corneal deformities and disorders

395

0.81

0.55

1.5

1.6

1170.31

1001.52

mu/l

0.47

316

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1240

12546

0.97

0.55

1.5

1.6

1056.48

1017.71

mu/l

0.18

971

10449

Juvenile arthritis (FINNGEN)

245

2626

0.92

0.55

1.6

953.55

984.46

mu/l

0.23

208

2266

Benign neoplasm: Liver

685

0.85

0.55

1.5

1.6

1133.51

1002.97

mu/l

0.35

564

Monoarthritis, not elsewhere classified

758

1.14

0.55

1.5

1.6

1275.96

1012.15

mu/l

0.98

628

Benign neoplasm: Skin of trunk

711

1.15

0.55

1.5

1.6

1116.34

998.02

mu/l

0.51

592

Fasciculation

304

1.24

0.55

1.5

1000.52

971.65

mu/l

0.09

256

Congenital malformations of cardiac septa

171

1804

0.91

0.54

1.5

1.6

1111.43

975.89

mu/l

0.90

143

1569

Disturbances of smell and taste

438

0.82

0.54

1.7

1.6

1084.94

982.21

mu/l

0.26

366

Diseases of oral cavity, salivary glands and jaws

1103

5487

1.04

0.53

1.6

1023.91

1019.35

mu/l

0.05

904

4651

Isolated proteinuria

555

0.84

0.53

1.6

985.91

976.77

mu/l

0.01

461

Endocrine disorders, other/unspecified

403

0.81

0.53

1.5

1.6

949.55

996.76

mu/l

0.14

332

Other specified and unspecified disorders of eye and adnexa

534

0.84

0.53

1.6

830.14

1033.49

mu/l

0.92

446

Injury of unspecified body region

148

1621

0.91

0.53

1.6

971.76

997.14

mu/l

0.13

117

1381

Abnormal involuntary movements

229

2463

0.93

0.53

1.5

1.6

1098.37

993.57

mu/l

0.78

192

2070

Sequelae of external causes of morbidity and mortality

370

3917

0.94

0.52

1.5

1.6

955.36

991.95

mu/l

0.31

301

3293

Exposure to excessive natural cold

0.61

0.52

2.3

1.6

1293.40

929.88

mu/l

—

Thyroiditis, unspecified

370

1.20

0.52

1.5

1.6

934.33

995.74

mu/l

0.23

304

Other congenital malformations, including avohilmo

534

5586

0.95

0.52

1.5

1.6

1082.29

999.68

mu/l

1.08

462

4762

Protozoal diseases, including avohilmo

337

0.80

0.52

1.7

1043.67

979.57

mu/l

0.13

286

Other and unspecified epidermal thickening

532

0.84

0.52

1.4

1.6

681.77

957.98

mu/l

2.49

457

Other abnormal immunological findings in serum

638

0.85

0.52

1.5

1.6

1010.27

978.12

mu/l

0.12

541

Intestinal malabsorption

916

0.88

0.52

1.6

1066.92

1004.05

mu/l

0.24

780

Vascular diseases of the intestine

0.62

0.52

2.0

1.7

884.02

1015.88

mu/l

—

Autoimmune hepatitis, wide definition

810

0.87

0.52

1.5

1.6

1046.80

1007.99

mu/l

0.11

659

Follicular lymphoma, hilmo

0.60

0.52

1.7

1.6

760.37

792.36

mu/l

—

Other specified/unspecified inflammatory spondylopathies

139

1523

0.91

0.52

1.6

1010.38

1019.84

mu/l

0.04

115

1260

Scissor bite

873

0.88

0.52

1.6

1231.28

953.67

mu/l

0.74

791

Disorders of puberty, all

100

1109

0.89

0.51

1.6

1075.70

972.19

mu/l

0.46

997

Benign neoplasm: Sigmoid colon

500

0.84

0.51

1.8

1.6

1020.90

1011.93

mu/l

0.02

392

Benign neoplasm: Choroid

391

0.82

0.51

1.7

1.6

828.87

973.39

mu/l

0.88

319

Abnormal findings on diagnostic imaging of central nervous system

112

1240

0.90

0.51

1.6

1161.42

1008.31

mu/l

0.73

1037

Premenstrual syndrome

128

1170

1.12

0.51

1.5

1.6

1015.11

1033.65

mu/l

0.08

101

954

Ovarian dysfunction

859

8315

1.04

0.51

1.5

1.6

897.70

1006.50

mu/l

3.65

744

7134

Exclusion endpoint for supernumerary teeth

549

0.84

0.51

1.5

1.6

1072.98

945.45

mu/l

0.29

481

Cluster headache, wide

102

1134

0.89

0.50

1.5

1.6

1057.66

1025.12

mu/l

0.10

942

Other rupture of muscle

136

1.35

0.50

1.7

1342.18

999.10

mu/l

0.69

116

Left ventricular outflow tract obstruction, narrow definition

723

0.87

0.50

1.4

1.6

1032.25

983.22

mu/l

0.23

615

Hypothyroidism and >3 levothyroxin purchases

2164

11857

1.03

0.50

1.6

956.63

1029.30

mu/l

1.98

1866

10318

Hypothyroidism, levothyroxine purchases

2164

11857

1.03

0.50

1.6

956.63

1029.30

mu/l

1.98

1866

10318

Cleft palate

537

0.84

0.50

1.6

1139.22

973.05

mu/l

0.36

456

Anterior Iridocyclitis

340

3601

0.94

0.50

1.5

1.6

913.40

996.54

mu/l

1.19

283

3009

Other endocrine disorders

198

2040

0.92

0.50

1.7

1.6

1143.96

968.59

mu/l

1.37

171

1798

Need for other prophylactic measures

648

0.86

0.50

1.5

1.6

850.73

999.27

mu/l

0.55

534

Faecal incontinence

792

1.13

0.50

1.7

1.5

1053.17

1049.55

mu/l

0.01

650

Glucosamine medication

224

0.78

0.49

1.4

1.5

1360.46

1013.02

mu/l

0.47

169

Foreign body in alimentary tract

1007

0.89

0.49

1.6

941.19

1000.60

mu/l

0.25

869

Pneumonia due to other infectious organisms, not elsewhere classified

367

0.81

0.49

1.4

1.6

1220.39

1028.91

mu/l

0.33

297

Gingival hyperplasia

657

0.86

0.49

1.6

1634.73

998.79

mu/l

0.68

557

Ulcerative ileocolitis

953

0.89

0.49

1.7

1.6

1110.59

1023.29

mu/l

0.28

782

Other mycoses, not elsewhere classified/unspecified, including avohilmo

420

0.82

0.49

1.5

1.6

926.20

936.06

mu/l

0.03

356

Chronic suppurative otitis media

126

1383

0.91

0.49

1.5

1.6

921.78

1019.35

mu/l

0.51

101

1174

Mucosal proctocolitis

354

3738

0.94

0.49

1.6

1134.64

1006.96

mu/l

1.30

298

3165

Malignant neoplasm of urinary organs, including Hilmo

201

0.75

0.49

1.8

1.6

1272.27

960.52

mu/l

—

167

Acute pancreatitis (for exclusion)

148

1614

0.92

0.48

1.6

891.63

1016.14

mu/l

1.13

115

1329

Conotruncal defects

397

0.82

0.48

1.5

1.6

1138.57

950.37

mu/l

0.35

339

Other benign neoplasms of connective and other soft tissue

139

1519

0.91

0.48

1.4

1.6

954.58

1041.38

mu/l

0.52

116

1260

Other disorders starting during childhood or adolescence

347

3615

0.94

0.48

1.6

1108.91

971.31

mu/l

1.42

304

3190

Acanthosis nigricans

118

0.66

0.48

1.5

1.6

907.22

928.39

mu/l

—

100

Benign neoplasm: salivary glands, exclude unknown (D119)

742

0.87

0.48

1.6

977.04

1004.65

mu/l

0.09

613

Unspecified misadventure during surgical and medical care

699

0.87

0.48

1.6

844.48

1004.37

mu/l

1.46

575

Postprocedural disorders of digestive system, not elsewhere classified

322

0.80

0.48

1.4

1.6

975.19

991.55

mu/l

0.04

263

Other juvenile arthritis

236

2514

0.93

0.48

1.6

949.51

1004.36

mu/l

0.45

199

2189

Injury of eye and orbit

387

3675

1.06

0.48

1.5

1.6

1023.31

1001.05

mu/l

0.17

320

3146

Malignant melanoma of skin

700

1.13

0.47

1.4

1.6

866.07

1025.17

mu/l

0.92

563

Other congenital malformations of skin

112

1233

0.90

0.47

1.6

938.98

985.60

mu/l

0.25

103

1057

Viral conjunctivitis

646

1.14

0.47

1.6

933.79

978.18

mu/l

0.14

548

Other diseases of biliary tract

474

0.84

0.47

1.6

919.52

1012.67

mu/l

0.20

388

Congenital ptosis

103

1.40

0.47

1.3

1.6

931.92

885.61

mu/l

0.10

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

155

1.30

0.47

1.2

1.6

999.65

945.24

mu/l

0.08

126

Subarachnoid haemorrhage

387

0.83

0.47

1.4

1.5

776.09

1013.43

mu/l

1.60

310

Viral meningitis, including avohilmo

144

1324

1.10

0.47

1.6

930.39

1002.32

mu/l

0.51

130

1115

Other osteochondropathies

134

1463

0.91

0.47

1.5

1.6

1004.52

1021.80

mu/l

0.07

111

1227

Mucinous and mucinous cystic tumor

0.60

0.47

1.6

1.5

984.30

908.96

mu/l

—

Cystic kidney disease

483

0.84

0.47

1.6

1024.13

971.71

mu/l

0.14

402

Symptoms and signs involving speech and voice

503

5260

0.95

0.47

1.5

1.6

1133.46

1005.22

mu/l

1.48

414

4339

Congenital malformations, deformations and chromosomal abnormalities

2609

25190

0.98

0.47

1.6

1045.59

1012.76

mu/l

0.88

2247

21336

Caries of dentine, including avohilmo

2006

10488

0.98

0.46

1.6

968.08

1058.67

mu/l

3.60

1673

8984

Benign neoplasm: Other parts of oropharynx

183

1.28

0.46

1.4

1.6

819.70

974.44

mu/l

0.62

153

Iridocyclitis

400

4203

0.95

0.46

1.5

1.6

922.80

995.43

mu/l

1.11

340

3520

Eclampsia

122

1.37

0.46

1.6

1.7

1109.55

948.55

mu/l

0.27

105

Other vitreous opacities

496

1.15

0.46

1.7

1.6

1222.90

995.57

mu/l

0.80

410

Anogenital herpesviral [herpes simplex] infection, including avohilmo

927

8997

1.04

0.45

1.6

980.93

1006.49

mu/l

0.37

754

7750

Disorders of muscles

208

2227

0.93

0.45

1.6

1060.33

1016.06

mu/l

0.29

167

1874

Dental operations

1098

5474

1.03

0.45

1.6

1.5

1002.14

1058.58

mu/l

0.90

897

4580

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

319

0.81

0.45

1.3

1.6

1296.87

960.24

mu/l

0.58

271

Congenital malformations of the urinary system, including avohilmo

176

1634

1.08

0.45

1.6

1026.75

982.23

mu/l

0.27

159

1419

Presence of other devices

205

2162

0.93

0.45

1.4

1.6

982.37

1027.64

mu/l

0.34

169

1790

Parasetamol

3443

17109

1.02

0.45

1.6

952.82

1045.05

mu/l

5.55

2886

14742

Other female pelvic inflammatory diseases

438

4585

0.95

0.45

1.6

905.86

1004.44

mu/l

1.50

344

3832

Contusion of other and unspecified parts of foot

226

2407

0.93

0.45

1.6

939.86

994.73

mu/l

0.32

192

2088

Cardiomyopathy

652

0.87

0.44

1.5

1.6

868.34

1022.60

mu/l

0.67

533

Benign neoplasm: Adrenal gland

330

0.82

0.44

1.5

1058.98

1041.68

mu/l

0.03

264

Viral infections of the central nervous system, including avohilmo

205

1915

1.07

0.44

1.6

908.73

1010.22

mu/l

1.16

184

1601

FESS (DNB20)

261

2457

1.07

0.44

1.5

1.6

964.85

1008.44

mu/l

0.29

211

2029

Lactose intolerance

945

0.89

0.44

1.5

1.6

1008.46

1000.33

mu/l

0.03

811

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

141

1532

0.92

0.44

1.6

1041.06

1018.46

mu/l

0.10

111

1239

Meralgia paraesthetica

405

0.84

0.44

1.5

1.6

941.33

992.51

mu/l

0.11

333

Seronegative juvenile rheumatoid arthritis

116

1263

0.90

0.44

1.5

1.6

875.84

971.86

mu/l

0.75

1098

Diphyllobothriasis and sparganosis

0.00

0.44

0.0

1.7

—

797.79

—

Other congenital malformations of kidney

0.64

0.44

2.0

1.6

2107.39

934.60

mu/l

—

Caries in Clefts patients

487

0.85

0.43

1.5

1.6

1108.36

947.04

mu/l

0.31

416

Endometriosis ASRM stages 3,4

888

9158

0.97

0.43

1.4

1.6

963.89

1020.50

mu/l

1.06

735

7540

Ankylosing spondylitis, ICD10

138

1498

0.92

0.43

1.6

1029.41

1017.68

mu/l

0.04

121

1223

Other specified and unspecified retinal disorders

303

1.19

0.43

1.5

1.6

944.86

1015.95

mu/l

0.18

256

Intercostal neuropathy

0.65

0.43

1.5

1.6

871.60

893.85

mu/l

—

Heterophoria

342

3253

1.06

0.43

1.6

1021.17

997.43

mu/l

0.17

297

2800

Other misadventures during surgical and medical care

378

1.17

0.43

1.5

1.6

1073.28

955.47

mu/l

0.23

310

Microcephaly

0.00

0.43

0.0

1.5

—

745.92

—

Drug-induced systemic lupus erythematosus

0.62

0.43

1.8

1.6

1141.12

917.86

mu/l

—

Family history of mental and behavioural disorders

115

1.37

0.42

1.7

1.6

934.22

971.68

mu/l

0.07

101

Other and unspecified syphilis, including avohilmo

1.58

0.42

2.0

1.5

1274.08

856.86

mu/l

—

Asthma and allergy

798

8125

0.97

0.42

1.6

987.78

1029.21

mu/l

0.64

672

7090

Foreign body in respiratory tract

105

1151

0.91

0.42

1.5

1.6

1084.92

1013.53

mu/l

0.39

985

Cytomegaloviral disease, including avohilmo

294

0.81

0.42

1.3

1.6

1319.82

910.47

mu/l

0.79

246

Other epidermal thickening

732

0.88

0.42

1.4

1.6

775.18

961.50

mu/l

1.34

621

Neuralgic amyotrophy

0.00

0.41

0.0

1.7

—

1208.61

—

Other and unspecified disorders of white blood cells

509

0.86

0.41

1.7

1.6

908.73

989.95

mu/l

0.32

413

Post-traumatic wound infection, not elsewhere classified

423

0.85

0.41

1.5

1.6

1183.56

948.07

mu/l

0.68

366

Sequelae of hyperalimentation

1.51

0.41

1.8

1.6

444.36

1114.40

mu/l

—

Other localized connective tissue disorders

358

0.83

0.41

1.3

1.6

1032.82

943.86

mu/l

0.28

301

Other disorders of conjunctiva

1036

0.91

0.41

1.7

1.6

860.45

1034.30

mu/l

1.30

848

Helminthiases

399

1.16

0.41

1.5

1.6

818.19

937.85

mu/l

0.44

346

Vitreous prolapse

0.00

0.41

0.0

1.6

—

948.62

—

Adenocarcinomas of cervix

148

0.73

0.40

1.4

1.5

1098.69

973.16

mu/l

0.17

122

Burn and corrosion of hip and lower limb, except ankle and foot

655

0.88

0.40

1.6

1002.67

970.39

mu/l

0.12

555

Presbyopia

315

0.82

0.40

1.5

1.4

1089.05

1209.73

mu/l

0.23

208

Drug-induced fever

0.00

0.40

0.0

1.6

—

805.91

—

Enteropathogenic Escherichia coli infection

1.33

0.40

1.4

1.6

1179.86

771.20

mu/l

—

Chondromalacia

368

0.84

0.40

1.4

1.6

1050.85

1001.73

mu/l

0.10

294

Hypermetropia

222

2088

1.07

0.40

1.5

1.6

1170.50

971.55

mu/l

0.98

199

1833

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

194

0.77

0.40

1.8

1.6

1272.27

959.72

mu/l

—

160

Other or ill-defined heart diseases

518

0.87

0.40

1.6

989.68

999.08

mu/l

0.02

438

AV-block

543

0.88

0.40

1.6

789.66

966.40

mu/l

0.90

463

Cardiomyopathies, Primary/intrinsic

347

0.83

0.40

1.5

1.6

783.80

1025.02

mu/l

0.87

290

Other drug-induced secondary parkinsonism

0.00

0.40

0.0

1.6

—

908.71

—

Colorectal cancer, including Hilmo

523

0.87

0.40

1.6

1.5

986.54

973.84

mu/l

0.03

414

Malignant melanoma of skin, including Hilmo

815

1.11

0.40

1.4

1.6

861.43

1032.71

mu/l

1.14

655

Erythema nodosum

665

0.88

0.40

1.5

1.6

903.91

990.95

mu/l

0.25

557

Graves ophthalmopathy

409

1.16

0.40

1.4

1.6

1149.77

994.52

mu/l

0.31

333

Eccrine sweat disorders

1.45

0.40

1.2

1.6

989.56

861.90

mu/l

—

Allergic urticaria

295

3103

0.95

0.39

1.6

1017.97

993.46

mu/l

0.17

250

2643

Residual foreign body in soft tissue

106

1157

0.91

0.39

1.5

1.6

931.43

1021.23

mu/l

0.54

998

Spontaneous rupture of synovium and tendon

560

0.87

0.39

1.4

1.6

815.13

1019.30

mu/l

1.29

455

Pathological resorption of teeth

843

0.90

0.39

1.6

1080.14

1013.56

mu/l

0.18

720

Candidiasis

453

4348

1.04

0.39

1.6

1004.95

1005.76

mu/l

0.01

370

3640

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

918

0.90

0.39

1.6

892.16

971.35

mu/l

0.45

826

Contusion of toe(s) with damage to nail

387

0.84

0.39

1.4

1.6

981.69

963.03

mu/l

0.04

336

Asthma and allergy, excluding more controls

798

8114

0.97

0.39

1.6

987.78

1028.87

mu/l

0.64

672

7083

Other congenital malformations of face and neck

116

1069

1.09

0.39

1.5

1.6

857.30

1005.10

mu/l

1.62

905

Sequelae with surgical and medical care as external cause

245

2592

0.94

0.39

1.5

1.6

965.40

1006.51

mu/l

0.29

201

2163

Hypertrophy of tongue papillae

236

0.80

0.38

1.5

1.6

1126.14

936.94

mu/l

—

203

Congenital malformations of ear causing impairment of hearing

168

0.75

0.38

1.6

996.05

894.82

mu/l

0.23

143

Septal defects

166

1738

0.93

0.38

1.5

1.6

1190.96

980.69

mu/l

1.48

138

1506

Behçet disease

1.33

0.38

1.2

1.5

1450.32

976.70

mu/l

—

Separation of retinal layers (serosa)

224

1.21

0.38

1.4

1.5

704.38

1043.67

mu/l

1.59

178

Congenital malformations of the urinary system

162

1513

1.08

0.38

1.6

1039.78

979.27

mu/l

0.37

145

1308

Congenital lactase deficiency

121

0.72

0.38

1.6

1.5

1315.24

982.96

mu/l

—

103

Isolated patent ductus arteriosus

484

0.86

0.38

1.5

1.6

1121.61

938.24

mu/l

0.51

430

Personal history of medical treatment

224

0.79

0.37

1.3

1.6

600.06

916.92

mu/l

1.70

193

Conjunctivitis (acute, non atopic)

1054

10227

1.03

0.37

1.6

1003.15

1008.88

mu/l

0.05

862

8805

Appendectomy

2293

22192

0.98

0.37

1.6

1037.31

1015.39

mu/l

0.28

1882

18652

Impacted cerumen

104

953

1.09

0.37

1.5

1.6

831.49

1014.46

mu/l

2.00

816

Paracetamol or NSAID medication

826

4043

1.03

0.37

1.6

971.22

1089.19

mu/l

3.33

720

3530

Immunodeficiencies

902

0.91

0.37

1.5

1.6

1268.89

1013.68

mu/l

1.04

741

Other infective otitis externa

109

1183

0.92

0.37

1.5

1.6

902.76

1014.04

mu/l

0.77

995

Pain in thoracic spine

380

3965

0.96

0.36

1.5

1.6

1014.55

1009.84

mu/l

0.03

311

3345

Cleft lip, lip and palate or palate

637

0.88

0.36

1.5

1.6

1082.18

998.14

mu/l

0.20

535

Keratitis

894

9187

0.97

0.36

1.6

1069.52

1017.07

mu/l

0.61

739

7754

Ptosis of eyelid

619

0.89

0.36

1.6

863.81

1003.37

mu/l

0.65

499

Disease of hard tissues of teeth, NOS

1076

5487

1.03

0.36

1.6

980.16

1019.35

mu/l

0.53

875

4651

conjunctival haemorrhage

385

0.86

0.36

1.6

926.62

971.37

mu/l

0.13

316

Viral meningitis

131

1219

1.08

0.35

1.6

945.85

995.42

mu/l

0.30

118

1029

Foreign body in genitourinary tract

308

0.83

0.35

1.4

1.6

1009.01

987.60

mu/l

0.05

258

Other protozoal intestinal diseases

424

1.14

0.35

1.4

1.6

1022.75

1011.49

mu/l

0.03

349

Endometriosis of rectovaginal septum and vagina

251

2385

1.06

0.35

1.4

1.6

908.46

1041.84

mu/l

1.31

202

1947

Benign neoplasm: Rectum, anus and anal canal

631

1.11

0.35

1.5

1.6

1082.48

1019.46

mu/l

0.24

506

Follicular cysts of skin and subcutaneous tissue

297

3113

0.95

0.35

1.5

1.6

954.84

1003.59

mu/l

0.44

235

2609

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

115

1241

0.92

0.35

1.4

1.6

1081.24

1028.93

mu/l

0.24

1040

Other immunodeficiencies

254

0.82

0.35

1.4

1.7

1013.99

952.68

mu/l

0.11

217

Ankyloglossia

1026

0.91

0.35

1.6

967.23

980.79

mu/l

0.05

921

Other and unspecified myoneural disorders

1.38

0.35

1.5

2112.20

934.45

mu/l

—

Other complications of surgical and medical care, not elsewhere classified

198

2097

0.94

0.35

1.5

1.6

995.82

1004.00

mu/l

0.04

166

1745

Fibrosarcoma

1.37

0.34

1.7

1.6

974.78

1178.86

mu/l

—

Inguinal or femoral hernia, bilateral

292

1.17

0.34

1.6

1299.51

966.12

mu/l

0.55

251

Other sexually transmitted chlamydial diseases, including avohilmo

1001

10240

0.97

0.34

1.5

1.6

1117.19

992.28

mu/l

1.79

848

8958

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

794

7722

1.03

0.34

1.5

1.6

1006.95

1008.30

mu/l

0.01

643

6446

Ethmoidectomy

262

2494

1.05

0.34

1.5

1.6

964.85

1007.52

mu/l

0.28

211

2061

Toxic effect of other noxious substances eaten as food

0.67

0.34

1.5

1.6

606.70

928.00

mu/l

—

Toxic effect of alcohol

286

0.83

0.34

1.7

893.29

923.23

mu/l

0.09

255

Nutritional anaemias

985

9155

1.03

0.34

1.7

1.6

1040.80

1011.23

mu/l

0.36

816

7690

Otitis externa

585

6040

0.97

0.34

1.5

1.6

978.67

1009.51

mu/l

0.10

487

5126

Use of cabergoline

497

0.88

0.33

1.5

1.6

985.90

991.55

mu/l

0.02

423

Other viral diseases, not elsewhere classified

520

5359

0.96

0.33

1.6

970.71

990.34

mu/l

0.20

430

4575

Exposure to other and unspecified inanimate mechanical forces

172

1826

0.94

0.33

1.6

982.98

1015.10

mu/l

0.17

131

1535

Disorders of myoneural junction and muscle in diseases classified elsewhere

0.69

0.33

1.5

1.6

1384.03

920.02

mu/l

—

Contact with hypodermic needle

420

0.86

0.33

1.6

750.05

955.80

mu/l

1.25

362

Sequelae of other and unspecified infectious and parasitic diseases

698

0.90

0.33

1.5

1.4

1052.22

1104.49

mu/l

0.17

511

Benign neoplasm of mouth and pharynx

112

1208

0.93

0.33

1.5

1.6

856.88

1007.77

mu/l

1.85

1001

Certain disorders involving the immune mechanism

226

2381

0.95

0.33

1.5

1.6

1118.74

1020.59

mu/l

0.70

176

1937

Colorectal cancer

448

0.88

0.33

1.6

1.5

1038.25

961.78

mu/l

0.16

355

Benign neoplasm of other and unspecified sites

349

0.86

0.32

1.5

1.6

1203.21

988.96

mu/l

0.39

292

Disorders of porphyrin and bilirubin metabolism

187

0.80

0.32

1.4

1.6

1006.51

938.41

mu/l

—

158

Suppurative and unspecified otitis media

2381

20768

1.02

0.32

1.6

972.05

1019.39

mu/l

0.85

2047

17769

Abnormal findings in nipple discharge synovial fluid wound secretions

348

0.85

0.32

1.5

1.6

1001.37

960.16

mu/l

0.11

299

Undetermined asthma, excluding more controls

278

2907

0.95

0.32

1.6

949.95

1012.74

mu/l

0.45

216

2493

Oesophagitis

455

0.88

0.32

1.5

1.6

777.78

943.37

mu/l

0.75

375

Benign neoplasm: Transverse colon

317

0.85

0.32

1.5

1.6

983.55

956.90

mu/l

0.06

256

Benign neoplasm of middle ear and respiratory system

550

0.89

0.32

1.4

1.6

876.08

1003.70

mu/l

0.51

449

Graves ophthalmopathy, strict

370

1.14

0.32

1.4

1.6

1144.87

998.95

mu/l

0.27

303

Spondylolisthesis/Spondylolysis

161

1711

0.94

0.32

1.5

1.6

978.76

1028.58

mu/l

0.26

132

1408

Other and unspecified injuries of abdomen, lower back and pelvis

571

1.11

0.32

1.6

945.05

978.42

mu/l

0.12

506

Pyoderma

273

0.84

0.32

1.6

878.15

1004.13

mu/l

0.36

228

Pyogenic arthritis

591

0.89

0.31

1.4

1.6

982.69

1000.56

mu/l

0.05

489

Malignant melanoma

857

1.09

0.31

1.5

1.6

876.04

1030.53

mu/l

1.07

689

Undetermined asthma

278

2904

0.95

0.31

1.6

949.95

1012.29

mu/l

0.44

216

2490

Viral pneumonia

224

2355

0.95

0.31

1.5

1.6

1017.95

993.83

mu/l

0.11

187

1999

Other congenital malformations of circulatory system

411

0.87

0.31

1.5

1.6

1238.61

961.32

mu/l

0.61

350

Benign neoplasm of major salivary glands

758

0.91

0.31

1.6

941.51

1003.70

mu/l

0.23

623

Patent foramen ovale

379

0.87

0.31

1.4

1.6

1361.58

936.28

mu/l

0.73

324

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1980

19262

1.02

0.31

1.6

1078.66

1015.03

mu/l

0.57

1537

16423

Viral agents as the cause of diseases classified to other chapters, including avohilmo

667

1.10

0.31

1.7

1.6

872.99

961.85

mu/l

0.44

557

Perioral dermatitis

106

1138

0.92

0.31

1.6

997.81

1019.92

mu/l

0.10

968

Mycoses

679

6604

1.03

0.31

1.6

965.77

1004.65

mu/l

0.58

561

5552

Inguinal hernia, bilateral

286

1.15

0.31

1.6

1317.29

960.33

mu/l

0.57

245

Benign neoplasm of bone and articular cartilage

178

1881

0.94

0.31

1.6

941.36

1011.46

mu/l

0.43

161

1563

Scleritis and episcleritis

119

1274

0.93

0.30

1.5

1.6

945.58

1031.65

mu/l

0.59

1038

Assault by other specified means

356

0.86

0.30

1.2

1.6

1115.36

953.79

mu/l

0.42

307

Superficial injury of neck

858

0.91

0.30

1.6

1063.26

1004.41

mu/l

0.22

728

Malignant neoplasm of pancreas, including Hilmo

131

0.76

0.30

1.7

1.6

553.76

941.24

mu/l

—

105

Allergic contact dermatitis

460

4755

0.96

0.30

1.5

1.6

993.71

1011.27

mu/l

0.14

378

4019

Benign neoplasm: Bones of skull and face

231

1.18

0.30

1.6

773.68

978.89

mu/l

0.94

197

Superficial injury of ankle and foot, unspecified

206

0.81

0.30

1.4

1.6

1389.67

958.61

mu/l

0.37

179

Distal bite

135

1258

1.07

0.30

1.6

1294.99

977.98

mu/l

0.87

120

1107

Mixed connective tissue disease

335

0.86

0.30

1.6

1017.18

947.96

mu/l

0.14

281

Benign neoplasm: Connective and other soft tissue of abdomen

1.27

0.30

1.6

702.39

1030.12

mu/l

—

Excessive attrition of teeth

2443

23832

1.02

0.30

1.6

990.15

1021.02

mu/l

0.89

2047

20170

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

703

0.91

0.30

1.5

1052.22

1104.49

mu/l

0.17

515

Contact with heat and hot substances

149

1404

1.07

0.30

1.7

1.6

1012.72

978.00

mu/l

0.19

126

1206

Cysts of oral region, not elsewhere classified

983

0.92

0.30

1.7

1.6

986.89

1001.41

mu/l

0.05

831

Congenital ovarian cysts

287

2758

1.05

0.29

1.5

1.6

1106.77

994.21

mu/l

1.15

246

2302

Other diseases of upper respiratory tract

3730

19197

1.01

0.29

1.6

987.14

1022.52

mu/l

1.19

3143

16415

Other/unspecified disorders of vestibular function

430

0.88

0.29

1.4

1.6

972.24

999.25

mu/l

0.08

355

Tracheo-bronchomalasia

151

0.78

0.29

1.6

1137.94

1000.47

mu/l

0.26

125

Anogenital herpesviral [herpes simplex] infection

431

4174

1.04

0.29

1.6

970.76

996.40

mu/l

0.24

345

3534

Viral infections of the central nervous system

179

1697

1.06

0.29

1.6

897.31

999.35

mu/l

1.06

160

1419

Episcleritis

104

1116

0.93

0.29

1.5

1.6

973.38

1029.13

mu/l

0.30

908

Other congenital malformations of heart

195

1.20

0.29

1.6

902.26

925.61

mu/l

0.05

174

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

323

3104

1.04

0.29

1.5

1.6

954.23

1006.29

mu/l

0.47

261

2620

Acquired absence of organs, not elsewhere classified

109

0.73

0.29

1.5

1.6

1251.96

1020.76

mu/l

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

3599

23825

0.99

0.29

1.6

967.29

1022.52

mu/l

1.91

3001

20205

Other and unspecified acute skin changes due to ultraviolet radiation

1.23

0.29

1.3

1.5

1524.93

1108.62

mu/l

—

Salpingitis and oophoritis

257

2684

0.96

0.28

1.4

1.6

1077.50

1009.85

mu/l

0.45

211

2203

Diseases of pulp and periapical tissues, including avohilmo

4022

21017

0.99

0.28

1.6

958.72

1027.12

mu/l

3.94

3376

17986

Congenital ptosis, including avohilmo

131

1.25

0.28

1.3

1.6

922.74

946.07

mu/l

0.05

118

Mandibular hypoplasia

224

1.18

0.28

1.3

1.6

1056.31

953.90

mu/l

0.32

186

Ovarian dysfunction: estrogen excess

0.67

0.28

2.0

1.5

719.10

1067.62

mu/l

—

Memory loss

355

0.87

0.28

1.8

1.6

1094.03

990.98

mu/l

0.23

303

Ulcer of vagina/vulva

130

1379

0.94

0.28

1.5

1.6

1083.29

997.90

mu/l

0.44

109

1187

Other congenital malformations of tongue, mouth and pharynx

735

0.91

0.28

1.5

1.6

921.49

954.96

mu/l

0.13

670

Benign neoplasm: Brain, infratentorial

118

0.75

0.28

1.8

1.5

1188.93

892.11

mu/l

—

Other bursitis of hip

205

0.83

0.28

1.4

1.6

812.17

990.38

mu/l

—

170

Fall on and from ladder

374

1.12

0.28

1.6

1.5

871.62

987.36

mu/l

0.30

320

Nontoxic multinodular goitre

146

1546

0.94

0.27

1.5

819.71

1073.64

mu/l

3.67

109

1213

Erosion and ectropion of cervix uteri

413

1.12

0.27

1.4

1.6

1045.21

977.02

mu/l

0.22

336

ILD differential diagnosis

2880

14607

0.99

0.27

1.6

998.86

1041.37

mu/l

1.23

2413

12527

Essential (haemorrhagic) thrombocythaemia

226

0.84

0.27

1.3

1.6

1269.26

904.81

mu/l

0.48

184

COPD differential diagnosis

2882

14617

0.99

0.27

1.6

998.80

1041.20

mu/l

1.23

2415

12536

Disorders of lacrimal system and orbit in diseases classified elsewhere

423

1.12

0.27

1.4

1.6

1149.77

1002.28

mu/l

0.29

344

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

584

0.90

0.27

1.5

1.6

988.34

1005.74

mu/l

0.05

472

Meningitis

895

0.92

0.27

1.6

974.25

991.58

mu/l

0.05

740

Burn and corrosion of head and neck

374

0.88

0.27

1.6

1007.17

972.83

mu/l

0.09

323

Excluding asthma or asthma-COPD overlap

2881

14610

0.99

0.27

1.6

1000.33

1042.49

mu/l

1.21

2414

12527

Other pulmonary diagnosis

2881

14610

0.99

0.27

1.6

997.37

1042.49

mu/l

1.35

2416

12527

Thyroiditis

209

1996

1.05

0.27

1.6

892.48

1015.35

mu/l

1.50

173

1662

Cytomegaloviral disease

268

0.85

0.27

1.3

1.6

1360.42

939.13

mu/l

0.77

224

Mental and behavioural disorders due to tobacco

147

1553

0.94

0.26

1.5

1.6

855.79

996.13

mu/l

1.59

129

1302

Open wounds involving multiple body regions

0.67

0.26

2.2

1.5

1717.14

916.90

mu/l

—

Other/unspecified mastoiditis and related conditions

0.69

0.26

2.2

1.7

968.54

936.42

mu/l

—

Sequelae of injuries of upper limb

148

1563

0.95

0.26

1.5

1.6

1070.82

1004.63

mu/l

0.35

123

1304

Malignant melanoma, including Hilmo

102

953

1.07

0.26

1.5

1.6

858.84

1045.22

mu/l

1.54

769

Palatinal maxillary canine

506

0.89

0.26

1.4

1.6

1018.19

952.33

mu/l

0.21

465

Benign neoplasm of eye and adnexa

105

1121

0.94

0.26

1.6

925.26

1028.24

mu/l

0.90

942

Other congenital malformations of female genitalia

805

1.09

0.26

1.6

959.10

985.05

mu/l

0.11

682

Lactose intolerance, other/unspecified

758

0.92

0.26

1.4

1.6

916.65

966.34

mu/l

0.19

648

Special screening examination for other diseases and disorders

333

3445

0.96

0.26

1.6

1007.27

1003.74

mu/l

0.02

305

2951

Benign neoplasm: Skin of eyelid, including canthus

130

1226

1.06

0.26

1.5

1.6

987.89

1034.00

mu/l

0.32

108

994

Malignant neoplasm of rectum, including Hilmo

141

1.21

0.26

1.4

1.5

1312.99

941.74

mu/l

0.47

110

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

115

1221

0.94

0.26

1.5

1.6

955.04

1004.25

mu/l

0.24

1034

Chronic suppurative otitis media, including avohilmo

166

1745

0.95

0.26

1.5

1.6

900.79

991.73

mu/l

0.64

137

1491

Viral warts, including avohilmo

898

8798

1.02

0.26

1.6

1060.65

1002.01

mu/l

0.77

766

7555

Amyloidosis

0.66

0.26

1.6

891.58

816.22

mu/l

—

Generalized epilepsy, strict definition

901

0.93

0.25

1.4

1.6

1116.05

985.38

mu/l

0.46

767

Varicella [chickenpox], including avohilmo

129

1364

0.94

0.25

1.7

1.6

1035.14

979.44

mu/l

0.17

108

1170

HSIL lesion of the cervix uteri, vagina or vulva

1462

14844

0.98

0.25

1.5

1.6

1029.04

1024.84

mu/l

0.05

1173

12380

Benign neoplasm: Parotid gland

654

0.92

0.25

1.4

1.6

995.61

983.97

mu/l

0.03

539

Disorders of puberty

991

0.93

0.25

1.6

1093.22

964.21

mu/l

0.58

894

Osteomalacia

142

1.21

0.25

1.3

1.6

972.17

945.48

mu/l

0.03

118

Idiopathic urticaria

941

0.93

0.25

1.6

870.21

998.21

mu/l

1.01

796

Car occupant injured in other and unspecified transport accidents

813

8301

0.98

0.25

1.5

1.6

967.90

1010.57

mu/l

0.63

657

7139

Excessive, frequent and irregular menstruation

2709

14625

0.99

0.25

1.6

1011.92

1030.30

mu/l

0.29

2261

12610

Problems related to social environment

879

0.93

0.24

1.5

1.6

778.18

983.29

mu/l

1.73

753

Other and unspecified disorders of orbit

0.73

0.24

2.2

1.6

1250.67

882.07

mu/l

—

Otosclerosis

549

0.91

0.24

1.5

1.6

877.72

1011.11

mu/l

0.97

445

Family history of other specific disorders

630

1.09

0.24

1.6

1005.72

973.01

mu/l

0.15

525

Iliotibial band syndrome

180

0.83

0.24

1.4

1.6

624.27

989.25

mu/l

—

142

Tuberculosis, IBD comorbidity

198

1.16

0.24

1.7

1.5

1087.72

1016.39

mu/l

0.14

160

Gonococcal infection, including avohilmo

569

0.91

0.24

1.5

1.6

1031.03

963.41

mu/l

0.21

494

Oral leukoplakia, including avohilmo

137

0.80

0.24

1.3

1.6

919.07

949.30

mu/l

—

114

Injury of muscle and tendon at ankle and foot level

523

1.10

0.24

1.5

1.6

997.63

1006.44

mu/l

0.03

436

Impetigo

167

1749

0.95

0.24

1.6

901.34

985.57

mu/l

0.74

144

1513

Campylobacter enteritis

475

1.10

0.24

1.6

881.87

974.56

mu/l

0.41

393

Pain associated with micturition

254

2446

1.04

0.24

1.6

1028.61

1002.26

mu/l

0.16

203

2077

Congenital nasolacrimal duct obstruction or stenosis

189

0.83

0.23

1.8

1.6

1147.58

931.45

mu/l

0.59

178

Other and unspecified disease of Bartholin gland

495

0.91

0.23

1.4

1.6

1315.70

986.65

mu/l

1.38

394

Malignant neoplasm of colon, including Hilmo

400

0.90

0.23

1.7

1.5

821.40

974.21

mu/l

0.53

316

Congenital malformations of great arteries

526

0.91

0.23

1.5

1.6

1043.72

932.01

mu/l

0.49

465

Shigellosis, including avohilmo

209

1.16

0.23

1.8

1.5

854.09

963.31

mu/l

0.35

186

Benign neoplasm: Skin, unspecified

562

1.09

0.23

1.5

1.6

881.12

1004.74

mu/l

0.69

463

Benign neoplasm: Skin of upper limb, including shoulder

296

0.87

0.23

1.7

1.6

1135.36

931.47

mu/l

0.47

259

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

843

0.92

0.23

1.6

1761.56

1015.16

mu/l

0.47

716

Smoking dependency

147

1545

0.95

0.23

1.5

1.6

855.79

999.19

mu/l

1.64

129

1294

Other and unspecified nail disorders

432

0.90

0.23

1.5

1.6

1045.31

973.57

mu/l

0.28

367

Other mosquito-borne viral fevers

1.30

0.23

1.4

1.6

668.28

975.24

mu/l

—

Lung transplantation

0.00

0.23

0.0

1.6

—

910.72

—

Cystic kidney disease, including avohilmo

567

0.91

0.23

1.6

1011.86

974.31

mu/l

0.12

473

Immunodeficiency following hereditary defective response to Epstein-Barr virus

0.00

0.23

0.0

1.3

—

893.97

—

Von Willebrand disease

458

1.10

0.23

1.8

1.6

786.75

997.10

mu/l

1.21

391

In situ neoplasms

1040

10584

0.98

0.23

1.5

1.6

1041.90

1019.01

mu/l

0.25

861

8939

Mastocytosis

0.74

0.23

2.3

1.7

1092.26

880.21

mu/l

—

Acute pharyngitis

932

9062

1.02

0.23

1.6

939.81

1007.98

mu/l

1.06

769

7965

Nummular dermatitis

918

0.94

0.22

1.6

1120.71

1034.89

mu/l

0.24

760

Congenital malformations of ovaries, fallopian tubes and broad ligaments

332

3222

1.04

0.22

1.5

1.6

1068.14

1005.13

mu/l

0.57

281

2702

Viral infections characterized by skin and mucous membrane lesions

1111

11285

0.98

0.22

1.6

1010.94

1006.31

mu/l

0.05

947

9613

Zoster [herpes zoster], including avohilmo

908

8597

1.02

0.22

1.5

1.6

1007.31

1011.57

mu/l

0.04

761

7260

Cytomegalovirus infection, IBD co-morbidity

242

0.86

0.22

1.2

1.6

1360.03

974.86

mu/l

0.60

205

Peutz-Jeghers syndrome

0.00

0.22

0.0

1.3

—

833.25

—

Chorioretinal inflammation

493

0.91

0.22

1.4

1.6

945.07

979.34

mu/l

0.10

411

Guttate psoriasis

357

0.89

0.22

1.6

979.51

970.11

mu/l

0.02

303

Injury of urinary and pelvic organs

284

0.88

0.22

1.5

1.6

1477.21

996.79

mu/l

1.09

239

Dislocation, sprain and strain of joint and ligaments of hip

389

0.90

0.22

1.5

1.6

1048.19

973.17

mu/l

0.19

325

Toxic effect of ethanol

128

1346

0.95

0.22

1.5

1.6

898.66

959.60

mu/l

0.43

111

1169

Other viral diseases, including avohilmo

1939

18966

1.01

0.22

1.6

963.09

1018.78

mu/l

1.89

1652

16250

Abscess of external ear

346

0.89

0.22

1.5

1.6

1122.93

973.65

mu/l

0.31

295

Bacterial meningitis

430

0.90

0.22

1.6

1008.23

1014.40

mu/l

0.01

347

Benign lipomatous neoplasm of other sites/unspecified

468

1.09

0.21

1.5

1.6

1103.88

972.05

mu/l

0.43

379

Alzheimer’s disease, strict definition

0.00

0.21

0.0

1.2

—

939.72

—

Exposure to noise

0.00

0.21

0.0

1.4

—

752.18

—

Benign neoplasm: Rectum

468

1.09

0.21

1.4

1.5

1162.98

1026.40

mu/l

0.43

373

D07AA Corticosteroids, weak (group I)

746

7305

1.02

0.21

1.6

971.97

1001.50

mu/l

0.41

643

6291

Pneumoconiosis due to other inorganic dusts

0.00

0.21

0.0

1.8

—

759.23

—

Other congenital malformations of skin, including avohilmo

298

2888

1.03

0.21

1.5

1.6

1054.72

996.76

mu/l

0.43

256

2459

Rare circulating lymphoid malignancy

0.00

0.21

0.0

1.5

—

904.99

—

Degeneration of the brain due to alcohol

0.00

0.21

0.0

1.3

—

1000.75

—

Degeneration of nervous system due to alcohol

0.00

0.21

0.0

1.3

—

1000.75

—

Otitis externa, unspecified

320

3298

0.97

0.21

1.5

1.6

876.97

999.54

mu/l

1.86

257

2781

Nontoxic diffuse goitre

325

0.89

0.21

1.2

1.5

794.51

1051.86

mu/l

0.91

259

Third [oculomotor] nerve palsy

103

0.77

0.21

1.3

1.6

1368.33

915.42

mu/l

—

Other obstructive and reflux uropathy

151

1578

0.95

0.21

1.6

1022.47

994.26

mu/l

0.17

132

1338

Disorders of eyelid in diseases classified elsewhere

595

1.08

0.21

1.6

947.84

1022.86

mu/l

0.27

494

Other and/or unspecified nontoxic goitre

750

0.93

0.21

1.5

982.76

1062.06

mu/l

0.37

597

Provisional assignment of new diseases of uncertain etiology

1939

18993

1.01

0.21

1.6

1058.35

1011.53

mu/l

0.41

1643

16152

Congenital malformations of breast

141

1350

1.06

0.21

1.5

1.6

1165.05

980.59

mu/l

1.35

117

1159

Down's syndrome

111

0.80

0.21

1.8

1.6

567.80

966.77

mu/l

—

Other disorders of the musculoskeletal system and connective tissue

144

1375

1.05

0.20

1.5

1.6

1181.84

1029.91

mu/l

0.99

118

1126

Benign lipomatous neoplasm of of intra-abdominal organs

0.00

0.20

0.0

1.4

—

1171.49

—

Acute epiglottitis

292

0.89

0.20

1.4

1.6

1080.99

1032.67

mu/l

0.09

235

Codes for special purposes

1940

19008

1.01

0.20

1.6

1058.35

1011.41

mu/l

0.41

1643

16166

Foreign body or object entering through skin

137

1434

0.95

0.20

1.7

1.6

952.36

986.30

mu/l

0.21

119

1224

Diseases caused by chlamydiae, including avohilmo

481

1.09

0.20

1.6

1062.29

949.27

mu/l

0.21

424

Infections with a predominantly sexual mode of transmission

1909

19255

0.99

0.20

1.6

1013.35

1014.69

mu/l

0.02

1555

16223

Benign neoplasm: Bladder

1.23

0.20

1.7

1.5

754.67

970.51

mu/l

—

Hallux rigidus

417

0.91

0.19

1.4

1.5

818.17

1051.89

mu/l

1.50

319

Peritonsillar abscess

935

9202

1.02

0.19

1.6

1005.64

1026.41

mu/l

0.24

773

7798

Accidental poisoning by and exposure to alcohol

899

0.94

0.19

1.6

880.99

959.35

mu/l

0.47

798

Other and unspecified mononeuropathies, also in other diseases

239

0.88

0.19

1.4

1.6

962.69

913.82

mu/l

0.15

202

Sacroiliitis, not elsewhere classified

234

2417

0.96

0.19

1.5

1.6

994.08

1014.18

mu/l

0.12

203

2052

Other diseases caused by chlamydiae, including avohilmo

492

1.08

0.19

1.5

1.7

1036.21

946.45

mu/l

0.16

433

Burn and corrosion confined to eye and adnexa

511

1.08

0.19

1.5

1.6

949.31

1006.29

mu/l

0.21

421

Special screening examination for neoplasms

385

0.91

0.19

1.5

1.6

1024.28

963.47

mu/l

0.17

312

Diseases of external ear

717

7302

0.98

0.19

1.5

1.6

957.60

1000.85

mu/l

0.19

601

6204

Use of peginterferon beta-1a

301

1.12

0.19

1.4

1.6

900.55

941.63

mu/l

0.15

254

Other effects of reduced temperature

1.25

0.19

1.9

1.6

1178.77

823.96

mu/l

—

Other bullous disorders

347

1.10

0.19

1.6

1155.97

942.80

mu/l

0.52

299

Increased muscle tone

206

0.86

0.19

1.5

1.7

685.28

935.37

mu/l

0.86

185

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

131

1253

1.05

0.18

1.6

1207.60

1038.17

mu/l

0.65

110

1023

Other benign neoplasm of uterus: Corpus uteri

128

1.18

0.18

1.9

1.6

700.61

975.47

mu/l

1.43

109

Other specified/unspecified dorsopathies

415

0.91

0.18

1.4

1.6

895.91

993.18

mu/l

0.29

333

Unspecified jaundice

311

0.90

0.18

1.5

1.6

998.83

1048.22

mu/l

0.10

263

Dermatitis herpetiformis

223

1.13

0.18

1.4

1.6

1060.04

964.31

mu/l

0.18

196

Sleepwalking [somnambulism]

194

0.86

0.18

1.4

1.6

713.02

963.31

mu/l

0.67

166

Benign neoplasm of breast

273

2652

1.03

0.18

1.6

1062.56

1003.68

mu/l

0.44

236

2212

Acquired pure red cell aplasia [erythroblastopenia]

1.17

0.18

1.4

1.6

1308.89

954.61

mu/l

—

Infectious mononucleosis, including avohilmo

644

6329

1.02

0.18

1.6

953.32

1002.13

mu/l

0.79

574

5499

Infectious mononucleosis

644

6329

1.02

0.18

1.6

953.32

1002.13

mu/l

0.79

574

5499

Other helminthiases, including avohilmo

1.16

0.18

1.4

1.5

836.16

948.32

mu/l

—

Benign lipomatous neoplasm

285

2932

0.97

0.18

1.5

1.6

1030.34

1005.08

mu/l

0.17

225

2403

Diseases of tongue

938

0.95

0.18

1.6

1.5

879.03

1003.36

mu/l

0.67

812

Viral pneumonia (unknown virus, not influenza)

154

1481

1.04

0.18

1.5

1.6

920.28

1011.34

mu/l

0.81

129

1268

HSIL lesion of the vagina

268

0.89

0.17

1.2

1.6

1578.47

1011.21

mu/l

0.91

214

Sequelae of infectious and parasitic diseases

723

0.94

0.17

1.5

1048.11

1094.16

mu/l

0.15

531

Zoster [herpes zoster]

201

2079

0.97

0.17

1.5

1.6

939.61

1000.63

mu/l

0.50

168

1744

Polyglandular dysfunction

0.74

0.17

1.8

1.6

734.88

931.00

mu/l

—

Covid-19 suspected case

991

10049

0.98

0.17

1.5

1.6

1128.92

1000.57

mu/l

0.65

808

8611

Osteitis due to dental implant

1.13

0.17

1.0

1.7

825.66

798.88

mu/l

—

Glaucoma suspect

193

1996

0.97

0.17

1.4

1.6

1044.54

1031.31

mu/l

0.05

143

1616

Suppurative otitis media, unspecified

132

1267

1.05

0.17

1.6

1.7

952.63

971.99

mu/l

0.09

119

1124

Ulcerative proctitis

192

1985

0.96

0.17

1.6

1090.78

1014.62

mu/l

0.47

156

1646

Simple and mucopurulent chronic bronchitis

205

0.88

0.17

1.7

1.6

1177.68

951.90

mu/l

0.41

170

Hereditary retinal dystrophy

205

1.13

0.17

1.6

1093.62

961.74

mu/l

0.27

167

Assault by blunt object

309

0.90

0.17

1.4

1.5

796.29

961.61

mu/l

0.46

266

Malignant neoplasm of adrenal gland

0.72

0.17

1.4

1.6

652.92

825.76

mu/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

516

5262

0.98

0.17

1.6

1127.53

1006.65

mu/l

1.65

439

4441

Benign neoplasm: Stomach

351

0.91

0.17

1.6

1.5

1033.43

1017.86

mu/l

0.04

274

Colour vision deficiencies

0.71

0.17

2.0

1.6

623.52

959.39

mu/l

—

Motor- or nonmotor-vehicle accident in traffic area

244

1.12

0.17

1.4

1.6

1251.66

960.76

mu/l

1.13

211

Exposure to other and unspecified animate mechanical forces

124

1292

0.96

0.17

1.6

982.87

983.00

mu/l

0.00

1115

Other diseases of oesophagus

742

0.94

0.17

1.4

1.6

2426.09

1004.55

mu/l

0.51

613

Ulcerative rectosigmoiditis

190

1964

0.97

0.17

1.7

1.6

1130.20

1010.86

mu/l

0.77

158

1630

Other appendicitis

142

1476

0.96

0.16

1.6

915.19

1032.64

mu/l

0.77

113

1225

Other spirochaetal diseases, including avohilmo

554

5437

1.02

0.16

1.6

934.48

1013.18

mu/l

1.60

450

4530

Congenital malformations of breast, including avohilmo

155

1498

1.04

0.16

1.5

1.6

1200.80

993.92

mu/l

1.66

130

1293

Inflammatory disease of cervix uteri

772

0.94

0.16

1.6

995.07

1028.56

mu/l

0.13

620

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS